脳神経外科 周術期管理のすべて 第5版

出版社: メジカルビュー社
著者:
発行日: 2019-05-30
分野: 臨床医学:外科  >  脳神経外科学
ISBN: 9784758318495
電子書籍版: 2019-05-30 (第5版第2刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:約3営業日

11,000 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

11,000 円(税込)

商品紹介

第4版が2014年に刊行されてから5年が経とうとしている。その間の脳神経外科の進歩、ガイドラインの改訂、また脳神経外科を取り巻く環境の変化を踏まえて本書を改訂。また,「第I章 周術期における医療安全」では、「災害時の対策」の項を追加して、昨今頻発する災害に対して何をすべきかについて解説。
脳神経外科医をはじめ,周術期管理に携わるスタッフ必携の書籍である。

目次

  • I 周術期における医療安全
     医療安全管理とインフォームド・コンセント
     器機の洗浄・滅菌
     災害時の対策

    II 脳血管障害
     脳動脈瘤:くも膜下出血
     脳動脈瘤:未破裂
     脳内出血(高血圧性,特発性)
     脳動静脈奇形,硬膜動静脈瘻
     もやもや病
     脳梗塞:内科的治療
     脳梗塞:外科的治療
     頚動脈病変
     脳血管内治療
     遺伝子異常の検索の意義

    III 脳腫瘍
     脳実質性悪性腫瘍:成人
     脳実質性悪性腫瘍:小児
     間脳下垂体腫瘍
     聴神経腫瘍
     頭蓋底腫瘍
     転移性脳腫瘍
     放射線治療,化学療法:成人
     放射線治療,化学療法:小児
     覚醒下手術
     遺伝子異常の検索の意義

    IV 頭部外傷
     総論
     急性頭蓋内損傷
     慢性硬膜下血腫(成人型)
     広範性(びまん性)脳損傷
     骨折,髄液漏,顔面損傷
     小児の頭部外傷・虐待
     スポーツ頭部外傷

    V 脊髄・脊椎疾患
     脊髄・脊椎疾患

    VI 小児(新生児,乳児)
     総論
     水頭症
     先天性疾患
     血管疾患
     脊髄・脊椎疾患
     小児頭蓋内感染症
     先天性奇形の遺伝子検索の意義

    VII 感染症
     術後呼吸管理
     中枢神経系の炎症性疾患

    VIII 機能的脳神経外科
     てんかんの外科
     三叉神経痛,顔面痙攣
     ニューロモデュレーション:DBS とSCS を中心に

    IX 救急疾患
     救急処置
     人工呼吸管理

    X 症候
     痙攣,急性症候性発作,てんかん,外傷性てんかん
     頭痛
     意識障害,脳ヘルニア,脳死
     術中動脈損傷
     術中静脈損傷
     電解質異常
     DIC,悪性高熱,悪性症候群,輸血後合併症
     術後肺血栓塞栓症
     低髄液圧症(脳脊髄液減少症,脳脊髄液漏出症)
     特発性正常圧水頭症

    XI 検査・治療
     脳血管撮影
     ガンマナイフ治療,サイバーナイフ治療
     神経内視鏡治療(水頭症,脳室内腫瘍)
     CT・MRIガイド下手術,術中マッピング
     術中モニタリング(MEP,VEP)
     PET,SPECT,NIRS
     MRI

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[I] 周術期における医療安全

P.8 掲載の参考文献
1) Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991 ; 324 : 370-6.
2) Houkin K, Baba T, Minamida Y, et al. Quantitative analysis of adverse events in neurosurgery. Neurosurgery 2009 ; 65 : 587-94 ; discussion 94.
3) 宝金清博. 脳神経外科診療のリスク. 脳神経外科リスクマネジメント, 中外医学社, 東京, 2005, p 15-25.
4) 中島和江. 専門医の安全を支えるノンテクニカルスキル. 神経治療 2012 ; 29 : 295-8.
5) University of Aberdeen. The Non-Technical Skills for Surgeons (NOTSS) System Handbook vo1.2, 2006.
6) World Health Organization. WHO guidelines for safe surgery : 2009 : safe surgery saves lives, 2009.
P.16 掲載の参考文献
1) プリオン病及び遅発性ウイルス感染症に関する調査研究班. 2008.
2) 岸田日帯. 【プリオン病-up to date】ヒトのプリオン病 洗浄・滅菌法の現状と展望. Clinical Neuroscience 2013 ; 31 : 1041.
3) 浜口毅.【プリオン病-up to date】獲得性 (感染性) プリオン病 硬膜移植後Creutzfeldt-Jakob病. Clinical Neuroscience 2013 ; 31 : 1071.
4) 日詰正樹. 【プリオン病-up to date】ヒトのプリオン病 わが国のサーベイランス体制. Clinical Neuroscience 2013 ; 31 : 1039.
5) プリオン病のサーベイランスと感染予防に関する調査研究班, 特定疾患治療研究事業による臨床調査個人票等をもとにしたプリオン病のサーベイランス結果. 2013.
6) 山田正仁. プリオン病の二次感染. NEUROINFECTION 2007 ; 12 : 74.
7) Will RG. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982 ; 45 : 235.
8) Foncin JF, Gaches J, Cathala F, et al. Transmission iatrogene interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet (Abstract). Rev Neurol (Paris) 1980 ; 136 : 280.
9) Nevin S, et al. Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). Brain 1960 ; 83 : 519.
10) Bernoulli C. Danger of accidental person-toperson transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977 ; 1 : 478.
11) 齊藤延人, 太組一朗.【プリオン病-up to date】ヒトのプリオン病 インシデント対策と2次感染予防. Clinical Neuroscince 2013 ; 31 : 1044.
12) 齋藤祐平. 単回使用器材の再使用. 医療関連感染 2008 ; 1 : 45.
13) 小林寛伊. シングルユース (単回使用) 器材の再滅菌使用に関する調査 2. 病院サプライ 2003 ; 8 : 22.
14) 中村好一. 【プリオン病-up to date】ヒトのプリオン病 わが国と世界におけるプリオン病の疫学. Clinical Neuroscience 2013 ; 31, 1035.
15) Hamaguchi T. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J Neurol Neurosurg Psychiatry 2013 ; 84 : 1171.
16) https://www.mhlw.go.jp/file/04-Houdouhappyou-10802000-Iseikyoku-Shidouka/0000095986_1.pdf, accessed on Sep 25 2018
17) http://www.opho.jp/news/a5969c5fb0a967de06f6718951918804298bd6dc.pdf, accessed on Sep 25, 2018
P.26 掲載の参考文献
1) 堀内義仁. 医療機関における「BCPマニュアル」作成の基本. 日本集団災害医学会誌 2015 ; 20 : 179-83.
2) 亀山元信, 庄子賢, 村田祐二, 他. 2011.3.11 その時当院では. 神経救急 2012 ; 24 : 41-6.
3) 小井戸雄一, 本間正人, 堀内義人, 他. BCPの考え方に基づいた病院災害対応計画作成の手引き. 平成24年度厚生労働科学研究班「東日本大震災における疾病構造と死因に関する研究」報告書, 2005. https://www.mhlw.go.jp/file/06-Seisakujouhou-10800000.../0000089048.pdf
4) 国土交通省 : 要配慮者利用施設の管理者等の避難確保計画の作成等の義務化について. www.mlit.go.jp/common/001189358.pdf
5) 国立大学法人東北大学病院 : 防災・業務継続計画 (略称 : 病院BCP) 第1版. www.hosp.tohoku.ac.jp/pc/pdf/bcp.pdf
6) 国際的組織犯罪等・国際テロ対策推進本部. 2020年東京オリンピック競技大会・東京パラリンピック競技大会等を見据えたテロ対策推進要綱. https://www.kantei.go.jp/jp/singi/sosikihanzai/20171211honbun.pdf
7) 厚生労働省医政局長. 災害拠点病院指定要件の一部改正について. 医政発第33号, 2017. https://www.mhlw.go.jp/web/t_doc?dataId=00tc2601&dataType=1&pageNo=1
8) 熊本赤十字病院. 熊本赤十字病院の活動記録 大震災の教訓と未来への提言-. 熊日出版, 熊本, 2017.
9) 國井修, 編. 災害時の公衆衛生. 南山堂, 東京, 2012.
10) 中川敦寛, 古川宗, 工藤大介, 他. 災害拠点病院の事業継続の見地からみたエレベーターの現状と課題-東日本大震災宮城県災害拠点病院調査-. 日本集団災害医学会誌 2013 ; 18 : 9-17.
11) 中山伸一. 災害時の医療活動 EMIS. 救急医学 2016 ; 40 : 279-87.
12) 災害対策基本法. http://www.bousai.go.jp/taisaku/kihonhou/index.html
13) 佐々木宏之, 山内 聡, 江川新一. 東日本大震災被災地医療機関における「受援計画」に関するアンケート調査報告. 日本集団災害医学会誌 2015 ; 20 : 40-50.
14) 佐々木勝. 病院のBCP災害時の医療継続のために. 新興医学出版社, 東京, 2014.
15) 消防法. http://elaws.e-gov.go.jp/search/elawsSearch/elaws_search/lsg0500/detail?lawId=323AC1000000186&openerCode=1
16) 総務省消防庁 東海地震に係る広域的な地震防災体制のあり方研究会. 東海地震にかかる広域的な地震防災体制のあり方に関する調査検討報告書. 2003. www.hiroi.iii.u-tokyo.ac.jp/index-iinkai-jishinbosai-tokai-koiki-hokokusho.pdf
17) 東京都福祉保健局. 大規模地震発生時における災害拠点病院の事業継続計画 (BCP) 策定ガイドライン. www.fukushihokenn.metro.tokyo.jp/iryo/kyuukyuu/saigai/zigyoukeizokukeikaku.files/honbunn.pdf
18) 山口芳裕, 中島幹男. NBC災害に備える 発災後, 安全に受け入れるための医療現場マニュアル. 羊土社, 東京, 2018.

[II] 脳血管障害

P.47 掲載の参考文献
1) Naganuma M, Fujioka S, Inatomi Y, et al. Clinical characteristics of subarachnoid hemorrhage with or without headache. J Stroke Cerebrovasc Dis 2008 ; 17 : 334-9.
2) Horiuchi T, Yamamoto Y, Kuroiwa M, et al. Pontine infarction caused by medial branch injury of the basilar artery as a rare complication of cisternal drain placement : Case report. J Clin Neurosci 2012 ; 19 : 592-3.
3) Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarcnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980 ; 6 : 1-9.
4) 堤圭治, 堀内哲吉, 本郷一博. 造影剤アレルギーを有する脳血管障害患者に対する直達手術. 脳卒中の外科 2017 ; 45 : 115-20.
5) Horiuchi T, Kusano Y, Yako T, et al. Ruptured anterior paraclinoid aneurysms. Neurosurg Rev 2011 ; 34 : 49-55.
6) 堀内哲吉, 本郷一博. くも膜下出血治療薬. 日本脳神経外科救急学 編. すぐに役立つ脳神経外科救急ハンドブック 改訂2版. メディカ出版, 大阪, 2015, p310-3.
7) Horiuchi T, Tanaka Y, Hongo K. Surgical treatment for aneurysmal subarachnoid hemorrhage in the 8th and 9th decades of life. Neurosurgery 2005 ; 56 : 469-75.
9) Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988 ; 68 : 985-6.
10) 堀内哲吉. 第II章 クリッピング術におけるモニタリングと基本手技, 4 クリップの選択と基本手技. 木内博之 編. プライム脳神経外科シリーズ 第1巻 脳動脈瘤.三輪書店, 東京, 2017, p42-7.
11) David CA, Vishteh AG, Spetzler RF, et al. Late angiographic follow-up review of surgically treated aneurysms. J Neurosurg 1999 ; 91 : 396-401.
12) Bendok BR, Gupta DK, Rahme RJ, et al. Adenosine for temporary flow arrest during intracranial aneurysm surgery : a single-center retrospective review. Neurosurgery 2011 ; 69 : 815-20.
13) Mori K, Yamamoto T, Nakao Y. Initial clinical experience of vasodilatory effect of intracisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2009 ; 49 : 139-44.
14) Rahmah NN, Horiuchi T, Kusano Y, et al. De novo aneurysm : case reports and literature review. Neurosurgery 2011 ; 69 : E761-7.
P.63 掲載の参考文献
1) Tominari S, Morita A, Ishibashi T, et al. Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol 2015 ; 77 (6) : 1050-9.
2) Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms : a pooled analysis of six prospective cohort studies. Lancet Neurol 2014 ; 13 (1) : 59-66.
3) Backes D, Rinkel GJE, Greving JP, et al. ELAPSS score for prediction of risk of growth of unruptured intracranial aneurysms. Neurology 2017 ; 88 (17) : 1600-6.
4) Etminan N, Rinkel GJ. Unruptured intracranial aneurysms : development, rupture and preventive management. Nat Rev Neurol 2016 ; 12 (12) : 699-713.
5) Brinjikji W, McDonald JS, Kallmes DF, et al. Rescue treatment of thromboembolic complications during endovascular treatment of cerebral aneurysms. Stroke 2013 ; 44 (5) : 1343-7.
6) Darsaut TE, Findlay JM, Magro E, et al. Surgical clipping or endovascular coiling for unruptured intracranial aneurysms : a pragmatic randomised trial. J Neurol Neurosurg Psychiatry 2017 ; 88 (8) : 663-8.
7) Shigematsu T, Fujinaka T, Yoshimine T, et al. Endovascular therapy for asymptomatic unruptured intracranial aneurysms : JR-NET and JR-NET2 findings. Stroke 2013 ; 44 (10) : 2735-42.
8) Toyooka T, Otani N, Wada K, et al. Head-up display may facilitate safe keyhole surgery for cerebral aneurysm clipping. J Neurosurg 2018 ; 129 (4) : 883-9.
9) Yamada M, Arai H. Predictive Value of Frailty Scores for Healthy Life Expectancy in Community-Dwelling Older Japanese Adults. J Am Med Dir Assoc 2015 ; 16 (11) : 1002 e7-11.
10) Kanaan H, Jankowitz B, Aleu A, et al. In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysms. Neurosurgery 2010 ; 67 (6) : 1523-32 ; discussion 32-3.
11) Morita A, Meyer FB. Perforating vessel preservation during aneurysm surgery. J Neurosurg 1996 ; 85 (6) : 1195-6.
12) Murai Y, Shirokane K, Kitamura T, et al. Aneurysm Tears Caused by an Aneurysm Clip Springing from the Clip Applier. Can J Neurol Sci 2017 ; 44 (3) : 326-8.
P.77 掲載の参考文献
1) 厚生労働省 人口動態調査 (2016年)
2) 松本圭蔵, 本藤秀樹. 脳内出血. Brain Nerve 1994 ; 46 : 105-17.
3) Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg 1994 ; 80 : 51-7.
4) Wada R, Aviv RI, Fox AJ, et al. CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007 ; 38 : 1257-62.
5) Sorimachi T, Osada T, Baba T, et al. The striate artery, hematoma, and spot sign on coronal images of computed tomography angiography in putaminal intracerebral hemorrhage. Stroke. 2013 ; 44 (7) : 1830-2.
6) Brouwers HB, Raff eld MR, van Nieuwenhuizen KM, et al. CT angiography spot sign in intracerebral hemorrhage predicts active bleeding during surgery. Neurology 2014 ; 83 : 883-9.
7) Miki K, Yagi K, Nonaka M, et al. Spot sign as a predictor of rebleeding after endoscopic surgery for intracerebral hemorrhage. J Neurosurg 2018 : 1-6.
8) Li Q, Zhang G, Xiong X, et al. Black Hole Sign : Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage. Stroke 2016 ; 47 : 1777-81.
9) Li Q, Zhang G, Huang YJ, et al. Blend Sign on Computed Tomography : Novel and Reliable Predictor for Early Hematoma Growth in Patients With Intracerebral Hemorrhage. Stroke 2015 ; 46 : 2119-23.
10) Morita N, Harada M, Yoneda K, et al. A characteristic feature of acute hematomas in the brain on echo-planar diffusion-weighted imaging. Neuroradiology 2002 ; 44 : 907-11.
11) 宇野昌明, 森田奈緒美, 原田雅史, 他. Stroke MRIと血栓溶解療法. 脳と循環 2008 ; 13 : 125-32.
12) Charidimou A, Linn J, Vernooij MW, et al. Cortical superficial siderosis : detection and clinical significance in cerebral amyloid angiopathy and related conditions. Brain 2015 ; 138 : 2126-39.
13) Boulouis G, van Etten ES, Charidimou A, et al. Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage. JAMA Neurol 2016 ; 73 : 1440-7.
14) Koga M, Toyoda K, Yamagami H, et al. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage : a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study). J Hypertens 2012 ; 30 : 2357-64.
15) Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage : A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015 ; 46 : 2032-60.
16) 日本脳卒中学会 脳卒中ガイドライン委員会 編. 第III章 2-2 血圧の管理. 脳卒中治療ガイドライン 2015. 協和企画, 東京, 2015.
17) Sakamoto Y, Koga M, Yamagami H, et al. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage : the stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study. Stroke 2013 ; 44 : 1846-51.
18) 有廣昇司, 豊田一則. 新たな視点からみた脳出血急性期管理 (1) 血圧は低いほどよいか. 分子脳血管病 2013 ; 12 : 251-5.
19) 金谷春之, 湯川英機, 神野哲夫, 他. 高血圧性脳出血における新しいNeurological GradingおよびCTによる血腫分類とその予後について. 高血圧性脳出血の外科 III. ニューロン社, 1978, p265-70.
20) 宇野昌明, 富田恵輔, 七條文雄, 他. 高血圧性小脳出血に対する外科的治療の選択. 特に定位的血腫吸引術の適応と特長. No Shinkei Geka 1988 ; 16 : 41-8.
22) Yao Z, Hu X, You C, He M. Effect and Feasibility of Endoscopic Surgery in Spontaneous Intracerebral Hemorrhage : A Systematic Review and Meta-Analysis. World Neurosurg 2018 ; 113 : 348-56.e342.
23) 安井信之. 高血圧性脳出血の開頭手術. 脳神経外科疾患の手術と適応 II. 朝倉書店, 東京, 1990, p202-36.
24) Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma : a randomized study. J Neurosurg 1989 ; 70 : 530-5.
25) 西原哲治, 永田和哉, 落合慈之 : 神経内視鏡による脳内血腫吸引術の現状. Brain Nerve 2003 ; 55 : 499-508.
26) 横須賀公彦, 宇野昌明. 神経内視鏡下血腫除去術 現状とこれからの展望. No Shinkei Geka 2015 ; 43 : 493-506.
27) 横須賀公彦, 宇野昌明, 松村浩平, 他. 【神経内視鏡と脳卒中の外科】被殻出血に対する内視鏡下血腫除去術手術手技の工夫. 脳卒中の外科 2015 ; 43 : 415-9.
28) 横須賀公彦, 平野一宏, 宮本健志, 他. 小脳出血における内視鏡下血腫吸引除去術の有用性. 脳卒中の外科 2011 ; 39 : 193-7.
29) Staykov D, Wagner I, Volbers B, et al. Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke 2011 ; 42 : 2061-4.
30) Gaberel T, Magheru C, Parienti JJ, et al. Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage : a meta-analysis. Stroke 2011 ; 42 : 2776-81.
31) Hanley DF, Lane K, McBee N, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke : results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet 2017 ; 389 : 603-11.
32) 溝渕佳史, 宇野昌明, 永廣信治, 他. 腎透析患者の脳出血の治療と予後の検討. 脳卒中の外科 2003 ; 31 : 290-4.
33) Consoli D, Bosco D, Postorino P, et al. Levetiracetam versus carbamazepine in patients with late poststroke seizures : a multicenter prospective randomized open-label study (EpIC Project). Cerebrovasc Dis 2012 ; 34 : 282-9.
34) 道免和久, 千野直一. 脳卒中のリハビリテーションの進め方の実際 : CT, MRI時代の脳卒中学 上巻. 日本臨床 1993 ; 51 (増刊) : p267-77.
35) 横須賀公彦. 脳内出血に対する神経内視鏡手術の現状. 脳外速報 2012 ; 22 : 1172-78.
36) 本村暁. 脳卒中による失語症-発生機序,回復, 治療 : CT, MRI時代の脳卒中学 上巻. 日本臨床 1993 ; 51 (増刊) : p278-90.
37) Sueda Y, Naka H, Ohtsuki T, et al. Positional relationship between recurrent intracerebral hemorrhage/lacunar infarction and previously detected microbleeds. AJNR Am J Neuroradiol 2010 ; 31 : 1498-503.
38) O'Donnell HC, Rosand J, Knudsen KA, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N +Engl J Med 2000 ; 342 : 240-5.
P.90 掲載の参考文献
1) Blackburn SL, Ashley WW Jr, Rich KM, et al. Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations. J Neurosurg 2011 ; 114 : 1758-67.
2) Brown RD Jr, Wiebers DO, Nichols DA.Intracranial dural arteriovenous fistulae : angiographic predictors of intracranial hemorrhage and clinical outcome in nonsurgical patients. J Neurosurg 1994 ; 81 : 531-8.
4) Gross BA, Du R. Natural history of cerebral dural arteriovenous fistulae. Neurosurgery 2012 ; 71 : 594-602.
5) Hartmann A, Stapf C, Hofmeister C, et al. Determinants of neurological outcome after surgery for brain arteriovenous malformation. Stroke 2000 ; 31 : 2361-4.
6) Hashimoto N. Microsurgery for cerebral arteriovenous malformations : a dissection technique and its theoretical implications. Neurosurgery 2001 ; 48 : 1278-81.
7) Kano H, Kondziolka D, Flickinger JC, et al. Stereotactic radiosurgery for arteriovenous malformations after embolization : a casecontrol study. J Neurosurg 2012 ; 117 : 265-75.
8) Kikuta K, Takagi Y, Nozaki K, et al. Introduction to tractography-guided navigation : using 3-tesla magnetic resonance tractography in surgery for cerebral arteriovenous malformations. Acta Neurochir (Suppl) 2008 ; 103 : 11-4.
9) Kondo R, Matsumoto Y, Endo H, et al. Endovascular embolization of cerebral arteriovenous : results of the Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2. Neuro Med Chir (Tokyo) 2014 ; 54 : 54-62.
10) 桑山直也. わが国における硬膜動静脈瘻 (dAVF) の治療の現状. 脳外誌 2011 ; 20 : 12-9.
11) Miyamoto S, Hashimoto N, Nagata I, et al. Posttreatment sequelae of palliative treated cerebral arteriovenous malformations. Neurosurgery 2000 ; 46 : 589-95.
12) Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy unruptured brain arteriovenous malformations (ARUBA) : a multicenter, nonblinded, randomized trial. Lancet 2014 ; 383 : 614-21.
13) Natarajan SK, Ghodke B, Britz GW, et al. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx : single-center experience and technical nuances. Neurosurgery 2008 ; 62 : 1213-25.
14) Nozaki K. Benefits and risks of radiosurgery to brainstem arteriovenous malformations. World Neurosurgery 2011 ; 76 : 57-8.
15) Ogilvy CS, Stieg PE, Awad I, et al. Recommendations for the management of intracranial arteriovenous malformations. A statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Circulation 2001
16) Pellettieri L, Svendsen P, Wikholm G, et al. Hidden compartments in AVMs-A new concept. Acta Radiol 1997 ; 38 : 2-7.
17) Perret G, Nishioka H. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Section VI. Arteriovenous malformations. J Neurosurg 1966 ; 25 : 467-90.
18) Saatci I, Geyik S, Yavuz K, et al. Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique : long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg 2011 ; 115 : 78-88.
19) Sonstein WJ, Kader A, Michelsen WJ, et al. Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations : an immunohistochemical study. J Neurosurg 1996 ; 85 : 838-45.
23) Starke RM, Kano H, Ding D, et al. Stereotactic radiosurgery for cerebral arteriovenous malformations : evaluation of long-term outcomes in a multicenter cohort. J Neurosurg 2017 ; 126 : 36-44.
24) Takagi Y, Sawamura K, Hashimoto N, et al. Evaluation of serial intraoperative surgical microscope-integrated intraoperative nearinfrared indocyanine green videoangiography in patients with cerebral arteriovenous malformations. Neurosurgery 2012 ; 70 : 34-42.
25) Van Dijk JM, Terbrugge KG, Willinsky RA, et al. Clinical course of cranial dural arteriovenous fistulas with long-term persistent cortical venous reflux. Stroke 2002 ; 33 : 1233-6.
P.103 掲載の参考文献
1) Baba T, Houkin K, Kuroda S. Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 2008 ; 79 : 900-4.
2) Dauser RC, Tuite GF, McCluggage CW. Dural inversion procedure for moyamoya disease. Technical note. J Neurosurg 1997 ; 86 : 719-23.
3) Endo M, Kawano N, Miyaska Y, et al. Cranial burr hole for revascularization in moyamoya disease. J Neurosurg 1989 ; 71 : 180-5.
5) Fujimura M, Mugikura S, Kaneta T, et al. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 2009 ; 71 : 442-7.
6) Fujimura M, Shimizu H, Mugikura S, et al. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease : possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 2009 ; 71 : 223-7 ; discussion 227.
7) Funaki T, Fushimi Y, Takahashi JC, et al. Visualization of Periventricular Collaterals in Moyamoya Disease with Flow-sensitive Blackblood Magnetic Resonance Angiography : Preliminary Experience. Neurol Med Chir (Tokyo) 2015 ; 55 : 204-9.
8) Funaki T, Takahashi JC, Houkin K, et al. Angiographic features of hemorrhagic moyamoya disease with high recurrence risk : a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 2018 ; 128 : 777-84.
9) Funaki T, Takahashi JC, Houkin K, et al. High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease : analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg [epub ahead of print]
10) Funaki T, Takahashi JC, Miyamoto S. Late Cerebrovascular Events and Social Outcome after Adolescence : Long-term Outcome of Pediatric Moyamoya Disease. Neurol Med Chir (Tokyo), 2018 [epub ahead of print]
11) Funaki T, Takahashi JC, Yoshida K, et al. Periventricular anastomosis in moyamoya disease : detecting fragile collateral vessels with MR angiography. J Neurosurg 2016 ; 124 : 1766-72.
12) Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya : a review of the literature. Childs Nerv Syst 2005 ; 21 : 358-64.
13) Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009 ; 111 : 927-35.
14) Hojo M, Hoshimaru M, Miyamoto S, et al. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg 1998 ; 89 : 623-9.
15) Houkin K, Kamiyama H, Takahashi A, et al. Combined revascularization surgery for childhood moyamoya disease : STA-MCA and encephalo-duro-arterio-myo-synangiosis. Childs Nerv Syst 1997 ; 13 : 24-9.
16) Iwama T, Hashimoto N, Murai BN, et al. Intracranial rebleeding in moyamoya disease. J Clin Neurosci 1997 ; 4 : 169-72.
17) Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996 ; 38 : 1120-5 ; discussion 1125-6.
18) Kamiyama H, Takahashi A, Houkin K, et al. Visualization of the ostium of an arteriotomy in bypass surgery. Neurosurgery 1993 ; 33 : 1109-10.
19) Karasawa J, Kikuchi H, Furuse S, et al. Treatment of moyamoya disease with STA-MCA anastomosis. J Neurosurg 1978 ; 49 : 679-88.
20) Karasawa J, Kikuchi H, Furuse S, et al. A surgical treatment of "moyamoya" disease "encephalo-myo synangiosis". Neurol Med Chir (Tokyo) 1977 ; 17 : 29-37.
21) Karasawa J, Touho H, Ohnishi H, et al. Long-term follow-up study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 1992 ; 77 : 84-9.
22) Kashiwagi S, Kato S, Yasuhara S, et al. Use of a split dura for revascularization of ischemic hemispheres in moyamoya disease. J Neurosurg 1996 ; 85 : 380-3.
23) Kawaguchi T, Fujita S, Hosoda K, et al. Multiple burr-hole operation for adult moyamoya disease. J Neurosurg 1996 ; 84 : 468-76.
24) Kim SK, Seol HJ, Cho BK, et al. Moyamoya disease among young patients : its aggressive clinical course and the role of active surgical treatment. Neurosurgery 2004 ; 54 : 840-4 ; discussion 844-6.
25) Kinugasa K, Mandai S, Kamata I, et al. Surgical treatment of moyamoya disease : operative technique for encephalo-duro-arterio-myosynangiosis, its follow-up, clinical results, and angiograms. Neurosurgery 1993 ; 32 : 527-31.
26) Kobayashi E, Saeki N, Oishi H, et al. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 2000 ; 93 : 976-80.
27) Kodama N, Fujiwara S, Horie Y, et al. [Transdural anastomosis in moyamoya diseasevault moyamoy (author's transl)]. No Shinkei Geka 1980 ; 8 : 729-37.
28) Kodam a N, Suzuki J. Cerebrovascular Moyamoya Disease IIIrd Report-The Study on the Aging of the Perforating Branches and the Possibility of Collateral Pathway. Neurol Med Chir (Tokyo) 1974 ; 14 pt 1 : 55-67.
29) Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan : findings from a nationwide epidemiological survey. Stroke 2008 ; 39 : 42-7.
30) Kuroda S, Houkin K, Ishikawa T, et al. Novel bypass surgery for moyamoya disease using pericranial flap : its impacts on cerebral hemodynamics and long-term outcome. Neurosurgery 2010 ; 66 : 1093-101 ; discussion 1101.
31) Kuroda S, Kashiwazaki D, Akioka N, et al. Specific Shrinkage of Carotid Forks in Moyamoya Disease : A Novel Key Finding for Diagnosis. Neurol Med Chir (Tokyo) 2015 ; 55 : 796-804.
32) Kuroda S, Kashiwazaki D, Ishikawa T, et al. Incidence, locations, and longitudinal course of silent microbleeds in moyamoya disease : a prospective T2*-weighted MRI study. Stroke 2013 ; 44 : 516-8.
33) Kuwabara Y, Ichiya Y, Sasaki M, et al. Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 1997 ; 28 : 701-7.
34) Matsushima Y, Inaba Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Childs Brain 1984 ; 11 : 155-70.
35) Miyamoto S. Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset--the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 2004 ; 44 : 218-9.
36) Miyamoto S, Akiyama Y, Nagata I, et al. Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus 1998 ; 5 : e5.
37) Miyamoto S, Kikuchi H, Karasawa J, et al. Study of the posterior circulation in moyamoya disease. Part 2 : Visual disturbances and surgical treatment. J Neurosurg 1986 ; 65 : 454-60.
38) Miyamoto S, Kikuchi H, Karasawa J, et al. Study of the posterior circulation in moyamoya disease. Clinical and neuroradiological evaluation. J Neurosurg 1984 ; 61 : 1032-7.
39) Miyamoto S, Kikuchi H, Karasawa J, et al. Pitfalls in the surgical treatment of moyamoya disease. Operative techniques for refractory cases. J Neurosurg 1988 ; 68 : 537-43.
40) Miyamoto S, Nagata I, Hashimoto N, et al. Direct anastomotic bypass for cerebrovascular moyamoya disease. Neurol Med Chir (Tokyo) 1998 ; 38 Suppl : 294-6.
41) Miyamoto S, Yoshimoto T, Hashimoto N, et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease : results of the Japan Adult Moyamoya Trial. Stroke 2014 ; 45 : 1415-21.
42) Mukawa M, Nariai T, Matsushima Y, et al. Long-term follow-up of surgically treated juvenile patients with moyamoya disease. J Neurosurg Pediatr 2012 ; 10 : 451-6.
43) Okada Y, Shima T, Nishida M, et al. Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease : cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 1998 ; 29 : 625-30.
44) Phi JH, Wang KC, Cho BK, et al. Long-term social outcome in children with moyamoya disease who have reached adulthood. J Neurosurg Pediatr 2011 ; 8 : 303-9.
45) Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis ; Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases : Guidelines for diagnosis and treatment of moyamoya disease (Spontaneous Occlusion of the Circle of Willis). Neurol Med Chir (Tokyo) 2012 ; 52 : 245-66.
46) Scott RM, Smith JL, Robertson RL, et al. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg 2004 ; 100 : 142-9.
47) Suzuki J, Kodama N. Cerebrovascular "Moyamoya" disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 1971 ; 22 : 223-36.
48) Takahashi JC, Funaki T, Houkin K, et al. Significance of the Hemorrhagic Site for Recurrent Bleeding : Prespecified Analysis in the Japan Adult Moyamoya Trial. Stroke 2016 ; 47 : 37-43.
49) Takahashi JC, Ikeda T, Iihara K, et al. Pregnancy and delivery in moyamoya disease : results of a nationwide survey in Japan. Neurol Med Chir (Tokyo) 2012 ; 52 : 304-10.
50) Takahashi JC, Miyamoto S. Moyamoya disease : recent progress and outlook. Neurol Med Chir (Tokyo) 2010 ; 50 : 824-32.
51) Waga S, Tochio H. Intracranial aneurysm associated with moyamoya disease in childhood. Surg Neurol 1985 ; 23 : 237-43.
52) Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan : findings from a nationwide survey. Clin Neurol Neurosurg 1997 ; 99 Suppl 2 : S1-5.
53) Yasaka M, Ogata T, Yasumori K, et al. Bottle neck sign of the proximal portion of the internal carotid artery in moyamoya disease. J Ultrasound Med 2006 ; 25 : 1547-52 ; quiz 1553-44.
54) 宮本享, 永田泉, 森本将史, 他. 血管吻合の基本手技 (<特集> これだけはマスターしたいMicrosurgeryの基本手技). 脳外誌 2000 ; 9 : 451-6.
55) 宮本享, 菊池晴彦, 永田泉, 他. Omental graft. No Shinkei Geka 1993 ; 21 : 1083-8.
56) 舟木健史, 高橋淳, 宮本享 ; JAM Trial Group. 出血発症もやもや病に対する外科治療のエビデンスと最新の知見. 脳外誌 2017 ; 26 : 4-11.
57) 寶金清博, 冨永悌二, 宮本享, 他. もやもや病 (ウイリス動脈輪閉塞症) 診断・治療ガイドライン (改訂版). 脳卒中の外科 2018 ; 46 : 1-24.
P.122 掲載の参考文献
1) 日本脳卒中学会脳卒中ガイドライン委員会. 脳卒中治療ガイドライン 2015. 協和企画, 東京, 2015.
2) 日本脳卒中学会脳卒中ガイドライン [追補2017] 委員会. 脳卒中治療ガイドライン 2015 [追補2017]. http://www.jsts.gr.jp/img/guideline2015_tuihO2017.pdf (2018年9月20日閲覧)
3) National Institute of Neurological Disorder and Stroke early rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 ; 333 : 1581-7.
4) Yamaguchi T, Mori E, Minematsu K, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset : Japan Alteplase Clinical Trial (J-ACT). Stroke 2006 ; 37 : 1810-5.
5) Nakagawara J, Minematsu K, Okada Y, et al ; J-MARS Investigators. Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice : The Japan post-Marketing Alteplase Registration Study (J-MARS). Stroke 2010 ; 41 : 1984-9.
6) Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008 ; 359 : 1317-29.
7) 日本脳卒中学会医療向上・社会保険委員会rt-PA (アルテプラーゼ) 静注療法指針部会. 『rt-PA (アルテプラーゼ) 静注療法適正治療指針 第二版』http://www.jsts.gr.jp/img/rt-PA02.pdf (2018年9月20日閲覧)
8) Minematsu K, Toyoda K, Hirano T, et al. Guidelines for the Intravenous Application of Recombinant Tissue-type Plasminogen Activator (Alteplase), the Second Edition, October 2012 : A Guideline From the Japan Stroke Society. J Stroke Cerebrovasc Dis 2013 ; 22 : 571-600.
9) 日本脳卒中学会 脳卒中医療向上・社会保険委員会「抗凝固療法中患者への脳梗塞急性期再開通治療に関する推奨」作業部会 : 抗凝固療法中患者への脳梗塞急性期再開通治療に関する推奨. 脳卒中 2018 ; 40 : 123-35.
11) Yasaka M, Yamaguchi T, Miyashita T, et al. Predisposing factors of recurrent embolization in cardiogenic cerebral embolism. Stroke 1990 ; 21 : 1000-7.
12) Bruno A, Biller J, Adams HR Jr, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in acute sroke treatment (TOAST) Investigators. Neurology 1999 ; 52 : 280-4.
13) Gariballa SE, Parker SG, Taub N, et al. A randomized, controlled, sigle-blind trial of nutritional supplementation after acute stroke. J Parenter Enteral Nutr 1998 ; 22 : 315-9.
14) 木村和美, 山口武典, 矢坂正弘. アテローム血栓性脳梗塞急性期における抗圧薬投与の梗塞巣と予後に及ぼす影響. 臨床神経 1994 ; 34 : 114-7.
15) 外山祐一郎, 矢坂正弘, 桑城貴弘, 他. 後頭部痛のみを呈し, 積極的降圧療法で良好な転帰を得た椎骨動脈解離の2例. 脳卒中 2015 ; 37 : 428-33.
16) Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-contorolled, double-blind study at multicenter. Cerebrovasc Dis 2003 ; 15 : 222-9.
17) Yasaka M, Yamaguchi T, Oita J, et al. Clinical features of recurrent embolization in acute cardioembolic stroke. Stroke 1993 ; 24 : 1681-5.
18) Pessin MS, Estol CJ, Lafranchise F, et al. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993 ; 43 : 1298-303.
19) Yasaka M, Yamaguchi T, Moriyasu H, et al. Antithrombin III and Low Dose Heparin in Acute Cardioembolic Stroke. Cerebrovasc Dis 1995 ; 5 : 35-42.
20) 宮田茂樹, 山本晴子. ヘパリン起因性血小板減少症 (HIT) の治療. 血栓止血誌 2008 ; 19 : 195-8.
21) The International Stroke Trial (IST). A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997 ; 349 : 1569-81.
22) CAST (Chinese Acute Stroke Trial) Collaborative Group. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997 ; 349 : 1641-9.
23) Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013 ; 369 : 11-9.
24) Kimura M, Robinson RG, Kosier JT. Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial. Stroke 2000 ; 31 : 1482-6.
25) Europian Atrial Fibrillation Trial Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993 ; 342 : 1255-62.
26) Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation : Stroke prevention in atrial fibrillation III randomized clinical trial. Lancet 1996 ; 348 : 633-8.
27) Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 ; 361 : 1139-51 and Erratum in : N Engl J Med 2010 ; 363 : 1877.
28) Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation. N Engl J Med 2011 ; 365 : 883-91.
29) Granger CB, Alexander JH, McMurray JJ, et al. ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011 ; 365 : 981-92.
30) Hori M, Matsumoto M, Tanahashi N, et al. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation. Circ J 2012 ; 76 : 2104-11.
31) Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2013 ; 369 : 2093-104.
32) Yasaka M, Yamaguchi T, Miyashita T, et al. Regression of intracardiac thrombus after embolic stroke. Stroke 1990 ; 21 : 1540-4.
33) Yamaguchi T for Japanese NVAF-Embolism Secondary Prevention Cooperative Study Group. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. A multicenter prospective randomized trial. Stroke 2000 ; 31 : 817-21.
34) Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001 ; 40 : 1183-8.
35) Wakita M, Yasaka M, Minematsu K, et al. Effects of anticoagulation on infarct size and clinical outcome in acute cardioembolic stroke. Angiology 2002 ; 53 : 551-6.
36) 小谷英太郎, 新博次, 奥村謙, 他. 心房細動に対するワルファリン療法における日本人の至適INR-J-RHYTHM Registryからの報告-. 心電図 2013 ; 33 : 25-31.
37) Sato H, Ishikawa K, Kitabatake A, et al. Lowdose aspirin for prevention of stroke in low-risk patients with atrial fibrillation : Japan atrial fibrillation stroke trial. Stroke 2006 ; 37 : 447-51.
38) Ogawa S, Koretsune Y, Yasaka M, et al. Antithrombotic therapy in atrial fibrillation : evaluation and positioning of new oral anticoagulant agents. Circ J 2011 ; 75 : 1539-47.
39) 友田昌徳, 矢坂正弘, 中西泰之, 他. 血漿プロトロンビンフラグメント1+2濃度測定によるワルファリンや非ビタミンK拮抗経口抗凝固薬療法中の抗凝固作用の評価に関する検討. BRAIN NERVE 2017 ; 69 : 571-6.
40) 前田世絵良, 矢坂正弘, 鶴崎雄一郎, 他. 脳梗塞急性期における抗血栓療法導入前後における可溶性フィブリンモノマー複合体値の変化の検討. 脳卒中 2016 ; 38 : 387-92.
41) Wahl MJ. Dental surgery in anticoagulated patients. Arch Inter Med 1998 ; 158 : 1610-6.
42) 心房細動治療 (薬物) ガイドライン (2013年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf (2018年9月20日閲覧)
43) Pollack CV Jr, Reilly PA, van Ryn J. Idarucizumab for Dabigatran Reversal-Full Cohort Analysis. N Engl J Med. 2017 ; 377 : 431-41.
44) Sarode R, Milling TJ Jr, Refaai MA, et al. Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding A Randomized, Plasma-Controlled, Phase IIIb Study. Circulation 2013 ; 128 : 1234-43.
45) Yasaka M, Minematsu K, Naritomi H, et al. Predisposing factors for enlargement of intracerebral hemorrhage in patients treated with warfarin. Thromb Haemost 2003 ; 89 : 278-83.
46) Kaatz S, Kouides PA, Garcia DA, et al. Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol 2012 ; 87 Suppl 1 : S141-5.
47) Mas JL, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001 ; 345 : 1740-6.
48) Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale. Patent foramen ovale in cryptogenic stroke study. Circulation 2002 ; 105 : 2625-31.
49) PROGRESS collaborative group. Randomised trial of a peridopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001 ; 358 : 1033-41.
50) Toyoda K, Yasaka M, Uchiyama S, et al. Bleeding with Antithrombotic Therapy (BAT) Study Group : Blood pressure levels and bleeding events during antithrombotic therapy : the Bleeding with Antithrombotic Therapy (BAT) Study. Stroke 2010 ; 41 : 1440-4.
51) Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 ; 355 : 549-59.
54) CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996 ; 348 : 1329-39.
55) Gotoh F, Tohgi H, Hirai S, et al. Cilostazol stroke prevention study : a placebo-contorolled doubleblind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000 ; 9 : 147-57.
56) 日本脳卒中学会 脳卒中医療向上・社会保険委員会潜因性脳梗塞患者診断手引き作成部会. 植込み型心電図記録計の適応となり得る潜因性脳梗塞患者の診断の手引き. 脳卒中 2016 ; 38 : 277-86.
P.135 掲載の参考文献
1) Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy after Middle Cerebral Artery infarction with Life-thretening Edema Trial [HAMLET]) : a multicenter, open, randomized trial. Lancet Neurol 2009 ; 8 (4) : 326-33.
2) Vahedi K, Hofmeijer J, Juettler E, et al. Early decompression surgery in malignant infarction of the middle cerebral artery : a pooled analysis of three randomized controlled trials. Lancet Neurol 2007 ; 6 (3) : 215-22.
3) Juttler E, Unterberg A, Woitzik J, et al. Hemicraniectomy in older patients with extensive middle cerebral artery stroke. N Engl J Med 2014 ; 370 (12) : 1091-100.
4) 日本脳卒中学会 脳卒中ガイドライン委員会 編. 脳梗塞急性期 1-5 開頭外減圧療法. 脳卒中治療ガイドライン 2015. 協和企画, 東京, 2015, p66.
5) Jauss M, Krieger D, Hornig C, et al. Surgical and medical management of patients with massive cerebellar infarction : results of the German-Austrian Cerebellar Infarction Study. J Neurol 1999 ; 246 (4) : 257-64.
6) 日本脳卒中学会 脳卒中ガイドライン委員会 編. 脳梗塞慢性期 3-11 EC-ICバイパス. 脳卒中治療ガイドライン 2015. 協和企画, 東京, 2015, p135-6.
7) JET Study Group. Japanese EC-IC Bypass Trial (JET Study) 中間解析結果 (第二報). 脳卒中の外科 2002 ; 30 : 434-7.
8) Powers WJ, Clarke WR, Grubb RL, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia : the Carotid Occlusion Surgery Study randomized trial. JAMA 2011 ; 306 : 1983-92.
9) Amin-Hanjani S, Barker FG, Charbel FT, et al. Extracranial-intracranial bypass for stroke-Is this the end of the line or a bump in the road? Neurosurgery 2012 ; 71 : 557-61.
10) Sasoh M, Ogasawara K, Kuroda K, et al. Effects of EC-IC bypass surgery on cognitive impairment in patients with cerebral ischemia. Surg Neurol 2003 ; 59 (6) : 455-60.
11) Fiedler J, Privan V, Skoda O, et al. Cognitive outcome after EC-IC bypass surgery in hemodynamic cerebral ischemia. Acta Neurochir (Wien) 2011 ; 153 (6) : 1303-11.
12) Inoue T, Ohwaki K, Tamura A, et al. Postoperative transient neurological symptom and chronic subdural hematoma after extracranial-intracranial bypass for internal carotid/middle cerebral atherosclerotic steno-occlusive disease : negative effect on cognitive performance. Acta Neurochir (Wien) 2016 ; 158 : 207-16.
13) Fujimura M, Niizuma K, Inoue T, et al. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 2014 ; 74 (2) : 163-70.
14) Inoue T, Tamura A, Tsutsumi K, et al. Surgical embolectomy for large vessel occlusion of anterior circulation. Br J Neurosurg 2013 ; 27 : 783-790
15) Hasegawa H, Inoue T, Tamura A, et al. Emergent intracranial surgical embolectomy in conjunction with carotid endoarterectomy for acute internal carotid artery terminus embolic occlusion and tandem occlusion of the cervical carotid artery due to plaque rupture. J Neurosurg 2015 ; 122 : 939-47.
16) Inoue T, Tamura A, Saito I, et al. Response to "Role of surgical embolectomy for the treatment of acute large vessel occlusion" Br J Neurosurg 2014 ; 18 (3) : 431-2.
17) Horiuchi T, Nitta J, Miyaoka Y, et al. Open embolectomy of large vessel occlusion in the endovascular era : Results of a 12 year single center experience. World Neurosurg 2017 ; 102 : 65-71.
18) Hino A, Oka H, Hashimoto Y, et al. Direct microsurgical embolectomy for acute occlusion of the internal carotid artery and middle cerebral artery. World Neurosurg 2016 ; 88 : 243-51.
19) Inoue T, Tamura A, Tsutsumi K, et al. Surgical embolectomy for internal carotid artery terminus occlusion. Neurosurg Rev 2015 ; 38 (4) : 661-9.
20) Hopkins LN, Budny JL. Complication of intracranial bypass for vertebrobasilar insufficiency. J Neurosurg 1989 ; 70 : 207-11.
21) Ogawa A, Kameyama M, Muraishi K, et al. Cerebral blood flow and metabolism following superficial temporal artery to superior cerebellar artery bypass for vertebrobasilar occlusive disease. J Neurosurg 1992 ; 76 : 955-60.
22) Inoue T, Tamura A, Tsutsumi K, et al. Acute to subacute surgical revascularization for progressing stroke in atherosclerotic vertebrobasilar occlusion. Acta Neurochir (Wien) 2012 ; 154 : 1455-61.
23) Goehre F, Yanagisawa T, Kamiyama H, et al. Direct microsurgical embolectomy for an acute distal basilar artery occlusion. World Neurosurg 2016 ; 86 : 497-502
P.146 掲載の参考文献
1) Aso K, Ogasawara K, Sasaki M, et al. Preoperative cerebrovascular reactivity to acetazolamide measured by brain perfusion SPECT predicts development of cerebral ischemic lesions caused by microemboli during carotid endarterectomy. Eur J Nucl Med Mol Imaging 2009 ; 36 : 294-301.
2) Barnett HJM, Taylor DW, Eliasziw M, et al. for the North American Symptomatic Carotid Endarterectomy Trial Collaborators : Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998 ; 339 : 1415-25.
4) Chaturvedi S, Bruno A, Feasby T, et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Carotid endarterectomy : An evidence-based review : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005 ; 65 : 794-801.
5) Chida K, Ogasawara K, Suga Y, et al. Postoperative cortical neural loss Associated with cerebral hyperperfusion and cognitive impairment after carotid endarterectomy. 123I-iomazenil SPECT study. Stroke 2009 ; 40 : 448-53.
6) Dalman JE, Beenakkers IC, Moll FL, et al. Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion. Eur J Vasc Endovasc Surg 1999 ; 18 : 222-7.
7) 遠藤俊郎, 平島豊, 桑山直也, 他. 頸動脈内膜剥離術の基本手技. 脳外誌 1999 ; 8 : 92-9.
9) Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995 ; 273 : 1421-8.
10) Fukuda T, Ogasawara K, Kobayashi M, et al. Prediction of cerebral hyperperfusion after carotid endarterectomy using cerebral blood volume measured by perfusion-weighted MR imaging compared with single-photon emission CT. AJNR Am J Neuroradiol 2007 ; 28 : 737-42.
11) Grφnholdt ML. Ultrasound and lipoproteins as predictors of lipid-rich, rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol 1999 ; 19 : 2-13.
12) Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms : randomised controlled trial. Lancet 2004 ; 363 : 1491-502.
13) Hosoda K, Kawaguchi T, Shibata Y, et al. Cerebral vasoreactivity and internal carotid artery flow help to identify patients at risk for hyperperfusion after carotid endarterectomy. Stroke 2001 ; 32 : 1567-73.
14) International Carotid Stenting Study investigators, Ederle J, Dobson J, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study) : an interim analysis of a randomised controlled trial. Lancet 2010 ; 375 : 985-97.
15) Kobayashi M, Ogasawara K, Yoshida K, et al. Intentional hypertension during dissection of carotid arteries in endarterectomy prevents postoperative development of new cerebral ischemic lesions caused by intraoperative microemboli. Neurosurgery 2011 ; 69 : 301-7.
16) Kuroda H, Ogasawara K, Hirooka R, et al. Prediction of cerebral hyperperfusion after carotid endarterectomy using middle cerebral artery signal intensity in preoperative single-slab three-dimensional time-of-flight magnetic resonance angiography. Neurosurgery 2009 ; 64 : 1065-71.
17) Loftus CM. Technical aspects of carotid endarterectomy with Hemashield patch graft. Neurol Med Chir (Tokyo) 1997 ; 37 : 805-18.
18) Mas JL, Chatellier G, Beyssen B, et al. EVA-3S Investigators : Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006 ; 355 : 1660-71.
19) North American Symptomatic Carotid Endarterectomy Trial Collaborators : Benefical effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991 ; 325 : 445-53.
20) Ogasawara K, Inoue T, Kobayashi M, et al. Cerebral hyperperfusion following carotid endarterectomy : diagnostic utility of intraoperative transcranial Doppler ultrasonography compared with single-photon emission computed tomography study. AJNR Am J Neuroradiol 2005 ; 26 : 252-7.
21) Ogasawara K, Konno H, Yukawa H, et al. Transcranial regional cerebral oxygen saturation monitoring during carotid endarterectomy as a predictor of postoperative hyperperfusion. Neurosurgery 2003 ; 53 : 309-14.
22) Ogasawara K, Sakai N, Kuroiwa T, et al. Japanese Society for Treatment at Neck in Cerebrovascular Disease Study Group : Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting : retrospective review of 4494 patients. J Neurosurg 2007 ; 107 : 1130-6.
23) Ogasawara K, Suga Y, Sasaki M, et al. Intraoperative microemboli and low middle cerebral artery blood flow velocity are additive in predicting development of cerebral ischemic events after carotid endarterectomy. Stroke 2008 ; 39 : 3088-91.
24) Ogasawara K, Yukawa H, Kobayashi M, et al. Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy using single photon emission computed tomography scanning. J Neurosurg 2003 ; 99 : 504-10.
25) 岡田芳和, 森竹浩三, 島健, 他. T型シャントシステムを用いた内膜剥離術. 脳外誌 1999 ; 8 : 77-83.
26) Orlandi G, Fanucchi S, Gallerini S, et al. Impaired clearance of microemboli and cerebrovascular symptoms during carotid stenting procedures. Arch Neurol 2005 ; 62 : 1208-11.
27) Saito A, Sasaki M, Ogasawara K, et al. Carotid plaque signal differences among four kinds of T1-weighted magnetic resonance imaging techniques : a histopathological correlation study. Neuroradiology 2012 ; 54 : 1187-94.
28) SPACE Collaborative Group, Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients : a randomised noninferiority trial. Lancet 2006 ; 368 : 1239-47.
29) Suzuki T, Ogasawara K, Hirooka R, et al. Preoperative single-slab three-dimensional timeof-flight magnetic resonance angiography predicts development of new cerebral ischemic events after carotid endarterectomy. J Neurosurg 2009 ; 111 : 141-6.
30) Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators : protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004 ; 351 : 1493-501.
31) Yamada N, Higashi M, Otsubo R, et al. Association between signal hyperintensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. AJNR Am J Neuroradiol 2007 ; 28 : 287-92.
P.158 掲載の参考文献
1) 日本脳卒中学会 脳卒中ガイドライン委員会 編. 脳卒中治療ガイドライン 2015. 協和企画, 東京, 2015.
2) Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (isat) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms : A randomised trial. Lancet 2002 ; 360 : 1267-74.
3) Molyneux AJ, Birks J, Clarke A, et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms : 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet 2015 ; 385 : 691-7.
4) Morita A, Kirino T, Hashi K, et al. The natural course of unruptured cerebral aneurysms in a japanese cohort. N Engl J Med 2012 ; 366 : 2474-82.
5) Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms : Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003 ; 362 : 103-10.
6) Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms : a pooled analysis of six prospective cohort studies. Lancet Neurol 2014 ; 13 (1) : 59-66.
7) Tominari S, Morita A, Ishibashi T, et al. Prediction model for 3-year rupture risk of unruptured cerebral aneurysms in Japanese patients. Ann Neurol 2015 ; 77 (6) : 1050-9.
8) Etminan N, Brown RD Jr, Beseoglu K, et al. The unruptured intracranial aneurysm treatment score : a multidisciplinary consensus. Neurology 2015 ; 85 (10) : 881-9.
9) Paciaroni M, Eliasziw M, Kappelle LJ, et al. Medical complications associated with carotid endarterectomy. North american symptomatic carotid endarterectomy trial (nascet). Stroke 1999 ; 30 : 1759-63.
10) Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. New Engl J Med 2004 ; 351 (15) : 1493-501.
11) Brott TG, Hobson RW 2nd, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010 ; 363 : 11-23.
12) Brott TG, Howard G, Roubin GS, et al. Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. New Engl J Med 2016 ; 374 (11) : 1021-31.
13) Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. New Engl J Med 2015 ; 372 (1) : 11-20.
14) Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. New Engl J Med 2015 ; 372 (11) : 1019-30.
15) Campbell BC, Mitchell PJ, Kleinig TJ, et al.Endovascular therapy for ischemic stroke with perfusion-imaging selection. New Engl J Med 2015 ; 372 (11) : 1009-18.
16) Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. New Engl J Med 2015 ; 372 (24) : 2285-95.
17) Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment : A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015 ; 46 (10) : 3020-35.
18) Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. New Engl J Med 2018 ; 378 (1) : 11-21.
19) Albers GW, Marks MP, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. New Engl J Med 2018 ; 378 (8) : 708-18.
20) 日本脳卒中学会, 日本脳神経外科学会, 日本脳神経血管内治療学会. 経皮経管的脳血栓回収用機器 適正使用指針 第3版. 脳卒中 2018 ; 40 : 285-309.
21) Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures : Part ii--clinical aspects and recommendations. Neurosurgery 2000 ; 46 : 1360-75 ; discussion 1375-6.
22) Yamada NK, Cross DT 3rd, Pilgram TK, et al. Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007 ; 28 : 1778-82.
23) Kanaan H, Jankowitz B, Aleu A, et al. In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysms. Neurosurgery 2010 ; 67 : 1523-32 ; discussion 32-3.
24) 吉村紳一, 他. 脳血管内治療指針 7. 頚動脈狭窄症. JNET 2009 ; 3 (Suppl 1) : 56-65.
25) Kato T, Sakai H, Takagi T, et al. Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting. AJNR Am J Neuroradiol 2012 ; 33 (7) : 1262-6.
26) Yamagami H, Sakai N, Matsumaru Y, et al. Periprocedural cilostazol treatment and restenosis after carotid artery stenting : The retrospective study of in-stent restenosis after carotid artery stenting (resister-cas). J Stroke Cerebrovasc Dis 2012 ; 21 : 193-9.
27) Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention : an open-label, randomised, controlled trial. Lancet 2013 ; 381 (9872) : 1107-15.
28) Lip GY, Windecker S, Huber K, et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions : a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014 ; 35 (45) : 3155-79.
29) Gibson CM, Mehran R, Bode C, et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. New Engl J Med 2016 ; 375 (25) : 2423-34.
30) Cannon CP, Bhatt DL, Oldgren J, et al. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. New Engl J Med 2017 ; 377 (16) : 1513-24.
31) 加藤元, 上堂文, 掃本誠, 他. 抗血栓薬服用者に対する消化器内視鏡診療ガイドライン 直接経口抗凝固薬 (DOAC) を含めた抗凝固薬に関する 追補 2017. Gastroenterological Endoscopy 2017 ; 59 (7) : 1547-58.
32) Leisch F, Kerschner K, Hofmann R, et al. Carotid sinus reactions during carotid artery stenting : Predictors, incidence, and influence on clinical outcome. Catheter Cardiovasc Interv 2003 ; 58 : 516-23.
33) Nonaka T, Oka S, Miyata K, et al. Prediction of prolonged postprocedural hypotension after carotid artery stenting. Neurosurgery 2005 ; 57 : 472-7 ; discussion 472-7.
34) Warkentin TE. Heparin-induced thrombocytopenia : Diagnosis and management. Circulation 2004 ; 110 : 454-8.
35) Li X, Bayliss G, Zhuang S. Cholesterol Crystal Embolism and Chronic Kidney Disease. Int J Mol Sci 2017 ; 18 (6).
P.168 掲載の参考文献
1) Kamada F, Aoki Y, Narisawa A, et al. A genomewide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 2011 ; 56 : 34-40.
2) Liu W, Morito D, Takashima S, et al. Identification of RNF 213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011 ; 6 : e22542.
3) Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576G > A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 2012 ; 78 : 803-10.
4) Liao X, Deng J, Dai W, et al. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk : a meta-analysis and systematic review. Environ Health Prev Med 2017 ; 22 : 75
5) Cavalcanti D, Kalani Y, Martirosyan N, et al. Cerebral cavernous malformations : from genes to proteins to disease. J Neurosurg 2012 ; 116 : 122-32.
6) Riant F, Bergametti F, Ayrignac X, et al. Recent insights into cerebral cavernous malformations : the molecular genetics of CCM. FEBS J 2010 ; 277 : 1070-5.
7) He Y, Zhang H, Yu L, et al. Stabilization of VEGFR2 Signaling by Cerebral Cavernous Malformation 3 Is Critical for Vascular Development. Sci Signal 2010 ; 3 : ra26.
8) Federico A, Di Donato I, Bianchi S, et al. Hereditary cerebral small vessel diseases : A Review. J Neurol Sci 2012 ; 322 : 25-30.
10) 森下恵理子. 血液凝固異常症の臨床と検査-血栓性素因の診断-. 血栓止血誌 2008 ; 19 : 467-70.
11) Bersano A, Lanfranconi S, Valcarenghi C, et al. Neurological features of Fabry disease : clinical, pathophysiological aspects and therapy. Acta Neurol Scand 2012 ; 126 : 77-97.
12) McDonald J, Bayrak-Toydemir P, Pyeritz R. Hereditary hemorrhagic telangiectasia : An overview of diagnosis, management, and pathogenesis. Genet Med 2011 ; 13 : 607-16.
13) Inoue K, Mineharu Y, Inoue S, et al. Search on chromosome 17 centromere reveals TNFRSF13B as a susceptibility gene for intracranial aneurysm : a preliminary study. Circulation 2006 ; 113 : 2002-10.
14) Kim H, Marchuk D, Pawlikowska L, et al. Genetic considerations relevant to intracranial hemorrhage and brain arteriovenous malformations. Acta Neurochir Suppl 2008 ; 105 : 199-206.
15) Nikolaev SI, Vetiska S, Bonilla X, et al. Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 2018 ; 378 : 250-61.
16) Kavanagh D, Spitzer D, Kothari PH, et al. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle 2008 ; 7 : 1718-25.
17) Furutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) : from discovery to gene identification. J Stroke Cerebrovasc Dis 2011 ; 20 : 85-93.
18) Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003 ; 73 : 1240-9.
19) 位田隆一. 個人遺伝情報は特殊か? ヒトゲノム全解析時代における遺伝情報の意味するもの. 医学のあゆみ 2011 ; 236 : 677-80.
20) 松下一之, 朝長毅, 西村基, 他. 遺伝子研究と倫理. 機器・試薬 2008 ; 31 : 685-92.

[III] 脳腫瘍

P.177 掲載の参考文献
1) Brain Tumor Registry of Japan (2005-2008). Neurol Med Chir (Tokyo) 2017 ; 57 (Supplement-1) : 9-102.
2) 日本脳神経外科学会, 日本病理学会. 脳腫瘍取り扱い規約 第4版. 金原出版, 東京, 2018.
3) 田村晃, 松谷雅生, 清水輝夫, 他. EBMに基づく脳神経疾患の基本治療指針 第4版. メジカルビュー社, 東京, 2017.
4) Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998 ; 82 (9) : 1749-55.
5) Chandra V, Rock AK, Opalak C, et al. A systematic review of perioperative seizure prophylaxis during brain tumor resection : the case for a multicenter randomized clinical trial. Neurosurg Focus 2017 ; 43 (5) : E18.
P.191 掲載の参考文献
1) Brain Tumor Registry of Japan (2005-2008). Neurol Med Chir (Tokyo) 2017 ; 57 (Supplement-1) : 9-102.
2) Rumboldt Z, Camacho DL, Lake D, et al. Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 200 ; 27 (6) : 1362-9.
3) Ogiwara H, Bowman RM, Tomita T. Long-term follow-up of pediatric benign cerebellar astrocytomas. Neurosurgery 2012 ; 70 (1) : 40-7.
4) Sainte-Rose C, Cinalli G, Roux FE, et al. Management of hydrocephalus in pediatric patients with posterior fossa tumors : the role of endoscopic third ventriculostomy. J Neurosurg 2001 ; 95 (5) : 791-7.
5) 師田信人. 生理学的検査. 小児脳神経外科学 改訂2版. 金芳堂, 京都, 2015.
6) Robertson PL, Muraszko KM, Holmes EJ, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma : a prospective study by the Children's Oncology Group. J Neurosurg 2006 ; 105 (6 Suppl) : 444-51.
7) Massimino M, Solero CL, Garre ML, et al. Second-look surgery for ependymoma : the Italian experience. J Neurosurg Pediatr 2011 ; 8 (3) : 246-50.
8) 松谷雅生. 松果体部腫瘍. 小児脳神経外科学 改訂2版. 金芳堂, 京都, 2015.
9) Phi JH, Kim SK, Lee J, et al. The enigma of bifocal germ cell tumors in the suprasellar and pineal regions : synchronous lesions or metastasis? J Neurosurg Pediatr 2013 ; 11 (2) : 107-14.
10) 依藤亨. 内分泌領域. 小児脳神経外科学 改訂2版. 金芳堂, 京都, 2015.
11) Ogiwara H, Morota N. Flexible endoscopy for management of intraventricular brain tumors in patients with small ventricles. J Neurosurg Pediatr 2014 ; 14 (5) : 490-4.
12) Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors : a clinical analysis of 153 histologically verified cases. J Neurosurg 1997 ; 86 (3) : 446-55.
13) Ogiwara H, Kiyotani C, Terashima K, et al. Second-look surgery for intracranial germ cell tumors. Neurosurgery 2015 ; 76 (6) : 658-61.
14) 師田信人, 荻原英樹. 松果体部腫瘍. 小児脳神経外科学 改訂2版. 金芳堂, 京都, 2015.
P.210 掲載の参考文献
1) Nishioka H, Fukuhara N, Horiguchi K, et al. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly : predictive factors, strategies, and outcomes. J Neurosurg 2014 ; 121 : 505-10.
2) Yoshino A, Katayama Y, Watanabe T, et al. Apoplexy accompanying pituitary adenoma as a complication of preoperative anterior pituitary function tests. Acta Neurochir (Wien) 2007 ; 149 : 557-65.
3) Aihara Y, Watanabe S, Amano K, et al. Placental alkaline phosphatase levels in cerebrospinal fluid can have a decisive role in the differential diagnosis of intracranial germ cell tumors. J Neurosurg 2018 [Epub ahead of print]
4) Iwama S, Sugimura Y, Kiyota A, et al. Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohyophysitis. J Clin Endocr Metab 2015 ; 100 : E946-54.
5) Nishioka H. Recent evolution of endoscopic endonasal surgery for treatment of pituitary adenomas. Neurol Med Chir (Tokyo) 2017 ; 57 : 151-8.
6) Nishioka H, Hara T, Usui M, et al. Simultaneous combined supra-infrasellar approach for giant/large multi-lobulated pituitary adenomas. World Neurosurg 2012 ; 77 : 533-9.
7) 西岡宏. 脳神経外科診療に役立つ薬物治療の知識 : 下垂体疾患に対する薬物療法. No Shinkei Geka 2017 ; 45 : 67-72.
8) Yamada S, Fukuhara N, Nishioka H, et al. Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging. World Neurosurg 2012 ; 77 : 525-32.
9) Yamada S, Fukuhara N, Horiguchi K, et al. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas : a single-center study of 90 cases. J Neurosurg 2014 ; 121 : 1462-73.
10) Nishioka H, Inoshita N, Sano T, et al. Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas. Endocr Pathol 2012 ; 23 : 151-6.
11) Nishioka H, Hara T, Nagata Y, et al. Inherent tumor characteristics that limit effective and safe resection of giant nonfunctioning pituitary adenomas. World Neurosurg 2017 ; 106 : 645-52.
12) Cavallo LM, Solari D, Esposito F, et al. The endoscopic endonasal approach of craniopharyngiomas involving the third ventricle. Neurosurg Rev 2013 ; 36 : 27-38.
13) 西岡宏. 頭蓋咽頭腫に対する外科治療 : 経鼻手術. 頭蓋咽頭腫パーフェクトガイド (井川房夫, 川俣貴一, 西岡宏 編). 中外医学社, 東京, 2016, p95-104.
14) 西岡宏. 嚢胞性病変 : ラトケ嚢胞. EBMに基づく脳神経疾患の基本治療指針 改訂第4版 (田村晃, 松谷雅生, 清水輝夫 編). メジカルビュー社, 東京, 2016, p217-9.
16) Kinoshita Y, Tominaga A, Usui S, et al. The long-term recurrence of Rathke's cleft cysts as predicted by histology but not by surgical procedure. J Neurosurg 2016 ; 125 : 1002-7.
17) Nagata Y, Inoshita N, Fukuhara N, et al. Low-grade glioma of the neurohypophysis : clinical characteristics and surgical outcomes. World Neurosurg 2018 ; 114 : e1225-31.
18) Otani R, Fukuhara N, Ochi T, et al. Rapid growth hormone measurement during transsphenoidal surgery : analysis of 252 acromegalic patients. Neurol Med Chir (Tokyo) 2012 ; 52 : 558-62.
19) 西岡宏. 経蝶形骨手術の術後管理. NS NOW No19 下垂体外科Update (寺本 明, 編). メジカルビュー社, 東京, 2012, p46-52.
20) Little AS, White WL. Prophylactic antibiotic trends in transsphenoidal surgery for pituitary adenomas. Pituitary 2011 ; 14 : 99-104.
21) Inder WJ, Hunt PJ. Glucocorticoid replacement in pituitary surgery : guidelines for perioperative assessment and management. J Clin Endocrinol Metab 2002 ; 87 : 2745-50.
22) Nishioka H, Haraoka J, Ikeda Y. Risk factors of cerebrospinal fluid rhinorrhea following transsphenoidal surgery. Acta Neurochir 2005 ; 147 : 1163-66.
23) Horiguchi K, Nishioka H, Fukuhara N, et al. A new multilayer reconstruction using nasal septal flap combined with fascia graft dural suturing for high-flow cerebrospinal fluid leak after endoscopic endonasal surgery. Neurosurg Rev 2016 ; 39 : 419-27.
24) Little AS, Kelly D, Milligan J, et al. Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery. J Neurosurg 2015 ; 122 : 1458-65.
25) Darendeliler F, Karagiannis G, Wilton P, et al. Recurrence of brain tumours in patients treated with growth hormone : analysis of KIGS (Pfizer International Growth Databank). Acta Paediatr 2006 ; 95 : 1284-90.
P.227 掲載の参考文献
1) 亀山茂樹. 脳神経外科手術のための電気生理モニタリング. 西村書店. 1997.
2) 佐々木富男, 谷口 真, 桐野高明. 聴神経腫瘍の手術. 脳外誌 1997 ; 6 : 761-8.
3) 佐々木富男. Lateral suboccipital approach. 脳神経外科手術のための解剖学. メジカルビュー社, 東京, 1998, p62-73.
4) 佐々木富男, 谷口真, 渡辺克成. 聴神経腫瘍摘出術における顔面神経ならびに蝸牛神経の機能温存. 脳腫瘍の外科手技-スタンダードと新しい展開-. メディカ出版, 大阪, 2000, p118-24.
5) 佐々木富男, 渡辺克成. schwannoma. 脳神経外科治療指針. 中外医学社, 東京, 2002, p333-8.
6) 中冨浩文, 斎藤延人. 神経鞘腫. EBMに基づく脳神経疾患の基本治療指針 第4版. メジカルビュー社, 東京, 2016, p169-76.
7) 谷口真. 聴神経腫瘍手術時の顔面神経温存のためのモニタリング. 臨床脳波 1998 ; 40 : 553-8.
8) Yoshino M, Kin T, Nakatomi H, et al. Presurgical planning of feeder resection with realistic three-dimensional virtual operation field in patient with cerebellopontine angle meningioma. Acta Neurochir (Wien). 2013 ; 155 (8) : 1391-9.
9) Nakatomi H, Miyazaki H, Tanaka M, et al. Improved preservation of function during acoustic neuroma surgery. J Neurosurg 2015 ; 122 (1) : 24-33. doi : 10.3171/2014.8. JNS 132525.
P.236 掲載の参考文献
1) Al-Mefty O, Borba LA. Skull base chordomas : a management challenge. J Neurosurg 1997 ; 86 : 182-9.
2) Gonzalez-Larriba JL, Garcia CI, Sastre VJ, et al. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer. Oncology 1997 ; 11 (9 Suppl 10) : 90-7.
3) Hadad G, Bassagasteguy L, Carrau RL, et al. A novel reconstructive technique after endoscopic expanded endonasal approaches : vascular pedicle nasoseptal flap. Laryngoscope 2006 ; 116 (10) : 1882-6.
4) Kassam A, Snyderman CH, Mintz A, et al. Expanded endonasal approach : the rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum. Neurosurg Focus 2005 ; 19 (1) : E4.
5) Komatsu F, Komatsu M, Di Ieva A, et al. Endoscopic extradural subtemporal approach to lateral and central skull base : a cadaveric study. World Neurosurg 2013 ; 80 (5) : 591-7.
6) Lustig LR, Jackler RK. The vulnerability of the vein of labbe during combined craniotomies of the middle and posterior fossae. Skull Base Surg 1998 ; 8 : 1-9.
7) McElroy EA Jr, Buckner JC, Lewis JE. Chemotherapy for advanced esthesioneuroblastoma : the Mayo Clinic experience. Neurosurgery 1998 ; 42 : 1023-8.
8) Nagata Y, Watanabe T, Nagatani T, et al. Fully endoscopic combined transsphenoidal and supraorbital keyhole approach for parasellar lesions. J Neurosurg 2018 ; 128 (3) : 685-94.
9) 行木英生. 一塊切除術式の適応と限界. 頭頸部腫瘍 1994 ; 20 : 481-6.
10) 西川邦男. 頭蓋底手術における病理組織学的検討. 頭頸部腫瘍 1994 ; 20 : 492-9.
11) 大畑健治, Haque M, 森野道晴, 他. 脳腫瘍に対する頭蓋底外科の術中トラブルとその回避. 脳外誌 1997 ; 6 : 752-60.
12) O'Malley BW Jr, Janecka IP. Evolution of outcomes in cranial base surgery. Semin Surg Oncol 1995 ; 11 : 221-7.
13) Origitano TC, al-Mefty O, Leonetti JP, et al. Vascular considerations and complications in cranial base surgery. Neurosurgery 1994 ; 35 : 351-63.
14) Robertson JH, Gardner G, Cocke EW Jr. Glomus jugulare tumors. Clin Neurosurg 1994 ; 41 : 39-61.
15) Rousseau P, Flamant F, Quintana E, et al. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit : results of the International Society of Pediatric Oncology MMT 84 Study. J Clin Oncol 1994 ; 12 : 516-21.
16) 齋藤清, 吉田純, 高橋正克, 他. 頭蓋底悪性腫瘍の手術. No Shinkei Geka 1999 ; 27 : 505-14.
17) Saito K, Fukuta K, Takahashi M, et al. Management of the cavernous sinus in en bloc resections of malignant skull base tumors. Head Neck 1999 ; 21 : 734-42.
18) Vinchon M, Pertuzon B, Lejeune JP, et al. Intradural epidermoid cysts of the cerebellopontine angle : diagnosis and surgery. Neurosurgery 1995 ; 36 : 52-7.
19) 渡邉督. 内視鏡によるkeyhole transcranial approachのバリエーション. No Shinkei Geka 2017 ; 45 (6) : 479-91.
P.246 掲載の参考文献
1) Brain Tumor Registry of Japan (2005-2008). Neurol Med Chir (Tokyo) 2017 ; 57 (Supplement-1) : 9-102.
2) Arita H, Narita Y, Miyakita Y, et al. Risk factors for early death after surgery in patients with brain metastases : reevaluation of the indications for and role of surgery. J Neurooncol 2014 ; 116 (1) : 145-52.
3) Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901) : a multi-institutional prospective observational study. Lancet Oncol 2014 ; 15 (4) : 387-95.
4) Magnuson WJ, Lester-Coll NH, Wu AJ, et al. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer : A Retrospective Multi-Institutional Analysis. J Clin Oncol 2017 : JCO2016697144.
5) Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996 ; 46 (4) : 985-91.
6) Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter : anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 ; 54 (10) : 1886-93.
7) Kayama T, Sato S, Sakurada K, et al. Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504) : A Phase III, Noninferiority, Randomized Controlled Trial. J Clin Oncol 2018 : JCO2018786186.
8) Brown PD, Ballman KV, Cerhan JH, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3) : a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 2017 ; 18 (8) : 1049-60.
9) Mahajan A, Ahmed S, McAleer MF, et al. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases : a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 2017 ; 18 (8) : 1040-8.
10) Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997 ; 37 (4) : 745-51.
11) Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases : a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010 ; 77 (3) : 655-61.
P.275 掲載の参考文献
1) Halperin EC, Bentel G, Heinz ER, et al. Radiation therapy treatment planning in supratentorial glioblastoma multiforme : an analysis based on post mortem topographic anatomy with CT correlations. Int J Radiat Oncol Biol Phys 1989 ; 17 (6) : 1347-50.
2) 永根基雄. 悪性脳腫瘍の治療効果判定の画像診断. CI研究 2015 ; 36 : 103-112.
3) Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000 ; 92 (3) : 205-16.
4) Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours : revised RECIST guideline (version 1.1). Eur J Cancer 2009 ; 45 (2) : 228-47.
5) Macdonald DR, Cascino TL, Schold SC Jr, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990 ; 8 (7) : 1277-80.
6) Wen PY, Macdonald DR, Reardon DA, et al. Updated response assessment criteria for neurooncology working group. J Clin Oncol 2010 ; 28 (11) : 1963-72.
7) Brandsma D, Stalpers L, Taal W, et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008 ; 9 (5) : 453-61.
8) van den Bent MJ, Wefel JS, Schiff D, et al. Response assessment in neuro-oncology (a report of the RANO group) : assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 2011 ; 12 (6) : 583-93.
9) Vogelbaum MA, Jost S, Aghi MK, et al. Application of novel response/progression measures for surgically delivered therapies for gliomas : Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 2012 ; 70 (1) : 234-43 ; discussion 43-4.
10) Okada H, Weller M, Huang R, et al. Immunotherapy response assessment in neurooncology : a report of the RANO working group. Lancet Oncol 2015 ; 16 (15) : e534-42.
11) Alexander BM, Brown PD, Ahluwalia MS, et al. Clinical trial design for local therapies for brain metastases : a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol 2018 ; 19 (1) : e33-42.
12) Camidge DR, Lee EQ, Lin NU, et al. Clinical trial design for systemic agents in patients with brain metastases from solid tumours : a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol 2018 ; 19 (1) : e20-32.
13) Chamberlain M, Junck L, Brandsma D, et al. Leptomeningeal metastases : a RANO proposal for response criteria. Neuro Oncol 2017 ; 19 (4) : 484-92.
14) Huang RY, Bi WL, Weller M, et al. Proposed Response Assessment and Endpoints for Meningioma Clinical Trials : Report from the Response Assessment in Neuro-Oncology (RANO) Working Group. Neuro Oncol 2018.
15) Lin NU, Lee EQ, Aoyama H, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 1 : patient population, response, and progression. A report from the RANO group. Lancet Oncol 2013 ; 14 (10) : e396-406. Epub 2013/09/03.
16) Lin NU, Wefel JS, Lee EQ, et al. Challenges relating to solid tumour brain metastases in clinical trials, part 2 : neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group. Lancet Oncol 2013 ; 14 (10) : e407-16. Epub 2013/09/03.
17) Nayak L, DeAngelis LM, Brandes AA, et al. The Neurologic Assessment in Neuro-Oncology (NANO) scale : a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria. Neuro Oncol 2017 ; 19 (5) : 625-35.
18) Warren KE, Vezina G, Poussaint TY, et al. Response assessment in medulloblastoma and leptomeningeal seeding tumors : recommendations from the Response Assessment in Pediatric Neuro-Oncology committee. Neuro Oncol 2018 ; 20 (1) : 13-23.
19) de Wit MC, de Bruin HG, Eijkenboom W, et al. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 2004 ; 63 (3) : 535-7.
20) Brandes AA, Franceschi E, Tosoni A, et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 2008 ; 26 (13) : 2192-7.
21) Taal W, Brandsma D, de Bruin HG, et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide. Cancer 2008 ; 113 (2) : 405-10.
22) Giglio P, Gilbert MR. Cerebral radiation necrosis. Neurologist 2003 ; 9 (4) : 180-8.
23) Kreisl TN, Lassman AB, Mischel PS, et al. A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). J Neurooncol 2009 ; 92 (1) : 99-105.
24) Clarke JL, Chang S. Pseudoprogression and pseudoresponse : challenges in brain tumor imaging. Curr Neurol Neurosci Rep 2009 ; 9 (3) : 241-6.
25) Nagane M NR, Narita Y, Kobayashi H, et al. Phase II study of single-agent bevacizumab in Japanese patients with reccurent malignant glioma. Jpn Clin Oncol 2012 ; 42 (10) : 887-95.
26) Brastianos PK, Batchelor TT. Vascular endothelial growth factor inhibitors in malignant gliomas. Target Oncol 2010 ; 5 (3) : 167-74.
27) Friedman HS, Prados MD, Wen PY, et al. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 2009 ; 27 (28) : 4733-40.
28) Wick W, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly : the NOA-08 randomised, phase 3 trial. Lancet Oncol 2012 ; 13 (7) : 707-15.
29) Malmstrom A, Gronberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma : the Nordic randomised, phase 3 trial. Lancet Oncol 2012 ; 13 (9) : 916-26.
30) Tsao MN, Mehta MP, Whelan TJ, et al. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Bio Phys 2005 ; 63 (1) : 47-55.
31) Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Bio Phys 1991 ; 21 (1) : 109-22.
32) Back M, Gzell CE, Kastelan M, et al. Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma. Neurooncol Pract 2015 ; 2 (1) : 48-53.
33) 浅井昭, 松谷雅生, 松田忠義. 脳腫瘍放射線治療後の亜急性障害としての脳萎縮と痴呆. 癌の臨床 1987 ; 35 : 753-61.
34) 兼平千裕. 放射線脊髄症の分析-脊髄耐容線量の時間-線量関係-. 日本医放会誌 1987 ; 47 : 606-20.
35) Munk J, Peyser E, Gruszkiewicz J. Radiation induced intracranial meningiomas. Clin Radiol 1969 ; 20 (1) : 90-4.
36) Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone ; report of 11 cases. Cancer 1948 ; 1 (1) : 3-29.
37) Harrison MJ, Wolfe DE, Lau TS, et al. Radiationinduced meningiomas : experience at the Mount Sinai Hospital and review of the literature. J Neurosurg 1991 ; 75 (4) : 564-74.
38) Kitanaka C, Shitara N, Nakagomi T, et al. Postradiation astrocytoma. Report of two cases. J Neurosurg 1989 ; 70 (3) : 469-74.
39) Liwnicz BH, Berger TS, Liwnicz RG, et al. Radiation-associated gliomas : a report of four cases and analysis of postradiation tumors of the central nervous system. Neurosurgery 1985 ; 17 (3) : 436-45.
40) Tsang RW, Laperriere NJ, Simpson WJ, et al. Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk. Cancer 1993 ; 72 (7) : 2227-33.
41) Loeffler JS, Niemierko A, Chapman PH. Second tumors after radiosurgery : tip of the iceberg or a bump in the road? Neurosurgery 2003 ; 52 (6) : 1436-40 ; discussion 40-2.
42) Kestle JR, Hoffman HJ, Mock AR. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 1993 ; 79 (1) : 32-5.
43) Larson JJ, Ball WS, Bove KE, et al. Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children. J Neurosurg 1998 ; 88 (1) : 51-6.
44) 杉山達也, 松谷雅生, 小倉弘章, 他. 小児悪性脳腫瘍放射線治療後の血管腫発生. 脳外誌 2002 ; 11 : 425-30.
45) Schultz C, Scott C, Sherman W, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas : initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1996 ; 14 (2) : 556-64.
46) Ott RJ, Brada M, Flower MA, et al. Deehan BJ. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991 ; 27 (11) : 1356-61.
47) Chamberlain MC. Recurrent intracranial ependymoma in children : salvage therapy with oral etoposide. Pediatr Neurol 2001 ; 24 (2) : 117-21.
48) 茶山公祐, 宮村能子, 鷲尾佳奈. 小児脳腫瘍に対する経口エトポシドを使った低用量持続化学療法の安全性・有効性の検討. 日児誌 2009 ; 113 (2) : 343.
49) Newlands ES, Stevens MF, Wedge SR, et al. Temozolomide : a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 1997 ; 23 (1) : 35-61.
50) Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study : 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009 ; 10 (5) : 459-66.
51) Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 2005 ; 352 (10) : 987-96.
52) Wakabayashi T, Natsume A, Mizusawa J, et al. JCOG0911 INTEGRA study : a randomized screening phase II trial of interferonbeta plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. J Neurooncol 2018 ; 138 (3) : 627-36.
53) Gerson SL. MGMT : its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 2004 ; 4 (4) : 296-307.
54) 永根基雄, 口野嘉幸, 浅井昭雄. ACNU耐性とMGMTの発現. Mebio 1993 ; 10 (7) : 107-13.
55) 永根基雄. 悪性神経膠腫に対するtemozolomide化学療法における耐性機序とその克服の道筋. 専門医に求められる最新の知識. 脳外速報 2010 ; 20 : 188-97.
56) Esteller M, Garcia-Foncillas J, Andion E, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. New Engl J Med 2000 ; 343 (19) : 1350-4.
57) Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. New Engl Journal Med 2005 ; 352 (10) : 997-1003.
58) 永根基雄. Temozolomide の有用性は確立したか? EBM癌化学療法-分子標的治療法 2011-2012 (大津敦, 古瀬純司, 中川和彦, 他), 中外医学社, 東京, 2010, p554-8.
59) van den Bent MJ, Dubbink HJ, Sanson M, et al. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors : a report from EORTC Brain Tumor Group Study 26951. J Clin Oncol 2009 ; 27 (35) : 5881-6.
60) Wick W, Hartmann C, Engel C, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 2009 ; 27 (35) : 5874-80.
61) Malley DS, Hamoudi RA, Kocialkowski S, et al. A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts. Acta Neuropathol 2011 ; 121 (5) : 651-61.
62) 永根基雄. ニムスチン. これだけは押さえておきたいがん化学療法の薬. 古瀬純司 (編). プロフェッショナルがんナーシング 2013 別冊 2013 : 100-1.
63) Jansen M, de Witt Hamer PC, Witmer AN, et al. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain res Rev 2004 ; 45 (3) : 143-63.
64) Vredenburgh JJ, Desjardins A, Herndon JE 2nd, et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 2007 ; 25 (30) : 4722-9.
65) Chinot O, Wick W, Mason W, et al. Phase III trial of bevacizumab added to standard radiotherapy and temozolomide for newly diagnosed glioblastoma : mature progression-free results in AVAGlio. Neuro-Oncology. 2012 ; 14 (Suppl 6) : vi101-vi105.
66) Gilbert MR, Dignam J, Won M, et al. RTOG 0825 : Phase III double-blind placebo-controlled trial evaluating bevacizumab in patients with newly diagnosed glioblastoma. J Clin Oncol. 2013 ; 31 (Suppl 18).
67) Sandmann T, Bourgon R, Garcia J, et al. Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide : Retrospective Analysis of the AVAglio Trial. J Clin Oncol 2015 ; 33 (25) : 2735-44.
68) Wakabayashi T, Kayama T, Nishikawa R, et al. A multicentric phase I trial of interferon-beta and temozolomide combination therapy for high grade gliomas (INTEGRA Study) : the final report. J Neurooncol 2011 ; 104 : 573-577.
69) Ferreri AJ, Cwynarski K, Pulczynski E, et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma : results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 2016 ; 3 (5) : e217-27.
70) Ferreri AJM, Ciceri F, Brandes AA, et al. MATILDE chemotherapy regimen for primary CNS lymphoma : results at a median follow-up of 12 years. Neurology 2014 ; 82 (15) : 1370-3.
71) Glass J, Won M, Schultz CJ, et al. Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma : NRG Oncology RTOG 0227. J Clin Oncol 2016 ; 34 (14) : 1620-5.
72) Laack NN, O'Neill BP, Ballman KV, et al. CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys 2011 ; 81 (2) : 476-82.
73) Morris PG, Correa DD, Yahalom J, et al. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma : final results and long-term outcome. J Clin Oncol 2013 ; 31 (31) : 3971-9. Epub 2013/10/09.
74) Rubenstein JL, Hsi ED, Johnson JL, et al. Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma : CALGB 50202 (Alliance 50202). J Clin Oncol 2013 ; 31 (25) : 3061-8. Epub 2013/04/10.
75) Glass J, Gruber ML, Cher L, et al. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma : long term outcome. J Neurosurg 1994 ; 81 (2) : 188-95.
76) Hiraga S, Arita N, Ohnishi T, et al. Rapid infusion of high-dose methotrexate resulting in enhanced penetration into cerebrospinal fluid and intensified tumor response in primary central nervous system lymphomas. J Neurosurg 1999 ; 91 (2) : 221-30.
77) O'Brien PC RD, Pratt G, Liew KH, et al ; Trans-Tasman Radiation Oncology Group. Combined-modality therapy for primaly central nervous system lymphoma : long-term data from a Phase II murticenter study (Trans-Tasman Radiation Oncology Group). Int J Radiat Oncol Bio Phys 2006 ; 64 (2) : 408-13.
78) 泉本修一, 森 鑑二, 有田憲生. 中枢神経系悪性リンパ腫研究会. 悪性リンパ腫に対するHD-MTX療法の長期成績と問題点- 多施設共同臨床試験から. 第26回日本脳腫瘍学会抄録集, 愛媛, 2008, p130.
79) Gavrilovic IT, Hormigo A, Yahalom J, et al. Longterm follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol 2006 ; 24 (28) : 4570-4.
80) Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma : the next step. J Clin Oncol 2000 ; 18 (17) : 3144-50.
81) Shah GD, Yahalom J, Correa DD, et al. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 2007 ; 25 (30) : 4730-5.
82) Morris PG,Correa DD, Yahalom J, et al. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma : final results and long-term outcome. J Clin Oncol 2013 ; 31 : 3971-3979.
83) Reni M, Ferreri AJ, Guha-Thakurta N, et al. Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront highdose methotrexate. Int J Radiat Oncol Bio Phys 2001 ; 51 (2) : 419-25.
84) Ferreri AJ, Reni M, Foppoli M, et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma : a randomised phase 2 trial. Lancet 2009 ; 374 (9700) : 1512-20.
85) Herrlinger U, Kuker W, Uhl M, et al. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma : final report. Ann Neurol 2005 ; 57 (6) : 843-7.
86) Batchelor T, Carson K, O'Neill A, et al. Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy : a report of NABTT 96-07. J Clin Oncol 2003 ; 21 (6) : 1044-9.
87) Momota H, Narita Y, Miyakita Y, et al. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation. Pediatr Blood Cancer 2010 ; 55 : 577-79.
88) Momota H, Narita Y, Miyakita Y, et al. Secondary hematological malignancies associated with temozolomide in patients with glioma. Neuro Oncol 2013 ; 15 : 1445-50.
89) 松谷雅生, 藤巻高光, 柳澤隆昭. 放射線治療, 化学療法. 脳神経外科周術期管理のすべて 第4版 (松谷雅生, 他, 編), メジカルビュー社, 東京, 2014, p233-261.
P.300 掲載の参考文献
1) Bouff et E, et al. Possibilities of new therapeutic strategies in brain tumours. Cancer Treat Rev 2010 ; 36 : 335-41.
2) Chastagner P, et al. What have we learnt from previous phase II trials to help in the management of childhood brain tumours? Eur J Cancer 2001 ; 37 : 1981-93.
3) Tyalor MD, et al. Molecular subgroups of medulloblastoma : the current consensus. Acta Neuropathol 2012 ; 123 : 465-72.
4) Northcott PA, et al. The whole genomue landscape of medulloblastoma subtypes. Nature 2017 ; 547 : 311-7.
5) Mack SC, et al. Genomic analysis of childhood brain tumors : Methods for genome-wide discovery and precision medicine become mainstream. J Clin Oncol 2017 ; 35 : 2346-54.
6) Walker DA, et al. A multi-disciplinary consensus statement concerning surgical approaches to lowgrade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method. Neuro Oncol 2013 ; 15 : 462-8.
7) Gajjar A, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96) : long-term results from a prospective, multicentre trial. Lancet Oncol 2006 ; 7 : 813-20.
9) Merchant TE, et al. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys 2005 ; 63 : 1546-54.
10) Moxon-Emre I, et al. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma. J Clin Oncol 2014 ; 32 : 1760-8.
11) Bouffet E, et al. Survival benefit for pediatric patients with recurrent ependymoma treated with reirradiation. Int J Radiat Oncol Biol Phys 2012 ; 83 : 1541-8.
12) Indelicato DJ, et al. Consensus report from the Stockholm Pediatric Proton Therapy Conference. Int J Radiat Oncol Biol Phys 2016 ; 96 : 387-92.
13) COG Supportive Care Endorsed Guidelines. https://childrensoncologygroup.org/index.php/cog-supportive-care-endorsed-guidelines
14) Qussama A, et al, eds. Handbook of Supportive Care in Pediatric Oncology. Jones & Bartlett Pub 1st ed, 2009.
15) Packer RJ, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006 ; 24 : 4202-8.
16) Finlay JL, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children with recurrent CNS tumors. J Clin Oncol 1996 ; 14 : 2495-503.
17) Modak S, et al. Thiotepa based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 2004 ; 22 : 1934-43.
18) Rutkowski S, et al. Survival and prognostic factors of early childhood medulloblastoma : an international meta-analysis. J Clin Oncol 2010 ; 28 : 4961-8.
P.312 掲載の参考文献
1) 赤松洋祐, 隈部俊宏, 金森政之, 他. 頭部固定を必要としない術中ニューロナビゲーションシステム. No Shinkei Geka 2009 ; 37 : 1193-9.
2) Beez T, Boge K, Wager M, et al ; European Low Grade Glioma Network. Tolerance of awake surgery for glioma : a prospective European Low Grade Glioma Network multicenter study. Acta Neurochir (Wien) 2013 ; 155 (7) : 1301-8. doi : 10.1007/s00701-013-1759-0. Epub 2013 May 21.
3) Berger MS, Kincaid J, Ojemann GA, et al. Brain mapping techniques to maximize resection, safety, and seizure control in children with brain tumors. Neurosurgery 1989 ; 25 : 786-92.
4) Berger MS, Ojemann GA, Lettich E. Neurophysiological monitoring during astrocytoma surgery. Neurosurgery clinics of North America 1990 ; 1 : 65-80.
5) Berger MS. Malignant astrocytomas : Surgical aspects. Seminars in Oncology 1994 ; 21 : 172-85.
6) Berger MS, Hadjipanayis CG. Surgery of intrinsic cerebral tumors. Neurosurgery 2007 ; 61 (1 Suppl) : 279-304 ; discussion 304-5.
7) Boetto J, Bertram L, Moulinie G, et al. Low Rate of Intraoperative Seizures During Awake Craniotomy in a Prospective Cohort with 374 Supratentorial Brain Lesions : Electrocorticography Is Not Mandatory. World Neurosurg 2015 ; 84 (6) : 1838-44. doi : 10.1016/j.wneu.2015.07.075. Epub 2015 Aug 14.
8) Boetto J, Bertram L, Moulinie G, et al. Electrocorticography Is Not Necessary During Awake Brain Surgery for Gliomas. World Neurosurg 2016 ; 91 : 656-7. doi : 10.1016/j.wneu.2016.03.030. Epub 2016 Mar 18.
9) Caverzasi E, Hervey-Jumper SL, Jordan KM, et al. Identifying preoperative language tracts and predicting postoperative functional recovery using HARDI q-ball fiber tractography in patients with gliomas. J Neurosurg 2016 ; 125 (1) : 33-45. doi : 10.3171/2015.6.JNS142203. Epub 2015 Dec 11.
10) Chan-Seng E, Moritz-Gasser S, Duff au H. Awake mapping for low-grade gliomas involving the left sagittal stratum : anatomofunctional and surgical considerations. J Neurosurg 2014 ; 120 (5) : 1069-77. doi : 10.3171/2014.1.JNS132015. Epub 2014 Jan 31.
11) Clark CA, Barrick TR, Murphy MM, et al. Singularities in diffusion tensor fields and their relevance in white matter fiber tractography. Neuroimage 2003 ; 20 : 1601-8.
12) Coenen VA, Krings T, Mayfrank L, et al. Three-dimensional visualization of the pyramidal tract in a neuronavigation system during brain tumor surgery : First experiences and technical note. Neurosurgery 2001 ; 49 : 86-93.
13) De Witte E1, Satoer D, Colle H, et al. Subcortical language and non-language mapping in awake brain surgery : the use of multimodal tests. Acta Neurochir (Wien) 2015 ; 157 (4) : 577-88. doi : 10.1007/s00701-014-2317-0. Epub 2015 Jan 14.
14) Deras P, Moulinie G, Maldonado IL, et al. Intermittent general anesthesia with controlled ventilation for asleep-awake-asleep brain surgery : a prospective series of 140 gliomas in eloquent areas. Neurosurgery 2012 ; 71 (4) : 764-71.
15) Dilmen OK, Akcil EF, Oguz A, et al. Comparison of Conscious Sedation and Asleep-Awake-Asleep Techniques for Awake Craniotomy. J Clin Neurosci 2017 ; 35 : 30-4. doi : 10.1016/j.jocn.2016.10.007. Epub 2016 Oct 19.
16) Duffau H, Capelle L, Sichez N, et al. Intraoperative mapping of the subcortical 293 language pathways using direct stimulations. An anatomo-functional study. Brain 2002 ; 125 : 199-214.
17) Fujii M, Maesawa S, Motomura K, et al. Intraoperative subcortical mapping of a language-associated deep frontal tract connecting the superior frontal gyrus to Broca's area in the dominant hemisphere of patients with glioma. J Neurosurg 2015 ; 122 (6) : 1390-6. doi : 10.3171/2014.10.JNS14945. Epub 2015 Mar 27.
18) Geyer S, Matelli M, Luppino G, et al. Functional neuroanatomy of the primate isocortical motor system. Anat Embryol (Berl) 2000 ; 202 : 443-74.
19) Gil-Robles S, Duff au H. Surgical management of World Health Organization Grade II gliomas in eloquent areas : the necessity of preserving a margin around functional structures. Neurosurg Focus. 2010 ; 28 (2) : E8. Review.
20) Guidelines Committee of The Japan Awake Surgery Conference. The Guidelines for Awake Craniotomy. Neurol Med Chir (Tokyo) 2012 ; 52 : 119-41.
21) Haglund MM, Ojemann GA, Blasdel GG. Optical imaging of bipolar cortical stimulation. J Neurosurg 1993 ; 78 : 785-93.
22) Hervey-Jumper SL, Li J, Lau D, et al. Awake craniotomy to maximize glioma resection : methods and technical nuances over a 27-year period. J Neurosurg 2015 ; 123 (2) : 325-39. doi : 10.3171/2014.10.JNS141520. Epub 2015 Apr 24.
23) Inoue T, Fujimura M, Kumabe T, et al. Combined threedimensional anisotropy contrast imaging and magnetoencephalography guidance to preserve visual function in a patient with an occipital lobe tumor. Minim Invasive Neurosurg 2004 ; 47 : 249-52.
24) Inoue T, Shimizu H, Yoshimoto T. Imaging the pyramidal tract in patients with brain tumors. Clin Neurol Neurosurg 1999 ; 101 : 4-10.
25) Itoi C, Hiromitsu K, Saito S,, et al. Predicting sleepiness during an awake craniotomy. Clin Neurol Neurosurg 2015 ; 139 : 307-10. doi : 10.1016/j.clineuro.2015.10.033. Epub 2015 Oct 31.
26) 刈部博, 隈部俊宏, 冨永悌二. 神経膠腫術前・術後の機能MRIと術中マッピングの比較. 日本臨床 63巻 増刊号 9 (通巻第878号) 脳腫瘍の診断と治療-最新の研究動向-V. 脳腫瘍の治療 外科療法, 2005, p395-400.
27) Kemerdere R, de Champfleur NM, Deverdun J, et al. Role of the left frontal aslant tract in stuttering : a brain stimulation and tractographic study. J Neurol 2016 ; 263 (1) : 157-67. doi : 10.1007/s00415-015-7949-3. Epub 2015 Nov 11.
28) Khan OH, Herbet G, Moritz-Gasser S, et al. The role of left inferior fronto-occipital fascicle in verbal perseveration : a brain electrostimulation mapping study. Brain Topogr 2014 ; 27 (3) : 403-11. doi : 10.1007/s10548-013-0343-5. Epub 2013 Dec 18.
29) Kinoshita M, de Champfleur NM, Deverdun J, et al. Role of fronto-striatal tract and frontal aslant tract in movement and speech : an axonal mapping study. Brain Struct Funct 2015 ; 220 (6) : 3399-412. doi : 10.1007/s00429-014-0863-0. Epub 2014 Aug 3.
30) Kinoshita M, Nakajima R, Shinohara H, et al. Chronic spatial working memory deficit associated with the superior longitudinal fasciculus : a study using voxel-based lesion-symptom mapping and intraoperative direct stimulation in right prefrontal glioma surgery. J Neurosurg 2016 ; 125 (4) : 1024-32. Epub 2016 Feb 19.
31) Kumabe T, Nakasato N, Inoue T, et al. Primary Thumb Sensory Cortex Located at the Lateral Shoulder of the Inverted Omega-shape on the Axial Images of the Central Sulcus. Neurol Med Chir (Tokyo) 2000 ; 40 : 392-403.
32) Kumabe T, Nakasato N, Nagamatsu K, et al. Intraoperative localization of the lip sensory area by somatosensory evoked potentialstechnical note-. J Clin Neurosci 2005 ; 12 : 66-70.
34) Kumabe T, Sato K, Iwasaki M, et al. Summary of 15 years experience of awake surgeries for neuroepithelial tumors in tohoku university. Neurol Med Chir (Tokyo) 2013 ; 53 : 455-66.
35) 隈部俊宏, 中里信和, 鈴木匡子, 他. 運動領野周辺神経膠腫に対する手術-術前解剖学的及び機能的マッピングの融合とニューロナビゲーションシステム及び術中マッピング併用による運動機能温存手術-. 脳外誌 2001 ; 10 : 56-64.
36) 隈部俊宏, 中里信和, 岩崎真樹, 他. 中心前回に存在する神経膠腫の手術. 脳外誌 2002 ; 11 : 271-7.
37) 隈部俊宏, 中里信和, 永松謙一, 他. 中心前回に存在する神経膠腫の解剖学的所見による分類. 顕微鏡下手術のための脳神経外科解剖 XV-機能温存のための脳神経外科解剖-, サイメッド・パブリケーションズ, 2003, p109-16.
38) Maldonado IL, Moritz-Gasser S, de Champfleur NM, et al. Surgery for gliomas involving the left inferior parietal lobule : new insights into the functional anatomy provided by stimulation mapping in awake patients. J Neurosurg 2011 ; 115 (4) : 770-9. doi : 10.3171/2011.5.JNS112. Epub 2011 Jun 24.
39) Moritz-Gasser S, Herbet G, Duff au H. Mapping the connectivity underlying multimodal (verbal and non-verbal) semantic processing : a brain electrostimulation study. Neuropsychologia 2013 ; 51 (10) : 1814-22. doi : 10.1016/j.neuropsychologia.2013.06.007. Epub 2013 Jun 15.
40) Motomura K, Fujii M, Maesawa S, et al. Association of dorsal inferior frontooccipital fasciculus fibers in the deep parietal lobe with both reading and writing processes : a brain mapping study. J Neurosurg 2014 ; 121 (1) : 142-8. doi : 10.3171/2014.2.JNS131234. Epub 2014 Mar 21.
41) Nagamatsu K, Nakasato N, Hatanaka K, et al. Neuromagnetic localization of N15, the initial cortical response to lip stimulus. Neuroreport 2001 ; 12 : 1-5.
42) 永松謙一, 隈部俊宏, 鈴木匡子, 他. 覚醒下手術時の言語野マッピングにおける陰性運動反応の特徴と意義. No Shinkei Geka 2008 ; 36 : 693-700.
43) Nakasato N, Kumabe T, Kanno A, et al. Neuromagnetic evaluation of cortical auditory function in patients with temporal lobe tumors. J Neurosurg 1997 ; 86 : 610-8.
44) 新妻邦泰, 隈部俊宏, 清水宏明, 他. Fiber Tracking法を用いた白質線維描出の問題点. 脳外誌 2007 ; 16 : 504-9.
45) Nossek E, Matot I, Shahar T, et al. Failed awake craniotomy : a retrospective analysis in 424 patients undergoing craniotomy for brain tumor. J Neurosurg 2013 ; 118 (2) : 243-9. doi : 10.3171/2012.10.JNS12511. Epub 2012 Nov 2.
46) Ohtomo S, Nakasato N, Kawamura T, et al. Correspondence of anatomy and function in the human digit sensory cortex revealed by an MRI linked whole-head MEG system. Electroencephalogr Clin Neurophysiol Suppl 1996 ; 47 : 91-5.
47) Papagno C, Casarotti A, Comi A, et al. Long-term proper name anomia after removal of the uncinate fasciculus. Brain Struct Funct 2016 ; 221 (1) : 687-94. doi : 10.1007/s00429-014-0920-8. Epub 2014 Oct 28.
48) Riquin E, Martin P, Duverger P, et al. A case of awake craniotomy surgery in an 8-year-old girl. Childs Nerv Syst 2017 ; 33 (7) : 1039-42. doi : 10.1007/s00381-017-3463-5. Epub 2017 Jun 3.
49) Roberts TP, Ferrari P, Perry D, et al. Presurgical mapping with magnetic source imaging : comparisons with intraoperative findings. Brain Tumor Pathol 2000 ; 17 : 57-64.
52) Sartorius CJ, Berger MS : Rapid termination of intraoperative stimulation-evoked seizures with application of cold Ringer's lactate to the cortex. Technical note. J Neurosurg 1998 ; 88 : 349-51.
53) Skrap M, Marin D, Ius T, et al. Brain mapping : a novel intraoperative neuropsychological approach. J Neurosurg 2016 ; 125 (4) : 877-87. Epub 2016 Feb 5.
54) Spena G, Schucht P, Seidel K, et al. Brain tumors in eloquent areas : A European multicenter survey of intraoperative mapping techniques, intraoperative seizures occurrence, and antiepileptic drug prophylaxis. Neurosurg Rev 2017 ; 40 (2) : 287-98. doi : 10.1007/s10143-016-0771-2. Epub 2016 Aug 1.
55) Szelenyi A, Bello L, Duff au H, et al ; Workgroup for Intraoperative Management in Low-Grade Glioma Surgery within the European Low-Grade Glioma Network. Intraoperative electrical stimulation in awake craniotomy : methodological aspects of current practice. Neurosurg Focus 2010 ; 28 (2) : E7. doi : 10.3171/2009.12.FOCUS09237. Review.
56) Templer JW, Gavvala JR, Tate MC, et al. Reexamining the Value of Intraoperative Electrocorticography During Awake Craniotomy. World Neurosurg 2016 ; 91 : 655. doi : 10.1016/j.wneu.2015.10.083.
57) Trevisi G, Roujeau T, Duff au H. Awake surgery for hemispheric low-grade gliomas : oncological, functional and methodological differences between pediatric and adult populations. Childs Nerv Syst 2016 ; 32 (10) : 1861-74. doi : 10.1007/s00381-016-3069-3. Epub 2016 Sep 20.
58) Trinh VT, Fahim DK, Maldaun MV, et al. Impact of preoperative functional magnetic resonance imaging during awake craniotomy procedures for intraoperative guidance and complication avoidance. Stereotact Funct Neurosurg 2014 ; 92 (5) : 315-22. doi : 10.1159/000365224. Epub 2014 Sep 18.
59) Vallar G, Bello L, Bricolo E,, et al. Cerebral correlates of visuospatial neglect : a direct cerebral stimulation study. Hum Brain Mapp 2014 ; 35 (4) : 1334-50. doi : 10.1002/hbm.22257. Epub 2013 Feb 18.
60) van Geemen K, Herbet G, Moritz-Gasser S, et al. Limited plastic potential of the left ventral premotor cortex in speech articulation : evidence from intraoperative awake mapping in glioma patients. Hum Brain Mapp 2014 ; 35 (4) : 1587-96. doi : 10.1002/hbm.22275. Epub 2013 Apr 24.
61) Wakana S, Jiang H, Nagae-Poetscher LM, et al. Fiber tract-based atlas of human white matter anatomy. Radiology 2004 ; 230 : 77-87.
62) Wu PY, Huang ML, Lee WP, et al. Effects of music listening on anxiety and physiological responses in patients undergoing awake craniotomy. Complement Ther Med 2017 ; 32 : 56-60. doi : 10.1016/j.ctim.2017.03.007. Epub 2017 Mar 31.
63) Yamada K, Kizu O, Mori S, et al. Brain fiber tracking with clinically feasible diffusion-tensor MR imaging : initial experience. Radiology 2003 ; 227 : 295-301.
64) Yingling CD, Ojemann S, Dodson B, et al. Identification of motor pathways during tumor surgery facilitated by multichannel electromyographic recording. J Neurosurg 1999 ; 91 : 922-7.
65) Yousry TA, Schmid UD, Alkadhi H, et al. Localization of the motor hand area to a knob on the precentral gyrus. Brain 1997 ; 120 : 141-57.
P.321 掲載の参考文献
1) 日本家族性腫瘍学会ホームページ Available from : http://jsft.umin.jp/.
2) Eckel-Passow JE, Lachance DH, Molinaro AM, et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N Engl J Med 2015 ; 372 (26) : 2499-508.
3) Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 2015 ; 372 (26) : 2481-98.
4) Ueki K, Nishikawa R, Nakazato Y, et al. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res. 2002 ; 8 (1) : 196-201.
5) van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma : long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 2013 ; 31 (3) : 344-50.
6) Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma : long-term results of RTOG 9402. J Clin Oncol 2013 ; 31 (3) : 337-43.
7) Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res 2013 ; 19 (4) : 764-72.
8) Malmstrom A, Gronberg BH, Marosi C, et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma : the Nordic randomised, phase 3 trial. Lancet Oncol 2012 ; 13 (9) : 916-26.
9) Wick W, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly : the NOA-08 randomised, phase 3 trial. Lancet Oncol 2012 ; 13 (7) : 707-15.
10) Olar A, Wani KM, Alfaro-Munoz KD, et al. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol 2015 ; 129 (4) : 585-96.
11) Jenkins RB, Blair H, Ballman KV, et al. At (1 ; 19) (q10 ; p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 2006 ; 66 (20) : 9852-61.
12) Suzuki H, Aoki K, Chiba K, et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 2015 ; 47 (5) : 458-68.
13) Venteicher AS, Tirosh I, Hebert C, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 2017 ; 355 (6332).
14) 厚生労働省 研究倫理指 Available from : https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/i-kenkyu/index.html.

[IV] 頭部外傷

P.337 掲載の参考文献
1) 平成29年の人口動態統計月報年計 (概数) の概況. https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai17/index.html
2) 日本外傷データバンク https://www.jtcr-jatec.org/traumabank/dataroom/dataroom.htm
3) Mass AI, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adult. Lancet Neurol 2008 ; 7 : 728-41
4) 横堀將司, 荒木尚, 恩田秀賢, 他. 高齢者重症頭部外傷に対する積極的治療と患者転帰の変遷~頭部外傷データバンクプロジェクト 1998, 2004, 2009における検討~. 神経外傷 2013 ; 36 : 61-70.
5) 日本外傷学会, 日本救急医学会 監修. 改訂第5版 外傷初期診療ガイドラインJATEC. へるす出版, 東京, 2016.
6) 日本脳神経外科学会, 日本脳神経外傷学会 監修. 重症頭部外傷治療・管理のガイドライン 第3版. 医学書院, 東京, 2013.
7) 重森稔, 小野純一, 小川武希, 他. 日本頭部外傷データバンクにおけるone week studyの総括. 神経外傷 2011 ; 34 : 1-6.
8) 小野純一, 小川武希, 鈴木倫保, 他. わが国における頭部外傷の最近の動向. One Week Study 2005と2012の比較検討から. 神経外傷 2013 ; 36 : 129-35.
9) Gennarelli TA. Emergency department of head injuries. Emerg Med Clin North Am 1984 ; 2 : 749-60.
10) 荒木千里. 頭部外傷, 日本外科全書. 南江堂, 東京, 1954, p44-7.
11) Marshall LF, Marchall SB, Klauber MR, et al. A new classification of head injury based on computerized tomography. J Neurosurg 1991 ; 75 (Suppl) : S14-20.
12) 頭部外傷分類 http://www.jast-hp.org/zouki/toubu.html
13) 横田裕行, 中村紀夫, 荒木尚, 他. 外傷医と脳神経外科医による頭部外傷分類. 日外傷会誌 2011 ; 25 : 19-24.
14) Vos PE. EFNS guideline on mild traumatic brain injury : report of an EFNS task forse. Eur J Neurol 2002 ; 9 : 207-19.
15) 一般社団法人JPTEC協議会 編著. 改訂第2版 JPTECガイドブック. へるす出版, 東京, 2016.
16) 横田裕行. 頭部外傷. 標準救急医学 (第5版). 医学書院, 東京, 2013.
P.352 掲載の参考文献
1) Freytag E. Autopsy findings in head injuries from blunt forces. Statistical evaluation of 1,367 cases. Arch Pathol 1963 ; 75 : 402-13.
2) Jamieson KG, Yelland JD. Extradural hematoma. Report of 167 cases. J Neurosurg 1968 ; 29 : 13-23.
3) Yilmazlar S, Kocaeli H, Dogan S, et al. Traumatic epidural haematomas of nonarterial origin : analysis of 30 consecutive cases. Acta Neurochir (Wien) 2005 ; 147 : 1241-48 ; discussion 1248.
4) Kushner D. Mild traumatic brain injury : toward understanding manifestations and treatment. Arch Intern Med 1998 : 158, 1617-24.
5) Greenberg J, Cohen WA, Cooper PR. The "hyperacute" extraaxial intracranial hematoma : computed tomographic findings and clinical significance. Neurosurgery 1985 ; 17 : 48-56.
6) Al-Nakshabandi NA. The swirl sign. Radiology 2001 ; 218 : 433.
7) Pruthi N, Balasubramaniam A, Chandramouli BA, et al. Mixed-density extradural hematomas on computed tomography-prognostic significance. Surg Neurol 2009 ; 71 : 202-6.
8) Hess JR, Brohi K, Dutton RP, et al. The coagulopathy of trauma : a review of mechanisms. J Trauma 2008 ; 65 : 748-54.
9) Laroche M, Kutcher ME, Huang MC, et al. Coagulopathy following traumatic brain injury. Neurosurgery 2012 ; 70 : 1334-45.
10) 日本外傷学会外傷初期診療ガイドライン改訂第5版編集委員会. 改訂第5版 外傷初期診療ガイドライン JATEC (日本外傷学会 監修). へるす出版, 東京, 2016.
11) Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017 ; 80 (1) : 6-15. doi : 10.1227/NEU.0000000000001432.
12) Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of acute subdural hematomas. Neurosurgery 2006 ; 58 : S16-24.
13) Shigemori M, Abe T, Aruga T, et al. Guidelines for the management of severe head injury, 2nd edition guidelines from the guidelines committee on the management of severe head injury, the Japan Society of Neurotraumatology. Neurol Med Chir (Tokyo) 2012 ; 52 : 1-30.
14) 重症頭部外傷治療管理のガイドライン作成委員会. 重症頭部外傷治療・管理のガイドライン 第3版. 医学書院, 東京, 2103.
15) Bullock, MR, Chesnut R, Ghajar J, et al. Surgical management of acute epidural hematomas. Neurosurgery 2006 ; 58, S7-15.
17) Wilberger JE Jr, Harris M, Diamond DL. Acute subdural hematoma : morbidity, mortality, and operative timing. J Neurosurg 1991 ; 74 : 212-8.
18) Miller JD, Butterworth JF, Gudeman SK, et al. Further experience in the management of severe head injury. J Neurosurg 1981 ; 54 : 289-99.
19) Seelig JM, Becker DP, Miller JD, et al. Traumatic acute subdural hematoma : major mortality reduction in comatose patients treated within four hours. N Engl J Med 1981 ; 304 : 1511-8.
20) Miller JD, Bullock R, Graham DI, et al. Ischemic brain damage in a model of acute subdural hematoma. Neurosurgery 1990 ; 27 : 433-9.
21) Kuroda Y, Bullock R. Local cerebral blood flow mapping before and after removal of acute subdural hematoma in the rat. Neurosurgery 1992 ; 30 : 687-91.
22) Yokobori S, Frantzen J, Bullock R, et al. The use of hypothermia therapy in traumatic ischemic/reperfusional brain injury : Review of the literatures. Ther Hypothermia Temp Manag 2011 ; 1 : 185-92.
23) Howard MA 3rd, Gross AS, Dacey RG Jr, et al. Acute subdural hematomas : an age-dependent clinical entity. J. Neurosurg 1989 ; 71 : 858-63.
24) Bruder N, N'Zoghe P, Graziani N, et al. A comparison of extradural and intraparenchymatous intracranial pressures in head injured patients. Intensive Care Med 1995 ; 21 : 850-2.
25) Raboel PH, Bartek J Jr, Andresen M, et al. Intracranial pressure monitoring : Invasive versus non-invasive methods-A review. Crit Care Res Pract 2012 ; 950393.
26) Smith WS, Weingart S. Emergency Neurological Life Support (ENLS) : what to do in the first hour of a neurological emergency. Neurocrit Care 2012 ; 17 Suppl 1 : S1-3.
27) Stevens RD, Huff JS, Duckworth J, et al. Emergency neurological life support : intracranial hypertension and herniation. Neurocrit Care 2012 ; 17 Suppl 1 : S60-5.
29) Okonkwo DO, Shutter LA, Moore C, et al. Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II : A Phase II Randomized Trial. Crit Care Med 2017 ; 45 (11) : 1907-14. doi : 10.1097/CCM.0000000000002619.
30) Maas AI, Dearden M, Servadei F, et al. Current recommendations for neurotrauma. Curr Opin Crit Care 2000 ; 6 : 281-92.
31) Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of traumatic parenchymal lesions. Neurosurgery 2006 ; 58 : S25-46.
32) Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of posterior fossa mass lesions. Neurosurgery 2006 ; 58 : S47-55.
33) Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of depressed cranial fractures. Neurosurgery 2006 ; 58 : S56-60.
34) Kelly DF, Goodale DB, Williams J, et al. Propofol in the treatment of moderate and severe head injury : a randomized, prospective double-blinded pilot trial. J Neurosurg 1999 ; 90 : 1042-52.
35) Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury : a randomized clinical trial. J Neurosurg 1991 ; 75 : 731-9.
36) Ng I, Lim J, Wong HB. Effects of head posture on cerebral hemodynamics : its influences on intracranial pressure, cerebral perfusion pressure, and cerebral oxygenation. Neurosurgery 2004 ; 54 : 593-7 ; discussion 598.
37) Ledwith MB, Bloom S, Maloney-Wilensky E, et al. Effect of body position on cerebral oxygenation and physiologic parameters in patients with acute neurological conditions. J Neurosci Nurs 2010 ; 42 : 280-7.
38) Kerr EM, Marion D, Sereika MS, et al. The effect of cerebrospinal fluid drainage on cerebral perfusion in traumatic brain injured adults. J Neurosurg Anesthesiol 2000 ; 12 : 324-33.
39) Knapp JM. Hyperosmolar therapy in the treatment of severe head injury in children : mannitol and hypertonic saline. AACN Clin 2005 ; Issues 16 : 199-211.
40) White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg 2006 ; 102 : 1836-46.
41) Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension : 2mL/kg 7.5% saline is more effective than 2mL/kg 20% mannitol. Crit Care Med 2003 ; 31 : 1683-7.
42) Battison C, Andrews PJ, Graham C, et al. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005 ; 33 : 196-202 ; discussion 257-8.
43) Pascual JL, Maloney-Wilensky E, Reilly PM, et al. Resuscitation of hypotensive head-injured patients : is hypertonic saline the answer? Am Surg 2008 ; 74 : 253-9.
44) Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury : a randomized controlled trial. JAMA 2004 ; 291 : 1350-7.
45) Sakellaridis N, Pavlou E, Karatzas S, et al. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries. J Neurosurg 2011 ; 114 : 545-8.
46) Ware ML, Nemani VM, Meeker M, et al. Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury : a preliminary study. Neurosurgery 2005 ; 57 : 727-36 ; discussion 727-36.
47) Peterson B, Khanna S, Fisher B, et al. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med 2000 ; 28 : 1136-43.
48) Kochanek PM, Carney N, Adelson PD, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents-second edition. Pediatr Crit Care Med 2012 ; 13 Suppl 1 : S1-82.
49) Taylor A, Butt W, Rosenfeld J, et al. A randomized trial of very early decompressive craniectomy in children with traumatic brain injury and sustained intracranial hypertension. Childs Nerv. Syst 2001 ; 17 : 154-62.
50) Morgalla MH, Will BE, Roser F, et al. Do long-term results justify decompressive craniectomy after severe traumatic brain injury? J Neurosurg 2008 ; 109 : 685-90.
51) Hutchinson PJ, Kolias AG, Timofeev IS, et al ; RESCUEicp Trial Collaborators. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension. N Engl J Med 2016 ; 375 (12) : 1119-30. doi : 10.1056/NEJMoa1605215. Epub 2016 Sep 7.
52) Schwartz ML, Tator CH, Rowed DW, et al. The University of Toronto head injury treatment study : a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984 ; 11 : 434-40.
53) Ward JD, Becker DP, Miller JD, et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985 ; 62 : 383-8.
55) Sganzerla EP, Tomei G, Rampini P, et al. A peculiar intracerebral hemorrhage : the gliding contusion, its relationship to diffuse brain damage. Neurosurg Rev 1989 ; 12 Suppl 1 : 215-8.
56) Yokota H, Naoe Y, Nakabayashi M, et al. Cerebral endothelial injury in severe head injury : the significance of measurements of serum thrombomodulin and the von Willebrand factor. J Neurotrauma 2002 ; 19 : 1007-15.
57) Stocchetti N, Paterno R, Citerio G, et al. Traumatic brain injury in an aging population. J Neurotrauma 2012 ; 29 : 1119-25.
58) Wong GK, Yeung JH, Graham CA, et al. Neurological outcome in patients with traumatic brain injury and its relationship with computed tomography patterns of traumatic subarachnoid hemorrhage. J Neurosurg 2011 ; 114 : 1510-5.
59) Bekar A, Dogan S, Abas F, et al. Risk factors and complications of intracranial pressure monitoring with a fiberoptic device. J Clin Neurosci 2009 ; 16 : 236-40.
60) Gelabert-Gonzalez M, Ginesta-Galan V, Sernamito-Garcia R, et al. The Camino intracranial pressure device in clinical practice. Assessment in a 1000 cases. Acta Neurochir (Wien) 2006 ; 148 : 435-41.
61) Stendel R, Heidenreich J, Schilling A, et al. Clinical evaluation of a new intracranial pressure monitoring device. Acta Neurochir (Wien) 2003 ; 145 : 185-93 ; discussion 193.
62) Hong WC, Tu YK, Chen, YS, et al. Subdural intracranial pressure monitoring in severe head injury : clinical experience with the Codman MicroSensor. Surg Neurol 2006 ; 66 Suppl 2 : S8-337 S13.
63) Koskinen LO, Olivecrona M. Clinical experience with the intraparenchymal intracranial pressure monitoring Codman MicroSensor system. Neurosurgery 2005 ; 56 : 693-8 ; discussion 693-8.
64) Lescot T, Reina V, Le Manach Y, et al. In vivo accuracy of two intraparenchymal intracranial pressure monitors. Intensive Care Med 2011 ; 37 : 875-9.
65) Al-Tamimi YZ, Helmy A, Bavetta S, et al. Assessment of zero drift in the Codman intracranial pressure monitor : a study from 2 neurointensive care units. Neurosurgery 2009 ; 64 : 94-8 ; discussion 98-9.
P.360 掲載の参考文献
1) Nakaguchi H, Tanishima T, Yoshimasu N. Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 2001 ; 95 : 256-62.
2) Ohno K, Suzuki R, Masaoka H, et al. Chronic subdural hematoma preceded by persistent traumatic subdural fluid collection. J Neurol Neurosurg Psychiatry 1987 ; 50 : 1694-7.
3) Lee KS, Bae WK, Bae HG, et al. The fate of traumatic subdural hygroma in serial computed tomographic scans. J Korean Med Sci 2000 ; 15 : 560-8.
4) Kageyama H, Toyooka T, Tsuzuki N, et al. Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. J Neurosurg 2013 ; 119 : 332-7.
5) 宮上光祐, 賀川幸英. 慢性硬膜下血腫に対する五苓散の有用性. No Shinkei Geka 2009 ; 37 : 765-70.
6) 長谷川秀, 松元淳, 大田和貴, 他. 慢性硬膜下血腫に対する柴苓湯の治療効果. 脳神経外科と漢方 2015 ; 1 : 7-12.
7) Thotakura AK, Marabathina NR. Nonsurgical Treatment of Chronic Subdural Hematoma with Steroids. World Neurosurg 2015 ; 84 : 1968-72.
8) Holl DC, Volovici V, Dirven CMF, et al. Dutch Chronic Subdural Hematoma Research Group. Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma : From Past to Present to Future. World Neurosurg 2018 ; 116 : 402-11.
9) Chari A1, Kolias AG, Santarius T, et al. Twist-drill craniostomy with hollow screws for evacuation of chronic subdural hematoma. J Neurosurg 2014 ; 121 : 176-83.
10) Lega BC, Danish SF, Malhotra NR, et al. Choosing the best operation for chronic subdural hematoma : a decision analysis. J Neurosurg 2010 ; 113 : 615-21.
11) Brennan PM, Kolias AG, Joannides AJ, et al. The management and outcome for patients with chronic subdural hematoma : a prospective, multicenter, observational cohort study in the United Kingdom. J Neurosurg 2017 Mar 17 : 1-8. doi : 10.3171/2016.8.JNS16134.test.
13) Alcala-Cerra G, Young AM, Moscote-Salazar LR. Efficacy and safety of subdural drains after burr-hole evacuation of chronic subdural hematomas : systematic review and meta-analysis of randomized controlled trials. World Neurosurg 2014 ; 82 : 1148-57.
14) Yuan Y, Wang QP, Cao YL, et al. Burr hole drainage and burr hole drainage with irrigation to treat chronic subdural hematoma : A systematic review and meta-analysis. Medicine (Baltimore) 2018 ; 97 : e11827.
15) 高山東春, 照井慶太, 大岩美嗣. 慢性硬膜下血腫の再発因子に関する後ろ向き統計学的分析 : 単変量,多変量解析による検討. No Shinkei Geka 2002 ; 40 : 871-6.
17) Ducruet AF, Grobelny BT, Zacharia BE. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012 ; 35 : 155-69.
18) Mino M, Nishimura S, Hori E, et al. Efficacy of middle meningeal artery embolization in the treatment of refractory chronic subdural hematoma. Surg Neurol Int 2010 ; 1 : 78.
P.364 掲載の参考文献
1) Povlishock JT, Christman CW. The pathobiology of traumatically induced axonal injury in animals and humans : a review of current thoughts. J Neurotrauma 1995 ; 12 : 555-64.
2) Jennett B, Adams JH, Murray LS, et al. Neuropathology in vegetative and severely disabled patients after head injury. Neurology 2001 ; 56 : 486-90.
3) Mittl RL, Grossman RI, Hiehle JF, et al. Prevalence of MR evidence of diffuse axonal injury in patients with mild head injury and normal head CT findings. AJNR Am J Neuroradiol 1994 ; 15, 1583-89.
4) Inglese M, Makani S, Johnson G, et al. Diffuse axonal injury in mild traumatic brain injury : a diffusion tensor imaging study. J Neurosurg 1994 ; 103 : 298-303.
5) Scheid R, Preul C, Gruber O, et al. Diffuse axonal injury associated with chronic traumatic brain injury : evidence from T2*-weighted gradientecho imaging at 3T. AJNR Am J Neuroradiol 2003 ; 24 : 1049-56.
6) Ezaki Y, Tsutsumi K, Morikawa M, et al. Role of diffusion-weighted magnetic resonance imaging in diffuse axonal injury. Acta Radiol 2006 ; 47 : 733-40.
7) Benson RR, Meda SA, Vasudevan S, et al. Global white matter analysis of diffusion tensor images is predictive of injury severity in traumatic brain injury. J Neurotrauma 2007 ; 24 : 446-59.
8) Wang JY, Bakhadirov K, Devous MD Sr, et al. Diffusion tensor tractography of traumatic diffuse axonal injury. Arch Neurol 2008 ; 65 : 619-26.
10) Honeybul S, Ho KM, Lind CR, et al. The future of decompressive craniectomy for diffuse traumatic brain injury. J Neurotrauma 2011 ; 28 : 2199-200.
11) Kitagawa RS, Bullock MR. Lessons from the DECRA Study. World Neurosurg 2012.
12) Ding K, Marquez de la Plata C, Wang JY, et al. Cerebral atrophy after traumatic white matter injury : correlation with acute neuroimaging and outcome. J Neurotrauma 2008 ; 25 : 1433-40.
13) Eisenberg HM, Gary HE J, Aldrich EF, et al. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1990 ; 73 : 688-98.
14) Marmarou A, Fatouros PP, Barzo P, et al. Contribution of edema and cerebral blood volume to traumatic brain swelling in headinjured patients. J Neurosurg 2000 ; 93 : 183-93.
15) Miller JD, Butterworth JF, Gudeman SK, et al. Further experience in the management of severe head injury. J Neurosurg 1981 ; 54 : 289-99.
16) Aldrich EF, Eisenberg HM, Saydjari C, et al. Diffuse brain swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1992 ; 76 : 450-4.
17) Bruce DA, Alavi A, Bilaniuk L, et al. Diffuse cerebral swelling following head injuries in children : the syndrome of "malignant brain edema". J Neurosurg 1981 ; 54 : 170-178.
18) Zwienenberg, M, Muizelaar JP. Severe pediatric head injury : the role of hyperemia revisited. J Neurotrauma 1999 ; 16, 937-43.
19) Unterberg AW, Stover J, Kress B, et al. Edema and brain trauma. Neuroscience 2004 ; 129, 1021-29.
20) Bullock R, Butcher S, McCulloch J. Changes in extracellular glutamate concentration after acute subdural haematoma in the rat-evidence for an "excitotoxic" mechanism? Acta Neurochir Suppl (Wien) 1990 ; 51 : 274-6.
21) Lang DA, Hadley DM, Teasdale GM, et al. Gadolinium DTPA enhanced magnetic resonance imaging in acute head injury. Acta Neurochir (Wien) 1991 ; 109, 5-11.
22) Todd NV, Graham DI. Blood-brain barrier damage in traumatic brain contusions. Acta Neurochir Suppl (Wien) 1990 ; 51 : 296-9.
23) Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017 ; 80 (1) : 6-15. doi : 10.1227/NEU.0000000000001432.
24) Jacob AT, Heuer GG, Grant R, et al. Decompressive hemicraniectomy for pediatric traumatic brain injury : long-term outcome based on quality of life. Pediatr Neurosurg 2011 ; 47 : 81-6.
25) Lang DA, Teasdale GM, Macpherson P, et al. Diffuse brain swelling after head injury : more often malignant in adults than children? J Neurosurg 1994 ; 80 : 675-80.
26) Iwamura A, Taoka T, Fukusumi A, et al. Diffuse vascular injury : convergent-type hemorrhage in the supratentorial white matter on susceptibility-weighted image in cases of severe traumatic brain damage. Neuroradiology 2012 ; 54 : 335-43.
27) Onaya M. Neuropathological investigation of cerebral white matter lesions caused by closed head injury. Neuropathology 2002 ; 22 : 243-51.
P.376 掲載の参考文献
1) Gladwell M, Viozzi C. Temporal bone fractures : a review for the oral and maxillofacial surgeon. J Oral Maxillofac Surg 2008 ; 66 : 513-22.
2) Read HS, Johnstone AJ, Scobie WG. Skull fractures in children : altered conscious level is the main indication for urgent CT scanning. Injury 1995 ; 26 : 333-4.
3) Wilberger J, Chen DA. Management of head injury. The skull and meninges. Neurosurg Clin N Am 1991 ; 2 : 341-50.
4) 重症頭部外傷治療管理のガイドライン作成委員会. 重症頭部外傷治療・管理のガイドライン 第3版, 医学書院, 東京, 2103.
5) Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of depressed cranial fractures. Neurosurgery 2006 ; 58 : S56-60.
6) Lopez-Elizalde R, Leyva-Mastrapa T, Munoz-Serrano JA, et al. Ping pong fractures : treatment using a new medical device. Childs Nerv Syst 2013 ; 29 : 679-83.
7) Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017 ; 80 (1) : 6-15. doi : 10.1227/NEU.0000000000001432.
8) Brawley BW, Kelly WA. Treatment of basal skull fractures with and without cerebrospinal fluid fistulae. J Neurosurg 1967 ; 26 : 57-61.
9) Ghorayeb BY, Yeakley JW. Temporal bone fractures : longitudinal or oblique? The case for oblique temporal bone fractures. Laryngoscope 1992 ; 102 : 129-34.
10) Dahiya R, Keller JD, Litofsky NS, et al. Temporal bone fractures : otic capsule sparing versus otic capsule violating clinical and radiographic considerations. J. Trauma 1999 ; 47 : 1079-83.
11) Little SC, Kesser BW. Radiographic classification of temporal bone fractures : clinical predictability using a new system. Arch Otolaryngol Head Neck Surg 2006 ; 132 : 1300-4.
12) Hato N, Nota J, Hakuba N, et al. Facial nerve decompression surgery in patients with temporal bone trauma : analysis of 66 cases. J Trauma 2011 ; 71 : 1789-92 ; discussion 1792-3.
13) Davis RE, Telischi FF. Traumatic facial nerve injuries : review of diagnosis and treatment. J Craniomaxillofac Trauma 1995 ; 1 : 30-41.
14) Yang QT, Zhang GH, Liu X, et al. The therapeutic efficacy of endoscopic optic nerve decompression and its effects on the prognoses of 96 cases of traumatic optic neuropathy. J Trauma Acute Care Surg 2012 ; 72 : 1350-5.
15) Eljamel MS, Foy PM. Post-traumatic CSF fistulae, the case for surgical repair. Br J Neurosurg 1990 ; 4 : 479-83.
16) Leech PJ, Paterson A. Conservative and operative management for cerebrospinal-fluid leakage after closed head injury. Lancet 1973 ; 1 : 1013-6.
17) de Man K, Wijngaarde R, Hes J, et al. Influence of age on the management of blow-out fractures of the orbital floor. Int J Oral Maxillofac Surg 1991 ; 20 : 330-6.
P.391 掲載の参考文献
1) 中村紀夫, 平川公義, 橋爪敬三. 幼小児頭部外傷の特殊性 診断と治療方針. 大日本製薬株式会社, 1970.
2) Kochanek PM, Carney N, Adelson PD, et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. Pediatr Crit Care Med 2012 ; Suppl 1. S1-82.
3) 日本脳神経外科学会, 日本神経外傷学会. 重症頭部外傷治療・管理のガイドライン 第4版. (出版前), 2019.
4) Mikrogianakis A, Valani R, Cheng A. The hospital for sick children manual of pediatric trauma. Lippincott, Williams & Wilkins, 2008.
5) Division of Injury Control, Center for Environmental Health and Injury Control, Centers for Disease Control : Childhood injuries in the United States. Am J Dis Child 1990 ; 144 : 627-46.
6) Wallen E, Venkataraman ST, Grosso J. Intrahospital transport of critically ill patients. Crit Care Med 1995 ; 23 : 1588-95.
7) Pediatric Advanced Life Support. American Heart Association, 2007.
8) Stiell IG, et al. The Canadian CT head rule for patients with minor head injury. Lancet 2001 ; 357 : 1391-6.
9) Stiell IG, et al. Comparison of the Canadian CT head rule and the New Orleans criteria in patients with minor head injury. JAMA 2005 ; 294 : 1511-8.
10) Lyttle MD, Cheek JA, Blackburn C, et al. Applicability of the CATCH, CHALICE and PECARN paediatric head injury clinical decision rules : pilot data from a single Australian centre. Emerg Med J 2013 ; 30 : 790-4.
11) Kuppermann N, Holmes JF, Dayan PS, et al. Identification of children at very low risk of clinically-important brain injuries after head trauma : a prospective cohort study. Lancet 2009 ; 374 : 1160-70.
14) Pandor A, Goodacre S, Harnan S, et al. Diagnostic management strategies for adults and children with minor head injury : a systematic review and an economic evaluation. Health Technology Assessment 2011 ; 15 (27) : 1-202.
15) Head Injury : Triage, assessment, investigation and early management of head injury in children, young people and adults. CG 176 (Partial update of NICE CG56) Methods, evidence and recommendations January 2014 Commissioned by the National Institute for Health and Care Excellence.
16) Zimmerman RA, Bilaniuk LT, Bruce D, et al. Computed tomography of pediatric head trauma : acute general cerebral swelling. Radiology 1978 ; 126 : 403-8.
17) Duhaime AC, Durham S. Traumatic brain injury in infants : the phenomenon of subdural hemorrhage with hemispheric hypodensity ("Big Black Brain"). Prog Brain Res 2007 ; 161 : 293-302.
18) Marmarou A, Barzo P, Fatourous P. Traumatic brain swelling in head injured patients : brain edema or vascular engorgement? Acta Neurochir Suppl (Wien) 1997 ; 70 : 68-70.
19) Ferrazzano PA, Rosario BL, Wisniewski SR, et al. Use of magnetic resonance imaging in severe pediatric traumatic brain injury : assessment of current practice. J Neurosurg Pediatr 2019 ; 1-9.
20) Dixon RR, Nocera M, Zolotor AJ, et al. Intracranial Pressure Monitoring in Infants and Young Children With Traumatic Brain Injury. Pediatr Crit Care Med 2016 ; 17 : 1064-72.
21) Alkhoury F, Kyriakides TC. Intracranial Pressure Monitoring in Children With Severe Traumatic Brain Injury : National Trauma Data Bank-Based Review of Outcomes. JAMA Surg 2014 ; 49 : 544-8.
22) Bell MJ, Adelson PD, Hutchison JS, et al. Differences in medical therapy goals for children with severe traumatic brain injury-an international study. Pediatr Crit Care Med 2013 ; 14 : 811-8.
23) Chambers IR, Stobbart L, Jones PA, et al. Age-related differences in intracranial pressure and cerebral perfusion pressure in the first 6 hours of monitoring after children's head injury : association with outcome. Childs Nerv Syst 2005 ; 21 : 195-9.
24) Shein SL, Ferguson NM, Kochanek PM, et al. Effectiveness of Pharmacological Therapies for Intracranial Hypertension in Children With Severe Traumatic Brain Injury--Results From an Automated Data Collection System Time-Synched to Drug Administration. Pediatr Crit Care Med 2016 ; 17 : 236-45.
25) Pfisterer W, Muhlbauer M, Czech T, et al. Early diagnosis of external ventricular drainage infection : results of a prospective study. J Neurol Neurosurg Psychiatry 2003 ; 74 : 929-32.
27) Goldsmith W, Plunkett J. A biomechanical analysis of the causes of traumatic brain injury in infants and children. Am J Forensic Med Pathol 2004 ; 25 : 89-100.
28) Duhaime AC, Christian CW, Rorke LB, et al. Nonaccidental head injury in infants-the "shaken-baby syndrome". N Engl J Med 1998 ; 338 : 1822-9.
30) Costine-Bartell BA, McGuone D, Price G, et al. Development of a Model of Hemispheric Hypodensity ("Big Black Brain"). J Neurotrauma. 2018 Sep 14. doi : 10.1089/neu.2018.5736.
31) 三木保, 原岡嚢. 本邦における小児虐待 : 脳神経外科医の役割. Jpn J Neurosurg 2007 ; 16 : 26-35.
32) Matlung SE, Bilo RAC, et al. Multicystic encephalomalacia as an end-stage finding in abusive head trauma. Forensic Sci Med Pathol 2011 ; 7 : 355-63.
33) Sharples PM, Stuart AG, Matthews DSF. Cerebral blood flow and metabolism in children with severe head injury. Part 1 : relation to age, Glasgow coma score, outcome, intracranial pressure, and time after injury. J Neurol Neurosurg Psychiatry 1995 ; 58 : 145-52.
34) Allen BB, Chiu YL, Gerber LM, et al. Age-specific cerebral perfusion pressure thresholds and survival in children and adolescents with severe traumatic brain injury. Pediatr Crit Care Med 2014 ; 15 : 62-70.
35) Downard C, Hulka F, Mullins RJ. Relationship of cerebral perfusion pressure and survival in pediatric brain-injured patients. J Trauma 2000 ; 49 : 654-8.
36) Shapiro K, Marmarou A. Clinical applications of the pressure volume index in treatment of pediatric head injuries. J Neurosurg 1982 ; 56 : 819-25.
37) Lewis PM, Czosnyka M, Carter BG, et al. Cerebrovascular Pressure Reactivity in Children With Traumatic Brain Injury. Pediatr Crit Care Med 2015 ; 16 : 739-49.
38) Young AM, Donnelly J, Czosnyka M, et al. Continuous Multimodality Monitoring in Children after Traumatic Brain Injury-Preliminary Experience. PLoS One 2016 ; 11 (3).
39) Hsiang JK, Chestnut RM, Crisp CB. Early, routine paralysis for ICP control in severe head injury : is it necessary? Crit Care Med 1994 ; 22 : 1471-6.
40) Fortune JB, Feustel PJ, Graca L. Effect of hyperventilation, mannitol, and ventriculostomy drainage on cerebral blood flow after head injury. J Trauma 1995 ; 39 : 1091-9.
41) White JR, Farukhi Z, Bull C. Predictors of outcome in severely head-injured children. Crit Care Med 2001 ; 29 : 534-40.
42) Khanna S, Davis D, Peterson B. Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000 ; 28 : 1144-51.
43) Araki T, Yokota H, Morita A. Pediatric Traumatic Brain Injury : Characteristic Features, Diagnosis, and Management. Neurol Med Chir (Tokyo) 2017, 57 : 82-93.
44) Roberts I, Sydenham E. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev 2012 ; 12 : CD000033. doi : 10.1002/14651858.CD000033.pub2.
45) Goodman JC, Valadka AB, Gopinpath SP. Lactate and excitatory amino acids measured by microdialysis are decreased by pentobarbital coma in head-injured patients. J Neurotrauma 1996 ; 13 : 549-56.
46) Mellion SA, Bennett KS, et al. High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury. Pediatr Crit Care Med 2013 ; 14 : 1-9.
47) Bruce DA, Alavi A, Bilaniuk L. Diffuse cerebral swelling following head injuries in children : the syndrome of "malignant brain edema". J Neurosurg 1981 ; 54 : 170-8.
48) Muizelaar JP, Marmarou A, Ward JD. Adverse effects of prolonged hyperventilation in patients with severe head injury : a randomized clinical trial. J Neurosurg 1991 ; 75 : 731-9.
49) Hutchison JS, Ward RE, Lacroix J, et al. Hypothermia therapy after traumatic brain injury in children. N Engl J Med 2008 ; 358 : 2447-56.
50) Polin RS, Shaffrey ME, Bogaev CA. Decompressive bifrontal craniectomy in the treatment of severe refractory posttraumatic cerebral edema. Neurosurgery 1997 ; 41 : 84-94.
51) Mhanna MJ, Mallah WE, Verrees M, et al. Outcome of children with severe traumatic brain injury who are treated with decompressive craniectomy. J Neurosurg Pediatr 2015 ; 16 : 508-14.
52) Taylor A, Butt W, Rosenfeld J, et al. A randomized trial of very early decompressive craniectomy in children with traumatic brain injury and sustained intracranial hypertension. Childs Nerv Syst 2001 ; 17 : 154-62.
53) Jagannathan J, Okonkwo DO, Dumont AS, et al. Outcome following decompressive craniectomy in children with severe traumatic brain injury : a 10-year single-center experience with long-term follow up. J Neurosurg (4 Suppl Pediatrics) 2007 ; 106 : 268-75.
54) Levin HS, Eisenberg HM, Wigg NR, et al. Memory and intellectual ability after head injury in children and adolescents. Neurosurgery 1982 ; 11 : 668-73.
55) Schrieff -Elson LE, Steenkamp N, Hendricks MI, et al. Local and global challenges in pediatric traumatic brain injury outcome and rehabilitation assessment. Childs Nerv Syst. 2017, 33 : 1775-84.
56) 栗原まな. 脳外傷. 小児リハビリテーション医学. 医歯薬出版, 東京, 2006, p173-182.
P.405 掲載の参考文献
1) 独立行政法人日本スポーツ振興センター学校安全部安全支援課 : 「学校の管理下における体育活動中の事故の傾向と事故防止に関する調査研究」-体育活動における頭頚部外傷の傾向と事故防止の留意点-. 調査研究報告書 第2編 体育活動における頭頚部外傷の傾向.
3) Mueller FO. Catastrophic Head Injuries in High School and Collegiate Sports. J Athl Train 2001 ; 36 : 312-5.
4) 谷諭, 川又達朗, 荻野雅宏, 他. スポーツにおける頭部外傷 (頻度, 分類, 特殊性など). 臨床スポーツ医学 2008 ; 25 : 309-12.
5) 永廣信治, 谷諭, 荻野雅宏, 他. スポーツ頭部外傷における脳神経外科医の対応 ガイドライン作成に向けた中間提言. 神経外傷 2013 ; 36 : 119-28.
6) 永廣信治. 柔道と頭部外傷. 日医会誌 2014 ; 142 : 2464-6.
7) 永廣信治, 溝渕佳史. スポーツ頭部外傷を可視化する. 脳外誌 2014 ; 23 : 957-64.
8) 永廣信治, 溝渕佳史, 本藤秀樹, 他. 柔道における重症頭部外傷. No Shinkei Geka 2011 ; 39 : 1139-47.
9) 重症頭部外傷治療・管理のガイドライン作成委員会 編. 重症頭部外傷治療・管理のガイドライン 第3版. 医学書院, 東京, 2013, p89.
10) 前田剛. 急性硬膜外血腫. 頭頚部・体幹のスポーツ外傷. メジカルビュー社, 東京, 2017, 36.
11) Giza CC, Kutcher JS, Ashwal S, et al. Summary of evidence-based guideline update : evaluation and management of concussion in sports : report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2013 ; 80 : 2250-7.
12) Guskiewicz KM, McCrea M, Marshall SW, et al. Cumulative effects associated with recurrent concussion in collegiate football players : the NCAA Concussion Study. JAMA 2003 ; 290 : 2549-55.
16) 平川公義. スポーツによる脳振盪-脳振盪と硬膜下血腫-. 臨床スポーツ医学 1991 ; 8 : 147-52.
18) Kelly JP, Rosenberg JH. Diagnosis and management of concussion in sports. Neurology 1997 ; 48 : 575-80.
19) McCrory P, Meeuwisse W, Dvorak J, et al. Consensus statement on concussion in sport-the 5th international conference on concussion in sport held in Berlin, October 2016. Br J Sports Med 2017 ; 51 : 838-47.
20) 溝渕佳史, 永廣信治, 他. スポーツにおける脳振盪に関する共同声明-第4回国際スポーツ脳振盪会議-. 神経外傷 2016 ; 39 : 1-26.
21) Mori T, Katayama Y, Kawamata T. Acute hemispheric swelling associated with thin subdural hematomas : pathophysiology of repetitive head injury in sports. Acta Neurochir Suppl 2006 ; 96 : 40-3.
22) Bailes JE, Petraglia AL, Omalu BI, et al. Role of subconcussion in repetitive mild traumatic brain injury. J Neurosurg 2013 ; 119 : 1235-45.
23) Silverberg ND, Iverson GL. Etiology of the post-concussion syndrome : Physiogenesis and Psychogenesis revisited. NeuroRehabilitation 2011 ; 29 : 317-29.
24) Lishman WA. Physiogenesis and psychogenesis in the 'post-concussional syndrome'. Br J Psychiatry 1988 ; 153 : 460-9.
25) McKee AC, Stein TD, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain 2013 ; 136 : 43-64.
26) Hernandez F, WuL C, Yip MC, et al. Erratum to : Six Degree-of-Freedom Measurements of Human Mild Traumatic Brain Injury. Ann Biomed Eng 2016 ; 44 (3) : 828-9.
27) McCrea M, Guskiewicz K, Randolph C. Effects of a symptom-free waiting period on clinical outcome and risk of reinjury after sport-related concussion. Neurosurgery 2009 ; 65 : 876.
29) Lishman WA. Physiogenesis and psychogenesis in the 'post-concussional syndrome'. Br J Psychiatry 1988 ; 153 : 460-9.
30) Ommaya AK, Gennarelli TA. Cerebral concussion and traumatic unconsciousness. Correlation of experimental and clinical observations of blunt head injuries. Brain 1974 ; 97 : 633-54.
31) 溝渕佳史, 他. 脳振盪への対応. 救急医学 2018 ; 42.
32) McKee AC, Cantu RC, Nowinski CJ, et al. Chronic traumatic encephalopathy in athletes : progressive tauopathy after repetitive head injury. J Neuropathol Exp Neurol 2009 ; 68 (7) : 709-35.
33) Baugh CM, Stamm JM, Riley DO, et al. Chronic traumatic encephalopathy : neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav 2012 ; 6 (2) : 244-54.
34) McCrory P, Meeuwisse WH, Kutcher JS, et, al. What is the evidence for chronic concussion-related changes in retired athletes : behavioural, pathological and clinical outcomes? Br J Sports Med 2013 ; 47 (5) : 327-30.
35) Tator CH. Chronic traumatic encephalopathy : how serious a sports problem is it? Br J Sports Med 2014 ; 48 (2) : 81-3.

[V] 脊髄・脊椎疾患

P.441 掲載の参考文献
1) 金 彪. 頚椎・頚髄のガイドブック 初診から顕微鏡手術まで. メジカルビュー社, 東京, 2007.
2) 下津浦広之, 井上聖啓. デルマトーム図. 脊椎外科 2012 ; 26 : 147-61.
3) Kadoya S. Grading and scoring system for neurological function in degenerative cervical spine disease- Neurosurgical Cervical Spine Scale. Nurol Med Chir (Tokyo) 1992 ; 32 : 40-1.
4) American Spinal Injury Association. International standards for neurological classification of spinal cord injury, revised 2000. 6th ed, American Spinal Injury Association, Chicago, IL, 2000.
5) 石原明. 正常人の頚椎柱彎曲に関するX線学的研究. 日整会誌 1968 ; 42 : 1033-44.
6) 阿部弘, 都留美都雄, 三森研自, 他. Atlanto-axial dislocation, Instability indexと手術適応. No Shinkei Geka 1976 ; 4 : 57-72.
7) 秋野実. 環軸椎脱臼. 脳神経外科疾患の手術と適応 I (阿部弘, 菊地晴彦, 田中隆一, 他編). 朝倉書店, 東京, 1990, p651-66.
8) Hollis PH, Malis LI, Zappulla RA. Neurological deterioration after lumbar puncture below complete spinal subarachnoid block. J Neurosurg 1986 ; 64 : 253-6.
9) 藤原佳樹. 頚部頚髄症の治療予後と関連する因子の研究. 日整会誌 1987 ; 61 : 143-54.
10) 岩崎洋明, 他. 頚椎症性脊髄症の画像診断. 整・災害 1986 ; 29 : 253-67.
11) 糸岐一茂, 金彪, 新郷哲郎, 他. 腰椎変性疾患におけるMRI curved-MPR画像の有用性. Spinal Surgery 2013 ; 27 (1) : 74-6.
12) 山口智, 武田正明, 梶原洋介, 他. 320列area detector CTを用いた脊髄疾患4D imagingの試み. Spinal Surgery 2012 ; 26 (3) : 322-4.
13) Yamamoto S, Kanaya H, Kim P. Spinal intraarterial computed tomography angiography as an effective adjunct for spinal angiography. J Neurosurg Spine 2015 ; 23 : 360-7.
14) Taniguchi M, Cedzich C, Schramm J. Modification of electric cortical stimulation technique for motor evoked potential monitoring under general anesthesia : Technical description. Neurosurgery 1993 ; 32 : 219-26.
15) Calancie B, Harris W, Broton JG, et al. "Thresholdlevel" multipulse transcranial electrical stimulation of motor cortex for intraoperative monitoring of spinal motor tracts : description of method and comparison to somatosensory evoked potential monitoring. J Neurosurg 1998 ; 88 : 457-70.
16) Kurokawa R, Kim P, Itoki K, et al. False positive and false negative results of motor evoked potential monitoring during surgery for intramedullary spinal cord tumors. Oper Neurosurg (Hagerstown) 2018 ; 14 : 279-87. Operative Neurosurgery, opx113. https://doi.org/10.1093/ons/opx113Published : 16 May 2017 Article history. https://doi.org/10.1093/ons/opx113
17) Itoki K, Kurokawa R, Shingo T, et al. Effect of Myoarchitectonic Spinolaminoplasty on Concurrent Hypertension in Patients with Cervical Spondylotic Myelopathy. Neurospine 2018 ; 15 (1) : 77-85.
18) Kim P, Murata H, Kurokawa R, et al. Myoarchitectonic spinolaminoplasty : efficacy in reconstituting the cervical musculature and preserving biomechanical function. J Neurosurg Spine 2007 ; 7 : 293-304.
19) 川本俊樹, 金彪. 頸椎後方手術 (筋層構築的棘突起椎弓形成術) 脊椎脊髄手術に必要な基本的知識. No Shinkei Geka 2013 ; 41 (12) : 1119-29.
20) Kim P, Wakai S, Matsuo S, et al. Bisegmental cervical interbody fusion using hydroxyapatite implants : Surgical results and long-term observation in 70 cases. J Neurosurg 1998 ; 88 : 21-7.
21) 金彪, 川本俊樹, 朝来野佳三. ハイドロキシアパタイトを用いた頚椎前方手術と長期成績. 脊椎脊髄 2000 ; 13 : 20-6.
22) Koyama T, Handa J. Cervical laminoplasty using apatite beads as implants : Experiences in 31 patients with compressive myelopathy due to developmental canal stenosis. Surg Neurol 1985 ; 24 : 663-7.
23) 川本俊樹. 椎弓切除術 棘突起縦割法 (lateral recess stenosisを含む). 脊椎脊髄外科サージカル・テクニック. メジカルビュー社, 東京, 2013, p212-9.
24) Kim P, Ebersold MJ, Onofrio BM. Surgery of spinal nerve schwannoma. Risk of neurological deficit after resection of involved root. J Neurosurg 1989 ; 71 : 810-14.
25) 金彪, 黒川龍. 上衣腫 脊髄腫瘍の最新動向 脊髄腫瘍-各腫瘍の概説ならびに手術手技のポイント. 脊椎脊髄 2009 ; 22 (1) : 41-54.
26) Kondziella D, Brodersen P, Laursen H, et al. Cavernous hemangioma of the spinal cordconservative or operative management? Acta Neurol Scand 2006 ; 114 : 287-90.
27) Gilbert RW, Kim JH, Posner JB. Epidural spinal compression from metastatic tumor : diagnosis and treatment. Ann Neurol 1978 ; 3 : 40-51.
28) 金彪, 川本俊樹, 朝来野佳三. 経皮的椎体形成術の適応と基本手技. 脊椎脊髄 2003 ; 16 : 939-44.
29) Vargas MI, Nguyen D, Viallon M, et al. Dynamic MR angiography (MRA) of spinal vascular disease at 3T. Eur Radiol 2010 ; 20 : 2491-5.
30) Kendall BE, Louge V. Spinal epidural angiomatous malformations draining into intrathecal veins. Neuroradiology 1977 ; 13 : 181-9.
31) Yamamoto S, Kim P, Abe Y, et al. Bone temperature elevation by drilling friction and neurological outcome in the cervical spino-laminoplasty. Acta Neurochir (Wien) 2013 ; 155 : 2321-5.
32) 小野寺俊輔, 西川昇, 白土博樹, 飛騨一利. 髄内動静脈奇形に対する定位放射線治療. 脊椎脊髄 2011 ; 24 (4) : 289-93.
33) Kulkarni MV, McArdle CB, Kopanicky D, et al. Acute spinal cord injury : MR imaging at 1.5T. Radiology 1987 ; 164 : 837-43.
34) Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylpredonisolone or naloxone in the treatment of acute spinalcord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990 ; 322 : 1405-11.
35) 大谷清, 阿部弘, 角家暁, 他. 急性期脊髄損傷に対するコハク酸メチルプレドニゾロンナトリウムの臨床成績. 脊椎脊髄 1994 ; 7 : 633-47.
36) Short DJ, El Masry WS, Jones PW. High dose methylpredonisolone in the management of acute spinal cord injury : a systemic review from a clinical respective. Spinal Cord 2000 ; 38 : 273-86.
37) Coleman WP, Benzel E, Cahill DW, et al. A clinical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II or III) of methylpredonisolone in acute spinal cord injury. J Spinal Disord 2000 ; 13 : 185-99.
38) Section on disorders of the spine and peripheral nerves of the American Association of Neurological Surgeons and Congress of Neurological Surgeons : Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery 2002 ; 50 (supplement).
39) Ratlife JK, Cooper PR. Cervical laminoplasty : a critical review. J Neurosurg (Spine 3) 2003 ; 98 : 230-8.
40) Caputy AJ, Luessenhop AJ. Long-term evaluation of decompressive surgery for degenerative lumbar stenosis. J Neurosurg 1992 ; 77 : 669-79.

[VI] 小児 ( 新生児, 乳児 )

P.457 掲載の参考文献
1) Nyberg DA, ed. Diagnostic Imaging of Fetal Abnormalities. Lippincott Williams & Wilkins, Philadelphia, 2003.
2) 胎児水頭症ガイドライン編集委員会編. 胎児水頭症-診断と治療ガイドライン 改訂2版. 金芳堂, 京都, 2010.
3) Galioti P, Danelon D, Bontempo S, et al. Fetal cerebral ventriclomegaly : outcome in 176 cases. Ultrasound Obset Genecol 2005 ; 25 : 372-77.
4) Boran P, Oguz F, Furman A, et al. Evaluation of fontanel size variation and closure time in children followed up from birth to 24 months. J Neurosurg Pediatr 2018 ; 22 : 323-29.
5) 坂本博昭. 3章 患者・家族への説明 §1 インフォームド・コンセント. 小児脳神経外科学 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p129-39.
6) Pang D, Zovickian J, Wong ST, et al. Limited dorsal myeloschisis : a not-so-rare form of primary neurulation defect. Childs Nerv Syst 2013 ; 29 : 1459-84.
7) Weprin BE, Oakes WJ. Coccygeal pits. Pediatrics 2000 ; 105 : E69.
8) 川名信, 和名由布子. 小児脳神経外科疾患の麻酔・鎮静法. 小児脳神経外科診療ガイドブック. メジカルビュー社, 東京, 2013, p46-51.
9) 坂本博昭, 松坂康弘. 小児脳神経外科領域での周術期管理. 脳外誌 2013 ; 22 : 269-75.
10) 小宮山正樹. 4章 治療 §3 血管内治療 小児脳神経外科 (横田晃, 監修, 山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2009, p194-215.
11) てんかん診療ガイドライン
12) 依藤亨. 12章 脳神経外科医が知っておくべき各領域の知識 §4 内分泌領域. 小児脳神経外科学 (山崎麻美, 坂本博昭, 編集), 金芳堂, 京都, 2015, p972-83.
13) 新井一. 4章 治療 §2 手術治療 2. 手術総論. 小児脳神経外科学 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p162-7.
14) 坂本博昭. I 総論 小児脳神経外科手術 (頭蓋・脊椎) の基本. 小児脳神経外科診療ガイドブック. メジカルビュー社, 東京, 2013, p2-13.
P.467 掲載の参考文献
1) Detwiler PW, Porter RW, Rekate HL. Hydrocephalus-Clinical features and management. In ; Choux M, et al, eds. Pediatric neurosurgery. Churchill Livingstone, 1999, p254-71.
2) Barkovich AJ, Edwards MSB. Applications of neuroimaging in hydrocephalus. Pediatr Neurosurg 1992 ; 18 : 65-83.
3) 山田晋也, 諸星行男, 宮崎美津恵, 他. 新しいCSF flow Imaging non contrast Time-Spatial Labeling Inversion Pulse (Time-SLIP) 法を応用して. 映像情報Medical 2009 ; 14 : 85-90.
4) 西本博. 髄液循環の障害-小児水頭症の病態生理からみた診断と治療-. 小児内科 1999 ; 21 : 419-28.
5) 板東邦秋, 和智明彦, 佐藤潔. 乳児水頭症における髄液圧, 頭蓋内圧容積関係, 髄液吸収抵抗並びに髄液吸収圧の臨床的意義について. 脳と発達 1993 ; 25 : 240-7.
6) Kestle JEW, Garton HJL, Grake JM. Treatment of hydrocephalus with shunts. In ; Albright AL, et al, eds. Principle and practice of pediatric neurosurgery. Thieme, 1999, p75-89.
7) Baird LC, Mazzola CA, Kurtis I, et al. Pediatric hydrocephalus : systematic literature review and evidence-based guidelines. Part 5 : Effect of valve type on cerebrospinal fluid shunt efficacy. J Neurosurg Pediatr (Suppl) 2014 ; 14 : 35-43.
8) Klimo P Jr, Thompson CJ, Baird LC, et al. Pediatric hydrocephalus : systematic literature review and evidence-based guidelines. Part 7 : Antibiotic-impregnated shunt systems versus conventional shunts in children : a systematic review and meta-analysis. J Neurosurg Pediatr (Suppl) 2014 ; 14 : 53-9.
9) Sainte-Rose C, Piatt JH, Renier D, et al. Mechanical complications in shunts. Pediatr Neurosurg 1991-1992 ; 17 : 2-9.
10) Kestle J, Drake J, Milner R, et al. Long-Term Follow-Up Data from the Shunt Design Trial Pediatr Neurosurg 2000 ; 33 : 230-36.
11) Kestle J, Riva-Cambrin J, Wellons JC III, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection : The Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatrics 2011 ; 8 : 22-9.
12) Pirotte BJ, Lubansu A, Bruneau M, et al. Sterile surgical technique for shunt placement reduces the shunt infection rate in children : preliminary analysis of a prospective protocol in 115 consecutive procedures. Childs Nerv Syst 2007 ; 23 : 1251-61.
13) Kestle J, Holubkov R, Cochrane DD, et al. A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr 2016 ; 17 : 391-96.
14) 大井静雄, 加藤正高, 入江是明. 水頭症. 脳神経外科手術アトラス 上巻 (山浦晶, 編). 医学書院, 東京, 2004, p122-3.
15) 松平哲史, 小林望, 岡田健, 他. VAシャント術における術前頚部CTによる評価および血管造影用ピールオフシースを用いた経皮的内頚静脈穿刺法. 脳外速報 2010 ; 20 : 574-9.
16) Jones RF, Currie BG, Kwok BC. Ventriculopleural shunts for hydro- cephalus : a useful alternative. Neurosurgery 1988 ; 23 : 753-5.
17) Piatt JH Jr. Cerebrospinal fluid shunt failure : late is different from early. Pediatr Neurosurg. 1995 ; 23 : 133-9.
18) James HE, Walsh JW, Wilson HD, et al. The managementof cerebrospinal fluid shunt infections : a clinical experience. Acta Neurochir (Wien) 1981 ; 59 : 157-66.
19) Tamber MS, Klimo P Jr, Mazzola CA, et al. Pediatric hydrocephalus : systematic literature review and evidence-based guidelines. Part 8 : Management of cerebrospinal fluid shunt infection. J Neurosurg Pediatrics (Suppl) 2014 ; 14 : 60-71.
20) 大井静雄, 松本悟. 水頭症・短絡術後の諸問題. 小児脳神経外科の進歩と展望 (牧豊, 編). にゅーろん社, 東京, 1988, p117-33.
21) Rekate HL. Treatment of hydrocephalus. In ; Albright AL, et al, eds. Principle and practice of pediatric neurosurgery. Thieme, 1999, p47-73.
22) Kulkarni AV, Drake JM, Mallucci CL, et al. Canadian Pediatric Neurosurgery Study Group. Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr 2009 ; 155 : 254-9.
23) Volpe JJ. Intraventricular hemorrhage in the premature infant--current concepts. Part I. Ann Neurol 1989 ; 25 : 3-11.
24) Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010 ; 126 : 443-56.
25) 西本博, 築山節, 大野勉, 他. 超未熟児における脳室内出血後水頭症-特にsubcutaneous ventricular catheter reservoirによる管理について-. 小児の脳神経 1988 ; 13 : 203-10.
26) 西本博, 牧山康秀, 大野勉, 他. 外科的治療を必要とした未熟児脳室内出血後水頭症の治療予後. 小児の脳神経 1994 ; 19 : 237-44.
27) Mazzola CA, Choudhri AF, Auguste KI, et al. Pediatric Hydrocephalus Systematic Review and Evidence-Based Guidelines Task Force : Pediatric hydrocephalus : systematic literature review and evidence-based guidelines. Part 2 : Management of post hemorrhagic hydrocephalus in premature infants. J Neurosurg Pediatrics 2014 ; 14 (Suppl 1) : 8-23.
28) 朴永鉄, 新居育世, 釜本智之, 他. 低出生体重児脳室内出血に対する新たな治療戦略 PIカテーテル(R) を用いた脳室ドレナージ管理とウロキナーゼ線溶療法. 小児の脳神経 2012 ; 37 : 447-56.
29) 宮嶋雅一, 下地一彰, 木村孝興, 他. 米国ガイドラインに基づいた小児水頭症の標準治療-小児水頭症に対する今日の最善の治療法は何か? 脳外誌 2017 ; 26 : 564-73.
30) 西本博, 前島貞裕, 城宏輔, 他. 小児化膿性髄膜炎における脳外科的合併症の発生率と治療成績. 小児の脳神経 1990 ; 15 : 169-76.
31) 坪川孝志, 西本博. 髄膜炎後水頭症. 脳神経外科疾患の手術と適応 (阿部弘, 他編), 朝倉書店, 東京, 1990, p673-96.
32) 岡一成, 朝長正道. 水頭症に対する神経内視鏡手術. No Shinkei Geka 1997 ; 25 : 883-92.
33) 胎児期水頭症ガイドライン編集委員会. 胎児期水頭症-診断と治療ガイドライン-改訂2版. 金芳堂, 京都, 2010, p22-34.
P.478 掲載の参考文献
1) Partington MD, et al. Malformation of the cerebral hemisphere. In ; Mclone DG ed. Pediatric Neurosurgery. 4th ed. WB Saunders Company, 2000, p201-8.
2) Bhagwati SN, Mahapatra AK. Encephalocele and anomalies of the scalp. In ; Choux M, et al, eds. Pediatric Neurosurgery, Churchill Livingstone, 1999, p101-19.
3) Naidich TP, Altman NR, Braffman BH et al. Cephaloceles and related malformations. AJNR Am J Neuroradiol 1992 ; 13 : 655-90.
4) 下川尚子. 二分頭蓋に関する臨床的検討. 平成13年度厚生労働省科学研究費補助金「難治水頭症」調査研究班研究報告書, p20-6, 2002.
5) Jimenez DF, Barone CM. Encephaloceles, meningoceles and dermal sinuses. In ; Albright AL, et al, eds. Principles and practice of pediatric neurosurgery 2nd ed, Thieme, 2008, p233-53.
6) 山田博是, 佐藤修. 脳瘤. 脳神経外科疾患の手術と適応 II (阿部弘, 他編). 朝倉書店, 東京, 1990, p628-37.
7) 梶井正. 頭蓋骨癒合を伴う症候群. 先天奇形症候群アトラス (梶井正, 他編). 南江堂, 東京, 1990, p378.
8) 西本博, 築山節, 西村二郎, 他. Three dimensional surface reconstruction CT (3D-CT) を用いたcraniosynostosisの術後follow-up. CT研究 1988 ; 10 : 697-705
9) 西本博, 牧山康秀, 西村二郎, 他. 狭頭症におけるThree dimensional surface reconstruction CT (3D-CT) を用いた頭蓋内容積の経時的検討. CT研究 1995 ; 17 : 201-7.
10) Renier D, Sainte-Rose C, Marchac D, et al. Intracranial pressure in craniosynostosis. J Neurosurg 1982 ; 57 : 370-7.
11) Marchac D, renier D, Broumand S. Timing of treatment for craniosynostosis and faciocraniosynostosis : a 20-year experience. Briti J Plast Surg 1994 ; 47 : 211-22.
12) MacCarthy JG, Glasberg SB, Cutting CB, et al. Twenty-year experience with early surgery for craniosynostosis : I Isolated craniofacial synostosis-results and unsolved problems. Plast Reconstr Surg 1994 ; 96 : 272-83.
13) 坂本博昭. 頭蓋縫合早期癒合症. 小児脳神経の外科 (山浦晶, 他編). 医学書院, 東京, 1998, p165-79.
14) Renier D, Lanjeunie F, Arnaud E, et al. Management of craniosynostosis. Childs Nerv Syst 2000 ; 16 : 645-58.
15) 西本博. 頭蓋骨縫合早期癒合症はいつ手術をするのが最もよいのか? 手術時期によって手術法は異なるのか? 脳神経外科専門医にきく最新の臨床 (片山容一, 他 編). 中外医学社, 東京, 2006, p372-4.
16) Jimenez DF, Barone CM. Endoscopic craniectomy for early surgical correction of sagittal craniosynostosis. J Neurosurg. 1998 ; 88 (1) : 77-81.
17) Wetjen NM, Walker ML. Section IV Pediatrics Chapter 178 Arachnoid cysts. In ; Ruchard Winn H, et al, eds. Youmans Neurological Surgery sixth edition. Elsevier, 2011, p1911-7.
18) 山崎麻美, 坂本博昭, 編. 第5章 先天性疾患 section 5 くも膜嚢胞・頭蓋内嚢胞性疾患. 小児脳神経外科 改訂2版. 金芳堂, 京都, 2015, p346-79.
19) Di Rocco C. Arachnoid cysts. In ; Youmans JR, eds. Neurological surgery, 4th ed, Vol 2. WB Saunders, 1996, p967-95.
20) Klaus MH, Kennel JH. Care of the parents. In ; Klaus MH, et al, eds. Care of the high-risk neonate. 4th ed, WB Saunders, 1993, p189-211.
21) 伊達裕昭, 伊藤千秋, 山浦晶. 開放性脊髄髄膜瘤の初期治療における説明と受容. 小児の脳神経 1998 ; 23 : 160-4.
22) 高橋義男. 小児中枢神経疾患, 手術例におけるインフォームド・コンセント. 小児脳神経の外科 (山浦晶, 他編). 医学書院, 東京, 1998, p63-9.
P.489 掲載の参考文献
7) Chevret L, Durand P, Alvarez H, et al. Severe cardiac failure in newborns with VGAM. Prognosis significance of hemodynamic parameters in neonates presenting with severe heart failure owing to vein of Galen arteriovenous malformation. Intensive Care Med 2002 ; 28 : 1126-30.
8) Dowd CF, Halbach VV, Barnwell SL, et al. Transfemoral venous embolization of vein of Galen malformations. AJNR Am J Neuroradiol 1990 ; 11 : 643-8.
11) Garcia-Monaco R. The management of vein of Galen aneurysmal malformations. Neurosurgery 2006 ; 59 (5 Suppl 3) : S184-94, (Erratum in Neurosurgery 60 4 Suppl : 393, 2007).
13) Mickle JP, Mericle RA, Burry MV, et al. Vein of Galen malformations. In ; Winn HR, ed. Youmans Neurological Surgery, ed 5, Philadelphia, Saunders, 2004, p3433-46.
16) Terada A, Komiyama M, Ishiguro T et al. Nationwide survey of pediatric intracranial arteriovenous shunts in Japan : Japanese Pediatric Arteriovenous Shunts Study (JPAS). J Neurosurg Pediatr. 2018 ; 27 : 1-9.
18) 小宮山雅樹. 脳静脈の機能解剖. 脳外誌 2009 ; 18 : 821-9.
19) Raybaud CA, et al. Aneurysms of the vein of Galen : embryonic considerations and anatomical features relating to the pathogenesis of the malformation. Neuroradiology 1989 ; 31 : 109-28.
20) 山崎麻美, 坂本博昭, 編. 小児脳神経外科 改訂2版. 第4章 治療 section 3 血管内治療. 金芳堂, 京都, 2015, p189-96.
21) Lasjaunias P, Ter Brugge K, Berenstein A. Vein of Galen aneurysmal malformation. In ; Surgical Neuroangiography 3. Clinical and Interventional Aspects in Children, ed 2. Berlin : Springer, 2006, Vol 3, p105-226.
22) Berenstein A, Niimi Y. Vein of Galen aneurysmal malformation. In ; Winn HR, ed. Youmans Neurological Surgery, ed 6. Philadelphia, Elsevier/Saunders, Vol 2, 2011, p2150-65.
25) 小宮山雅樹. 小児脳血管疾患に対する血管内治療. 第27回日本脳神経血管内治療学会学術総会CEPテキスト. メディカルブックサービス, 名古屋, 2012, p1-10.
26) Hoffman HJ, Chuang S, Hendrick EB, et al. Aneurysms of the vein of Galen. Experiences at the Hospital for Sick Children, Toronto. J Neurosurg 1982 ; 57 : 316-22.
27) Johnston IH, et al. Vein of Galen malformation : diagnosis and management. Neurosurgery 1987 ; 20 : 747-58.
29) Duckwiller G. Pediatric pial AVF. Interv Neuroradiol 2003 ; 9 (suppl 2) : 41-6.
30) Komiyama M, et al. Vein of Galen aneurysms : experiences with eleven cases. Intervent Neuroradiol 2003 ; 7 : 99-103.
31) Lasjaunias P, Rodesch G, Terbrugge K, et al. Vein of Galen aneurysmal malformations. Report of 36 cases managed between 1982 and 1988. Acta Neurochir (Wien) 1989 ; 99 : 26-37.
32) Lasjaunias P, Alvarez H, Rodesch G, et al. Aneurysmal Malformations of the Vein of Galen. Follow-up of 120 Children Treated between 1984 and 1994. Interv Neuroradiol 1996 ; 2 : 15-26.
34) Harrigan MR, Deveiks JP. Appendix. Vein of Galen malformations. In ; Handbook of Cerebrovascular Disease and Neurointerventional Technique, ed 2. New York, Humana Press, 2009, p527-31.
35) 新井一, 佐藤潔, 飯塚有応, 他. ガレン大静脈瘤の診断と治療. 脳外誌 2002 ; 11 : 379-88.
36) Mortazavi MM, Griessenauer CJ, Foreman P, et al. Vein of Galen aneurysmal malformations : critical analysis of the literature with proposal of a new classification system. J Neurosurg Pediatr 2013 ; 12 : 293-306. Epub 2013 Jul 26.
40) Morgan MK, Johnston IH, Sundt TM Jr. Normal perfusion pressure breakthrough complicating surgery for the vein of Galen malformation : report of three cases. Neurosurgery 1989 ; 24 : 406-10.
43) 白幡聡. 特輯新生児医療の最前線-産婦人科医が知っておきたい新生児の新知識 ビタミンK欠乏性頭蓋内出血とその予防. 産婦人科治療 2011 ; 102 : 360-4.
44) 塙嘉之. 乳児ビタミンK 欠乏性出血症の予防に関する研究, 総括報告. 厚生省心身障害研究, 昭和63年度研究報告書, 1989, p23-7.
45) 白幡聡, 伊藤進, 高橋幸博, 他. 乳児ビタミンK欠乏性出血症全国調査成績 (1999-2004). 日産外新生児会誌 2006 ; 16 : S55-6.
46) 白幡聡, 伊藤進, 高橋幸博, 他. 新生児・乳児ビタミンK欠乏性出血症に対するビタミンK製剤投与の改訂ガイドライン. 日本小児科学会雑誌 2010 ; 114 : 1263-70.
47) 藤原一枝. 血友病・ビタミンK欠乏症. 小児脳神経の外科 (山浦晶, 森竹浩三, 編), 医学書院, 東京, 1998, p203-9.
48) Cekinmez M, Cemil T, Cekinmez EK, et al. Intracranial hemorrhages due to late-type vitamin K deficiency bleeding. Childs Nerv Syst 2008 ; 24 : 821-5.
49) 西尾朋子, 野原玲子, 青木修一郎, 他. ビタミンK欠乏症にもとづく頭蓋内出血リング状の高吸収像を呈した多発性脳内出血の1例. 脳と神経 1987 ; 39 : 65-70.
50) Roach ES, Golomb MR, Adams R, et al. Management of stroke in infants and children : a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 2008 ; 39 : 2644-91.
51) Brady KM, Easley RB, Tobias JD. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Paediatr Anaesth 2006 ; 16 : 1042-6.
52) McLoan DG. Pediatric Neurosurgery 4th ed, Philadelphia, WB Saunders, 2001, p639-42.
53) 森本一良, 他. 脳神経外科体系 小児脳神経外科, 中山書店, 東京, 2004, p261-7.
54) Chalmers E, Williams M, Brennand J et al. Paediatric Working Party of United Kingdom Haemophilia Doctors' Organization. Guideline on the management of haemophilia in the fetus and neonate. Br J Haematol 2011 ; 154 : 208-15.
55) 瀧正志, 朝比奈俊彦,佐道俊幸, 他. エキスパートの意見に基づく血友病周産期管理指針 2017年版. 日本産婦人科・新生児血液学会誌 2017 ; 27 : 53-66.
56) 藤野英世, 桑原武夫. 血友病の治療. 頭部外傷と頭蓋内出血. b. 脳神経外科治療. 血友病 (福竹勝博, 藤巻道男, 長尾 大, 編), 全国ヘモフィリアの会, 1981, p409-25.
57) 嶋緑倫 : 【小児疾患の診断治療基準】血液・造血器疾患血友病, von Willebrand病 (解説/特集). 小児内科 2006 ; 38 増刊 : 551-3.
P.504 掲載の参考文献
1) 坂本博昭. 5章 先天性疾患, §2 二分脊椎. 小児脳神経外科学 改訂2版 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p248-317.
2) 胎児水頭症ガイドライン編集委員会, 編. 胎児水頭症-診断と治療ガイドライン 改訂2版. 金芳堂, 京都, 2010.
4) Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Dev Med Child Neurol 1971 ; 13 : 279-303.
5) McLone DG. Results of treatment of children born with a myelomeningocele. Clin Neurosurg 1983 ; 30 : 407-12.
6) Majed M, Nejat F, Khashab ME, et al. Risk factors for latex sensitization in young children with myelomeningocele. J Neurosurg Pediatr 2009 ; 4 : 285-8.
7) 北野元裕. 12章 脳神経外科が知っておくべき各領域の疾患, §6 整形外科・リハビリテーション領域. 小児脳神経外科学 改訂2版 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p996-1009.
8) Hunt GM, Oakeshott P. Lifestyle in adults aged 35 years who were born with open spina bifida : prospective cohort study. Cerebrospinal Fluid Res 2004 ; 1 : 4.
10) 伊地俊介, Chandra SKM, 富田忠則. 二分脊椎の原因と予防-特に母体の葉酸摂取が予防に働くメカニズムについて-. Jpn J Neurosurg (Tokyo) 2013 ; 22 : 256-68.
11) 新井一. 腰仙部脂肪腫. No Shinkei Geka 2004 ; 32 : 1019-26.
12) Weprin BE, Oakes WJ. Coccygeal Pits. Pediatrics 2000 ; 105 : 1-5.
13) Pierre-Khan A, Zerah M, Renier K, et al. Congenital lumbosacral lipoma. Child's Nerv Syst 1997 ; 13 : 298-335.
14) Pang D, Zovickian J, Oviedo A. Long-term outcome of total and near-total resection of spinal cord lipomas and radical reconstruction of the neural placode, part II : outcome analysis and preoperative profiling. Neurosurgery 2010 ; 66 : 253-73.
15) 師田信人, 井原哲. 小児脊髄脂肪腫手術と術中神経生理学的手技 球海綿体反射モニタリングの重要性. 脳外誌 2008 ; 17 : 27-37.
16) 尾原裕康. 9 先天性異常・発生異常 : 環椎と軸椎の偏位/環椎と後頭骨の癒合. 今日の神経疾患治療指針 第2版 (水澤英洋, 鈴木則宏, 他編). 医学書院, 東京. 2013, p629-8.
17) 坂本博昭, 山懸 徹. 5章 先天性疾患, §8 先天性脊椎疾患. 小児脳神経外科学 改訂2版 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p413-27.
18) Menezes AH, Ryken TC. Craniovertebral junction abnormalities. The Pediatric Spine : Pronciple and practice, Raven Press, 1994, p307-21.
19) Subach BR, McLaughlin MR, Albright AL, et al. Current management of pediatric atlantoaxial rotatory subluxation. Spine 1998 ; 23 : 2174-9.
20) 西本博. 8章 外傷, §10 脊椎・脊髄損傷. 小児脳神経外科学 改訂2版 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p781-91.
21) 師田信人, 中川洋. 小児脊椎・脊髄損傷 発生・解剖学的側面よりみた特殊性小児の脳神経. 1998, 23, p307-13.
22) Pang D. Spinal cord injury without radiographic abnormality in children, 2 decades later. Neurosurgery 2004 ; 55 : 1325-43.
24) 坂本博昭. 5章 先天性疾患 §4 菱脳の先天性疾患 1. キアリ奇形. 小児脳神経外科学 改訂2版 (山崎麻美, 坂本博昭, 編集). 金芳堂, 京都, 2015, p332-45.
25) King JA, Vachhrajani S, Drake JM, et al. Neurosurgical implications of achondroplasia. J Neurosurg Pediatr 2009 ; 4 : 297-306.
26) Trotter TL, Hall JG ; American Academy of Pediatrics Committee on Genetics. Health supervision for children with achondroplasia. Pediatrics 2005 ; 116 : 771-83.
P.515 掲載の参考文献
1) 日本神経学会, 日本神経治療学会, 日本神経感染症学会, 監修. 細菌性髄膜炎の診療ガイドライン 2014. 南江堂, 東京, 2014.
2) Shinjoh M, Yamaguchi Y, Iwata S. Pediatric bacterial meningitis in Japan, 2013-2015-3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines. J Infect Chemother 2017 ; 23 : 427-38.
3) 日本産婦人科学会, 日本婦人科医会 (編) : 産婦人科診療ガイドライン-産科編 2011 日本産婦人科学会, 東京, 2011.
4) Morozumi M, Wajima T, Kuwata Y, et al. Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections. Epidemiol Infect. 2014, 142 : 812-9.
5) Ubukata K, Chiba N, Morozumi M, et al. Working Group of Nationwide Surveillance for Bacterial Meningitis. Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011. J Infect Chemother 2013 ; 19 : 34-41.
6) 高橋恵子, 石川晴美, 森田昭彦, 他. 院内感染による細菌性髄膜炎本邦成人例における起因菌と転帰影響要因. 臨床神経学 2013 ; 53 : 1461.
7) Radetsky M. Duration of symptoms and outcome in bacterial meningitis : an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J 1992 ; 11 : 694-701.
8) 西本博, 前島貞裕, 城 宏輔, 他. 小児化膿性髄膜炎における脳外科的合併症の発生率と治療成績. 小児の脳神経 1990 ; 15 : 169-76.
9) Chen M, Low DCY, Low SYY et al. Management of brain abscesses : where are we now? Childs Nerv Syst 2018 ; 34 : 1871-80.
10) Boop AF, Jacobs RF, Yong RL. Brain abscess and encephalitis in children. In ; Albright AL, et al, eds. Principles and practice of pediatric neurosurgery. Thieme, 1999, p1203-26.
11) Goodkin HP, Harper MB, Pomeroy SL. Intracerebral abscess in children : historical trends at Children's hospital Boston. Pediatrics 2004 ; 113 : 1765-70.
12) Sharma RK, Cooke RPD. Intracranial abscesses : changes in epidemiology and management over five decades in Merseyside. Infection 2009 ; 37 : 39-43.
13) 竹下幹彦, 加川瑞夫, 谷藤誠司, 他. 先天性チアノーゼ性心疾患に伴う小児脳膿瘍の検討. 小児の脳神経 1996 ; 21 : 373-80.
14) 坂本敬三, 及川奏. 脳膿瘍, 硬膜上・下膿瘍. 臨床小児脳神経外科学 (松本悟, 他編), 医学書院, 東京, 1992, p609-31.
15) Britt RH, Enzmann DR. Clinical stages of human brain abscess on serial CT scan after contrast infusion. J Neurosurg 1983 ; 59 : 972-89.
16) Barkovich AJ, Raybaud C. Infection of the developing and mature nervous system. Pediatric neuroimaging 5th ed, Lippincot Williams & Wilkins, 2012, p954-1050.
17) Rath TJ, Hughes M, Arabi M, et al. Imaging of cerebritis, encephalitis and brain abscess. Neuroimaging Clin N Am 2012 ; 22 : 585-607.
18) Arlotti M, Grossi P, Pea F et al. Consensus document on controversial issues for the treatment of infections of the central nervous system : bacterial brain abscesses. Int J Infect Dis. 2010,14 : S79-92
19) 永井肇. 脳膿瘍. 脳神経外科疾患の手術と適応 II (阿部宏, 他編), 朝倉書店, 東京, 1990, p664-72.
20) Frazier JL, Ahn ES, Jallo GI. Management of brain abscesses in children. Neurosurg Focus 2008 ; 24 : E8.
21) Khan M, Griebel R. Subdural empyema : a retrospective study of 15 patients. Can J Surg 1984 ; 27 : 283-8.
22) Kubik CS, Adams RD. Subdural empyema. Brain 1943, 66 : 18-42.
23) Liu ZH, Chen NY, Tu PH, et al. The treatment and outcome of postmeningitic subdural empyema in infants. J Neurosurg Pediatr 2010 ; 6 : 38-42.
24) Germiller JA, Sparano AM. Intracranial complications of sinusitis in children and adolescents and their outcomes. Arch Otolaryngol Head Neck Surg 2006 ; 132 : 969-76.
25) De Bonis P, Anile C, Pompucci A, et al. Cranial and spinal subdural empyema. Br J Neurosurg 2009 ; 23 : 335-40.
26) Cowie R, Williams B. Late seizures and morbidity after subdural empyema. J Neurosurg. 1983 ; 58 : 569-73.
27) Madhugiri VS, Sastri BV, Bhagavatula ID, et al. Posterior fossa subdural em- pyema in children-management and outcome. Childs Nerv Syst 2011 ; 27 : 137-44.
28) Mauser HW, Ravijst RAP, Elderson A, et al. Nonsurgical treatment of subdural empyema. Case report. J Neurosurg 1985 ; 63 : 128-30.
29) Cochrane DD, Almquist PM, Dobson SRM. Intracranial epidural and subdural infections. In ; Albright AL, et al, eds. Principles and practice of pediatric neurosurgery. Thieme, 1999, p1187-201.
P.535 掲載の参考文献
1) Miller KA, Twigg SR, McGowan SJ, et al. Diagnostic value of exome and whole genome sequencing in craniosynostosis. J Med Genet 2017 ; 54 (4) : 260-8.
2) Girirajan S, Brkanac Z, Coe BP, et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011 ; 7 (11) : e1002334.
3) Yamasaki M, Nonaka M, Suzumori N, et al. Prenatal molecular diagnosis of a severe type of L1 syndrome (X-linked hydrocephalus). J Neurosurg Pediatr 2011 ; 8 (4) : 411-6.
4) Wilkie AOM, Johnson D, Wall SA. Clinical genetics of craniosynostosis. Curr Opin Pediatr 2017 ; 29 (6) : 622-8.
5) Lattanzi W, Barba M, Di Pietro L, et al. Genetic advances in craniosynostosis. Am J Med Genet A 2017 ; 173 (5) : 1406-29.
6) Twigg SR, Wilkie AO. A Genetic-Pathphysiological Framework for Craniosynostosis. Am J Hum Genet 2015 ; 97 (3) : 359-77.
7) Robin NH, Falk MJ, Haldeman-Englert CR. FGFR-Related Craniosynostosis Syndromes. GeneReviews? [Internet]. Seattle (WA) : University of Washington, Seattle ; 1993-2018.
8) Slaney SF, Oldridge M, Hurst JA, et al. Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome. Am J Hum Genet 1996 ; 58 (5) : 923-32.
9) Lajeunie E, Cameron R, El Ghouzzi V, et al. Clinical variability in patients with Apert's syndrome. J Neurosurg 1999 ; 90 (3) : 443-7.
10) Johnson D, Wilkie AO. Craniosynostosis. Eur J Hum Genet 2011 ; 19 (4) : 369-76.
11) Ornitz DM, Legeai-Mallet L. Achondroplasia : Development, pathogenesis, and therapy. Dev Dyn 2017 ; 246 (4) : 291-309.
12) Kousi M, Katsanis N. The Genetic Basis of Hydrocephalus. Annu Rev Neurosci 2016 ; 39 : 409-35.
13) Vos YJ, de Walle HE, Bos KK, et al. Genotype-phenotype correlations in L1 syndrome : a guide for genetic counselling and mutation analysis. J Med Genet 2010 ; 47 (3) : 169-75.
14) Adle-Biassette H, Saugier-Veber P, Fallet-Bianco C, et al. Neuropathological review of 138 cases genetically tested for X-linked hydrocephalus : evidence for closely related clinical entities of unknown molecular bases. Acta Neuropathol 2013 ; 126 (3) : 427-42.
15) Kanemura Y, Okamoto N, Sakamoto H, et al. Molecular mechanisms and neuroimaging criteria for severe L1 syndrome with X-linked hydrocephalus. J Neurosurg 2006 ; 105 (5 Suppl) : 403-12.
16) Yamasaki M, Kanemura Y. X-Linked Hydrocephalus. Textbook of Pediatric Neurosurgery. Springer, Cham, 2017.
17) Verhagen JM, Schrander-Stumpel CT, Krapels IP, et al. Congenital hydrocephalus in clinical practice : a genetic diagnostic approach. Eur J Med Genet 2011 ; 54 (6) : e542-7.
18) Romero DM, Bahi-Buisson N, Francis F. Genetics and mechanisms leading to human cortical malformations. Semin Cell Dev Biol 2018 ; 76 : 33-75.
19) Tan AP, Chong WK, Mankad K. Comprehensive genotype-phenotype correlation in lissencephaly. Quant Imaging Med Surg 2018 ; 8 (7) : 673-93.
20) Solomon BD, Gropman A, Muenke M. Holoprosencephaly Overview. GeneReviews? [Internet]. Seattle (WA) : University of Washington, Seattle ; 1993-2018.
21) Roessler E, Hu P, Muenke M. Holoprosencephaly in the genomics era. Am J Med Genet C Semin Med Genet 2018 ; 178 (2) : 165-74.
22) Kruszka P, Martinez AF, Muenke M. Molecular testing in holoprosencephaly. Am J Med Genet C Semin Med Genet 2018 ; 178 (2) : 187-93.

[VII] 感染症

P.552 掲載の参考文献
1) McAlister FA, Bertsch K, Man J, et al. Incidence of and risk factors for pulmonary complications after nonthoracic surgery. Am J Respir Crit Care Med 2005 ; 171 : 514.
2) 今井寛, 相馬一亥. 人工呼吸器関連肺障害. 救急・集中治療 2008 ; 20 (1・2) : 18-22.
3) The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Initial management. J Neurotrauma 2000 ; 17 (6-7) : 463-9.
4) 重症頭部外傷治療・管理ガイドライン作成委員会. 2-3 循環管理 3-7 過換気療法. 重症頭部外傷治療・管理のガイドライン 第3版. 医学書院, 東京, 2013.
5) McGuire G, Crossly D, Richards J, et al. Effects of varying levels of positive end-expiratory pressure on intracranial pressure and cerebral pressure. Crit Care Med 1997 ; 25 : 1059-62.
6) Georgiadis D, Schwarz S, Baumgartner RW, et al. Influence of positive end-expiratory pressure on intracranial pressure and cerebral perfusion pressure in patients with acute stroke. Stroke 2001 ; 32 : 2088.
7) Muench E, Bauhuf C, Roth H, et al. Effects of positive end-expiratory pressure on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation. Crit Care Med 2005 ; 33 : 2367.
8) Huynh T, Messer M, Sing RF, et al. Positive endexpiratory pressure alters intracranial and cerebral perfusion pressure in severe traumatic brain injury. J Trauma 2002 ; 53 : 488.
9) Pulitano S, Mancino A, Pietrini D, et al. Effects of positive end expiratory pressure (PEEP) on intracranial and cerebral perfusion pressure in pediatric neurosurgical patients. J Neurosurg Anesthesiol 2013 ; 25 (3) : 330-4.
10) Heuer JF, Pelosi P, Hermann P, et al. Acute effects of intracranial hypertension and ARDS on pulmonary and neuronal damage : a randomized experimental study in pigs. Intensive Care Med 2011 ; 37 (7) : 1182-91.
11) Elliott CG, Rasmusson BY, Crapo RO, et al. Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS). Am Rev Respir Dis 1987 ; 135 : 634.
12) 小谷透. PCVとVCV. 呼吸器ケア 2007 ; 5 (1) : 60-4.
13) 新井正康. 人工呼吸ブック, メディカル・サイエンス・インターナショナル. 東京, 2007, p14-21.
14) Papazian L, Forel JM, Gacouin A, et al ; ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010 ; 363 (12) : 1107-16.
15) Alhazzani W, Alshahrani M, Jaeschke R, et al. Neuromuscular blocking agents in acute respiratory distress syndrome : a systematic review and meta-analysis of randomized controlled trials. Crit Care 2013 ; 17 (2) : R43.
16) 大庭祐二. ARDSに対する人工呼吸管理 基礎編「歴史的変遷とスタンダードな管理の問題点」. Intensivist 2009 ; 1 (1) : 41-8.
17) 小谷透. ARDSに対する人工呼吸管理 応用編「リクルートメントとオープンラング戦略」. Intensivist 2009 ; 1 (1) : 49-57.
18) NHLBI ARDS Clinical Network http://www.ardsnet.org/
19) 中根正樹. 人工呼吸器関連肺炎と予防法. 第19回 呼吸療法医学会セミナー, 2004, p161-80.
20) Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989 ; 139 : 877-84.
21) Forel J-M, Voillet F, Pulina D, et al. Ventilator-associated pneumonia and ICU mortality in severe ARDS patients ventilated according to a lung-protective strategy. Crit Care 2012 ; 16 (2) : R65.
22) Fink JB, Krause SA, Barrett L, et al. Extending ventilator circuit change interval beyond 2 days reduces the likelihood of ventilator-associated pneumonia. Chest 1998 ; 113 : 405-11.
23) Kola A, Eckmanns T, Gastmeier P. Efficacy of heat and moisture exchangers in preventing ventilator-associated pneumonia : meta-analysis of randomized controlled trials. Intensive Care Med 2005 ; 31 : 5-11.
24) Tablan OC, et al. guidelines for preventing healthcare-associated pneumonia, 2003 : Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004 ; 53 : 1-36.
25) 日本呼吸療法医学会. 気管吸引ガイドライン 2013 (成人で人工気道を有する患者のための). 人工呼吸. Jpn J Respir Care 2013 ; 30 : 75-91.
26) Cereda M, Villa F, Colombo E, et al. Closed system endotracheal suctioning maintains lung volume during volume-controlled mechanical ventilation. Intensive Care Med 2001 ; 27 : 648-54.
27) Neumann P, Berglund JE, Fernadez Mondear E, et al. Dynamics of lung collapse and recruitment during prolonged breathing in porcine lung injury. J Appl Physiol 1998 ; 85 : 1533-43.
28) Witmer MT, Hess D, Simmons M. An evaluation of the effectiveness of secretion removal woth the Ballard closed-circuit suction catheter. Respir Care 1991 ; 36 : 844-8.
29) Subirana M, Sola I, Benito S. Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients. Cochrane Database Syst Rev 2007 ; 17 (4) : CD004581.
30) Siempos II, Vardakas KZ, Falagas ME. Closed tracheal suction systems for prevention of ventilator-associated pneumonia. Br J Anaesth 2008 ; 100 : 299-306.
31) Johnson KL, Kearney PA, Johnson SB, et al. Closed versus open endotracheal suctioning : costs and physiologic consequences. Crit Care Med 1994 ; 22 : 658-66.
32) Seguin P, Tanguy M, Laviolle B, et al. Effect of oropharyngeal decontamination by povidoneiodine on ventilator-associated pneumonia in patients with head trauma. Crit Care Med 2006 ; 34 : 1514-19.
33) Koeman M, van der Ven AJ, Hak E, et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006 ; 173 : 1348-55.
34) Girou E, Schortgen F, Delclaux C, et al. Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients. JAMA 2000 ; 284 : 2361-7.
35) Rello J, Sonora R, Jubert P, et al. Pneumonia in intubated patients : Role of respiratory airway care. Am J Respir Crit Care Med 1996 ; 154 : 111.
36) Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995 ; 122 : 179.
37) Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients : a randomised trial. Lancet 1999 ; 354 (9193) : 1851-8.
38) 尾崎孝平. ARDSに対する人工呼吸管理 : 応用編「非侵襲的陽圧換気・体位呼吸療法」. Intensivist 2009 ; 1 (1) : 59-73.
39) Gattinoni L, Tognoni G, Peserti A, et al. Effect of prone positioning on survival of patients with acute respiratoy failure. New Engl J Med 2001 ; 345 : 568-73.
40) 尾崎孝平. 非侵襲的陽圧換気・体位呼吸療法. ARDSに対する人工呼吸管理応用編. Intensivist 2009 ; 1 (1) : 59-73.
P.565 掲載の参考文献
1) 北川泰久. 中枢神経系感染症へのアプローチ. medicina 1991 ; 28 : 1738-45.
2) 日本神経学会, 日本神経治療学会, 日本神経感染症学会 監修. 細菌性髄膜炎診療ガイドライン 2014. 南江堂, 東京, 2014.
3) 島田馨. 中枢神経系感染症に対する抗生物質の選択について. 神経疾患の臨床-今日の論点 (柳澤信夫 編). 中外医学社, 東京, 1993, p209-15.
4) 中村功. リステリア髄膜炎. 日本臨床 別冊・感染症症候群 I. 日本臨床社, 大阪, 1999, p297-300.
5) 砂川慶介, 竹内百合子, 岩田敏. 無莢膜型インフルエンザ菌 (NTHi) の疫学. 感染症学雑誌 2011 ; 85 : 227-37.
6) 斧康雄. 中枢神経感染症. 治療学 1998 ; 32 : 1299-302.
7) 伊藤章. レプトスピラ症 (Weil病). 日本臨床 別冊・感染症症候群 II. 日本臨床社, 大阪, 1999, p298-9.
8) 田中真. 脳膿瘍. 日本臨床 別冊・感染症症候群 I. 日本臨床社, 大阪, 1999, p308-11.
9) 日本神経学会, 日本神経治療学会, 日本神経感染症学会 監修. 単純ヘルペス脳炎の治療. 単純ヘルペス脳炎診療ガイドライン 2017. 南江堂, 2017, p68-98.
10) 野崎博之. 結核性髄膜炎. 神経内科 2001 ; 55 : 443-8.
11) 黒岩義之, 長友秀樹. 重要な神経系の感染症-結核性・真菌性髄膜炎-. 日内会誌 1996 ; 85 : 705-10.
12) 阿部千代治. 結核症の迅速診断. 結核 1997 ; 72 : 659-72.
13) 鈴木克洋, 露口一成, 松本久子, 他. Mycobacteria Growth Indicator Tube (MGIT) による結核菌の迅速薬剤感受性検査. 結核 1997 ; 72 : 187-92.
14) 阿部千代治, 青野昭男, 平野和重. BACTEC MGIT 960 システムにおける結核菌の迅速薬剤感受性試験 : 固形培地を用いる比率法との比較. 結核 2001 ; 76 : 657-62.
15) Jinkins JR, Gupta R, Chang KH, et al. MR imaging of central nervous system tuberculosis. Radiol Clin North Am 1995 ; 33 : 771-86.
16) American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America : Treatment of Tuberculosis. Am J Respir Crit Care Med 2003 ; 167 : 603-62.
17) 日本結核病学会 編. 結核の治療. 結核診療ガイドライン 改訂第3版. 南江堂, 東京, 2015, p77-96.
18) 日本神経治療学会治療指針作成委員会 編. 日本神経治療学会 標準的神経治療 結核性髄膜炎. 神経治療学 2015 ; 32 : 511-32.
19) 小林裕. 結核性髄膜炎の治療. 神経内科治療 1989 ; 6 : 213-9.
20) Peter G, Plotkin S, Easton JG, et al. American academy of pediatrics. Chemotherapy for tuberculosis in infants and children. Pediatrics 1992 ; 89 : 161-5.
21) 野崎博之, 豊田丈夫, 高嶋修太郎 他. 当院で経験した頭蓋内結核症6例のCT所見-特にその経過を中心にして-. 結核 1992 ; 67 : 383-92.
22) 亀井聡. 神経感染症の疫学. 神経研究の進歩 1999 ; 43 : 5-15.
23) 庄司紘史. 真菌性髄膜炎. Clinical Neuroscience 1999 ; 17 : 458.
24) 吉田耕一郎, 二木芳人, 大野学, 他. 胸水中および髄液中の (1→3) -β-D-glucan値の臨床的意義についての検討. 感染症学雑誌 1997 ; 71 : 1210-5.
25) 渡辺徹, 佐藤雅久, 阿部時也, 他. 細菌性髄膜炎の合併症-内科的立場から-. 小児内科 1996 ; 28 : 906-9.
26) 遠藤俊郎, 高久晃. 細菌性髄膜炎の合併症-外科的立場から-. 小児内科 1996 ; 28 : 910-3.

[VIII] 機能的脳神経外科

P.578 掲載の参考文献
3) Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy : consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010 ; 51 : 1069-77
5) Matsuzaka T, Baba H, Matsuo A, et al. Developmental assessment-based surgical intervention for intractable epilepsies in infants and young children. Epilepsia 2001 ; 42 Suppl 6 : 9-12.
7) Dwivedi R, Ramanujam B, Chandra PS, et al. Surgery for drug-resistant epilepsy in children. N Engl J Med 2017 ; 377 : 1639-47.
10) Ryvlin P, Gilliam FG, Nguyen DK, et al. The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy : the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. Epilepsia 2014 ; 55 : 893-900.
13) Devous MD Sr, Thisted RA, Morgan GF, et al. SPECT brain imaging in epilepsy : a metaanalysis. J Nucl Med 1998 ; 39 : 285-93.
14) LoPinto-Khoury C, Sperling MR, Skidmore C, et al. Surgical outcome in PET-positive, MRInegative patients with temporal lobe epilepsy. Epilepsia 2012 ; 53 : 342-8.
15) 日本神経学会. てんかん治療ガイドライン 2018. 医学書院, 東京, 2018, p23-4.
16) 川合謙介. てんかん外科治療における高次脳機能イメージングの役割. Brain Nerve 2012 ; 64 : 1013-22.
17) Sharan A, Ooi YC, Langfitt J, et al. Intracarotid amobarbital procedure for epilepsy surgery. Epilepsy Behav 2011 ; 20 : 209-13.
18) 日本神経学会. てんかん治療ガイドライン 2018. 医学書院, 東京, 2018, p97-8.
19) 川合謙介, 鎌田恭輔, 太田貴裕, 他. 器質性病変を持つてんかんにおける焦点局在診断と頭蓋内電極留置の適応 てんかん外科を始めるために必要な知識. 脳外誌 2009 ; 18 : 586-95.
20) Kawai K. Epilepsy surgery : current status and ongoing challenges. Neurol Med Chir (Tokyo) 2015 ; 55 : 357-66.
21) Kunii N, Kamada K, Ota T, et al. Characteristic profiles of high gamma activity and blood oxygenation level-dependent responses in various language areas. Neuroimage 2013 ; 65 : 242-9.
22) 川合謙介. 海馬硬化症に対する外科治療. NS NOW 16 機能的脳神経外科手術の基本-コツと注意点 (新井一, 編). メジカルビュー社, 東京, 2011, p104-16.
23) 川合謙介, 清水弘之. 難治性てんかんに対する大脳半球切除術と大脳半球離断術. 脳外誌 2007 ; 16 : 184-93.
24) Kawai K, Morino M, Iwasaki M. Modification of vertical hemispherotomy for refractory epilepsy. Brain Dev 2014 ; 36 : 124-9.
25) Usami K, Kubota M, Kawai K, et al. Long-term outcome and neuroradiologic changes after multiple hippocampal transection combined with multiple subpial transection or lesionectomy for temporal lobe epilepsy. Epilepsia 2016 ; 57 : 931-40.
26) Kawai K, Tanaka T, Baba H, et al. Outcome of vagus nerve stimulation for drug-resistant epilepsy : the first three years of a prospective Japanese registry. Epileptic Disord 2017 ; 19 : 327-38.
27) Kurita N, Kawaguchi M, Hoshida T, et al. The effects of sevoflurane and hyperventilation on electrocorticogram spike activity in patients with refractory epilepsy. Anesth Analg 2005 ; 101 : 517-23, table of contents.
28) Boshuisen K, Arzimanoglou A, Cross JH, et al. Timing of antiepileptic drug withdrawal and longterm seizure outcome after paediatric epilepsy surgery (Time To Stop) : a retrospective observational study. Lancet Neurol 2012 ; 11 : 784-91.
29) Menon R, Rathore C, Sarma SP, et al. Feasibility of antiepileptic drug withdrawal following extratemporal resective epilepsy surgery. Neurology 2012 ; 79 : 770-6.
30) Macrodimitris S, Sherman EM, Forde S, et al. Psychiatric outcomes of epilepsy surgery : a systematic review. Epilepsia 2011 ; 52 : 880-90.
31) Engel JJ, Van Ness PC, Rasmussen TB, et al. Outcome with respect to epileptic seizures. In ; Engel JJ, ed. Surgical Treatment of the Epilepsies, Second Edition, Lippincott-Raven, New York, 1993, p609-21.
32) Wieser HG, Blume WT, Fish D, et al. ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001 ; 42 : 282-6.
33) Hader WJ, Tellez-Zenteno J, Metcalfe A, et al. Complications of epilepsy surgery-a systematic review of focal surgical resections and invasive EEG monitoring. Epilepsia 2013 ; 54 : 80-7.
P.589 掲載の参考文献
2) Kondo A. Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm. Neurosurgery 1997 ; 40 : 46-52.
3) Fujimaki T, et al. Recurrent trigeminal neuralgia caused by an inserted prosthesis : report of two cases. Acta Neurochir (Wien) 1996 ; 138 : 1307-9.
4) Illingworth RD, et al. Hemifacial spasm : a prospective long-term follow up of 83 cases treated by microvascular decompression at two neurosurgical centres in the United Kingdom. J Neurol Neorosurg Psychiatry 1996 ; 60 : 72-7.
5) Barker FG II, Jannetta PJ, et al. Microvascular decompression for hemifacial spasm. J Neurosurg 1995 ; 82 : 201-10.
6) Acevedo JC, et al. Microvascular decompression for the treatment of hemifacial spasm. Retrospective study of a consecutive series of 75 operated patients-electrophysiologic and anatomical surgical analysis. Stereotact Funct Neurosurg 1997 ; 68 : 260-5.
7) Lovely TJ, Getch CC, Jannetta PJ. Delayed facial weakness after microvascular decompression of cranial nerve VII. Surg Neurol 1998 ; 50 : 449-52.
8) 永廣信治. 顔面痙攣の病態と手術. No Shinkei Geka 1998 ; 26 : 101-11.
9) Kalkanis SN, Eskandar EN, Carter BS, Baker FG 2nd. Microvascular decompression surgery in the United States, 1996 to 2000 : mortality rates, morbidity rates and the effects of hospital and surgeon volumes. Neurosurgery 2003 ; 52 : 1251-62.
10) Ohta M, Fujimaaki T, et al. Preoperative assessment of hemifacial spasm by the coronal heavily T2-weighted MR cisternography. Acta Neoruchir (Wien) 2014 ; 156 : 565-9.
P.598 掲載の参考文献
1) Servello D, Porta M, Sassi M, et al. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment : the surgery and stimulation. J Neurol Neurosurg Psychiatry 2008 ; 79 : 136-42.
2) Halpern CH, Wolf JA, Bale TL, et al. Deep brain stimulation in the treatment of obesity. J Neurosurg 2008 ; 109 : 625-34.
3) Hamani C, McAndrews MP, Cohn M, et al. Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol 2008 ; 63 : 119-23.
4) Gao G, Wang X, He S, et al. Clinical study for alleviating opiate drug psychological dependence by a method of ablating the nucleus accumbens with stereotactic surgery. Stereotact Funct Neurosurg 2003 ; 81 : 96-104.
5) Yamamoto T, Katayama Y. Deep brain stimulation therapy for the vegetative state. Neuropsychol Rehabil 2005 ; 15 : 406-13.
6) Schiff ND, Giacino JT, Kalmar K, et al. Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature 2007 ; 448 : 600-3.
7) Defer GL, Widner H, Marie RM, et al. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999 ; 14 : 572-84.
8) French Stimulation for Tardive Dyskinesia (STARDYS) Study Group : Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Arch Gen Psychiatry 2007 ; 64 : 170-6.
11) 深谷親, 山本隆充, 片山容一. 脳深部刺激療法のデバイスを知る・使う. 脳外誌 2010 ; 19 : 540-6.
14) Yamamoto T, Katayama Y, Hirayama T, et al. Pharmacological classification of central poststroke pain : comparison with the results of chronic motor cortex stimulation therapy. Pain 1997 ; 72 : 5-12.

[IX] 救急疾患

P.619 掲載の参考文献
1) 日本蘇生協議会監修. JRC蘇生ガイドライン 2015. 医学書院, 東京, 2016.
2) 野々木宏 監修. アメリカ心臓協会 心蘇生と救急心血管治療のためのガイドライン 2010 American Heart Association. シナジー, 東京, 2012.
3) 井上哲夫, 近江明文, 須崎紳一郎, 他. 緊急気道処置管理マニュアル. メディカル・サイエンス・インターナショナル, 東京, 2003.
4) 中川雅史, 上農喜朗. Difficult Airway Management-気道管理スキルアップ講座-. 克誠堂出版, 東京, 2010.
5) 清水敬樹. 救急・ICU画像診療マニュアル. 羊土社, 東京, 2007.
6) 森脇龍太郎, 中田一之. 必ずうまくなる! 中心静脈穿刺. 羊土社, 東京, 2007.
7) 柴垣有吾. CRRT. メディカル・サイエンス・インターナショナル, 東京, 2010.
8) 稲田英一. ICUブック 第4版. メディカル・サイエンス・インターナショナル, 東京, 2015.
9) 日本呼吸療法医学会, 人工呼吸中の鎮静ガイドライン作成委員会. 人工呼吸中の沈静のためのガイドライン. 人工呼吸 2008 ; 24 : 146-67.
10) Berg RD, Garling AW. Translocation of certain indigenous bacterial from the gastro-intestinal tract to mesenteric lymph nodes and other organs in a gnotobiotic mouse medel. Infect Immun 1979 ; 23 : 403-11.
11) Kaneko T, Kasaoka S, Nakahara T, et al. Effectiveness of lower target temperature therapeutic hypothermia in post-cardiac arrest syndrome patients with resuscitation interval of < 30min. J Intensive Care 2015 ; 3 : 28.
12) 重症頭部外傷治療・管理のガイドライン作成委員会 編. 重症頭部外傷治療・管理のガイドライン 第3版. 医学書院, 東京, 2013.
13) Hollenberg SG, Parrillo JE. Pharmacological circulatory support. In ; Barie PS, Shires GT eds. Surgical Intensive Care. Little Brown, Boston 1993.
14) Cremer OL, et al. Long-term Propofol infusion and cardiac failure in adult head-injury patients. Lancet 2001 ; 357 : 117-8.
P.637 掲載の参考文献
1) Siemieniuk RAC, Chu DK, et al. Oxygen therapy for acutely ill medical patients : a clinical practice guideline. BMJ 2018 ; 363 : k4169. doi : 10.1136/bmj.k4169.
2) 3学会合同ARDS診療ガイドライン 2016 作成委員会, 編. ARDS診療ガイドライン. 総合医学社, 東京, 2016.
3) 日本版敗血症診療ガイドライン 2016. 日本版敗血症診療ガイドライン 2016 作成特別委員会
4) Carney N, Totten AM, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017 ; 80 (1) : 6-15.
5) Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury. I. Blood pressure and oxygenation. J Neurotrauma 2007 ; 24 Suppl 1 : S7.
6) Diringer MN, Yundt K, Videen TO, et al. No reduction in cerebral metabolism as a result of early moderate hyperventilation following severe traumatic brain injury. J Neurosurg 2000 ; 92 : 7.
7) Stocchetti N, Maas AI, Chieregato A, et al. Hyperventilation in head injury : a review. Chest 2005 ; 127 : 1812.
8) Marion DW, Puccio A, Wisniewski SR, et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002 ; 30 : 2619.
9) Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury. XIV. Hyperventilation. J Neurotrauma 2007 ; 24 Suppl 1 : S87.
10) Boone MD, Jinadasa SP, Mueller A, et al. The Effect of Positive End-Expiratory Pressure on Intracranial Pressure and Cerebral Hemodynamics. Neurocrit Care 2017 ; 26 : 174.
11) Nemer SN, Caldeira JB, Santos RG, et al. Effects of positive end-expiratory pressure on brain tissue oxygen pressure of severe traumatic brain injury patients with acute respiratory distress syndrome : A pilot study. J Crit Care 2015 ; 30 : 1263.
12) Fletcher JJ, Wilson TJ, Rajajee V, et al. Changes in Therapeutic Intensity Level Following Airway Pressure Release Ventilation in Severe Traumatic Brain Injury. J Intensive Care Med 2018 ; 33 : 196.
13) Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke : experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998 ; 29 : 447.
14) Finlayson O, Kapral M, Hall R, et al. Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology 2011 ; 77 : 1338.
15) Ingeman A, Andersen G, Hundborg HH, et al. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke 2011 ; 42 : 3214.
16) Kim BR, Lee J, Sohn MK, et al. Risk Factors and Functional Impact of Medical Complications in Stroke. Ann Rehabil Med 2017 ; 41 : 753.
17) Hilker R, Poetter C, Findeisen N, et al. Nosocomial pneumonia after acute stroke : implications for neurological intensive care medicine. Stroke 2003 ; 34 : 975.
18) Dziewas R, Ritter M, Schilling M, et al. Pneumonia in acute stroke patients fed by nasogastric tube. J Neurol Neurosurg Psychiatry 2004 ; 75 : 852.
19) Silver FL, Norris JW, Lewis AJ, et al. Early mortality following stroke : a prospective review. Stroke 1984 ; 15 : 492.
20) Grau AJ, Buggle F, Schnitzler P, et al. Fever and infection early after ischemic stroke. J Neurol Sci 1999 ; 171 : 115.
21) North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch Neurol 1974 ; 31 : 338.
22) Bassetti C, Aldrich MS, Quint D. Sleep-disordered breathing in patients with acute supra- and infratentorial strokes. A prospective study of 39 patients. Stroke 1997 ; 28 : 1765.
23) Lee MC, Klassen AC, Resch JA. Respiratory pattern disturbances in ischemic cerebral vascular disease. Stroke 1974 ; 5 : 612.
24) Frank JI. Abnormal breathing patterns. In ; Hanley DF, Einhaupl KM, Bleck TP, et al, eds. Neurocritical Care. Springer-Verlag, Heidelberg, 1994, p366.
25) Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients : a metaanalysis. J Clin Sleep Med 2010 ; 6 : 131. 0
26) McMichan JC, Michel L, Westbrook PR. Pulmonary dysfunction following traumatic quadriplegia. Recognition, prevention, and treatment. JAMA 1980 ; 243 : 528.
27) Wicks AB, Menter RR. Long-term outlook in quadriplegic patients with initial ventilator dependency. Chest 1986 ; 90 : 406.
28) Mueller G, de Groot S, van der Woude L, et al. Time-courses of lung function and respiratory muscle pressure generating capacity after spinal cord injury : a prospective cohort study. J Rehabil Med 2008 ; 40 : 269.
29) Brown R, DiMarco AF, Hoit JD, et al. Respiratory dysfunction and management in spinal cord injury. Respir Care 2006 ; 51 : 853.
30) Derenne JP, Macklem PT, Roussos C. The respiratory muscles : mechanics, control, and pathophysiology. Am Rev Respir Dis 1978 ; 118 : 119.
31) Urmey W, Loring S, Mead J, et al. Upper and lower rib cage deformation during breathing in quadriplegics. J Appl Physiol (1985) 1986 ; 60 : 618.
32) McCool FD, Pichurko BM, Slutsky AS, et al. Changes in lung volume and rib cage configuration with abdominal binding in quadriplegia. J Appl Physiol (1985) 1986 ; 60 : 1198.
33) Scanlon PD, Loring SH, Pichurko BM, et al. Respiratory mechanics in acute quadriplegia. Lung and chest wall compliance and dimensional changes during respiratory maneuvers. Am Rev Respir Dis 1989 ; 139 : 615.
34) Schilero GJ, Grimm DR, Bauman WA, et al. Assessment of airway caliber and bronchodilator responsiveness in subjects with spinal cord injury. Chest 2005 ; 127 : 149.
35) Schilero GJ, Spungen AM, Bauman WA, et al. Pulmonary function and spinal cord injury. Respir Physiol Neurobiol 2009 ; 166 : 129.
36) Manning HL, Brown R, Scharf SM, et al. Ventilatory and P0.1 response to hypercapnia in quadriplegia. Respir Physiol 1992 ; 89 : w97.

[X] 症候

P.656 掲載の参考文献
1) Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010 ; 51 : 671-75.
2) Scheff er IE, Berkovic S, Capovilla G, et al. ILAE classification of the epile sies : Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017 ; 58 : 512-21.
3) Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy : Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017 ; 58 : 522-30.
4) Chen DK, So YT, Fisher RS. Use of serum prolactin in diagnosing epileptic seizures : report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005 ; 65 : 668-75.
6) Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke : a prospective multicenter study. Arch Neurol 2000 ; 57 : 1617-22.
7) Rathlev NK, Ulrich AS, Delanty N, et al. Alcoholrelated seizures. J Emerg Med 2006 ; 31 : 157-63.
8) Lempert T, Bauer M, Schmidt D. Syncope : a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 1994 ; 36 : 233-7.
9) Beghi E, Berg AT, Shinnar S, et al. Treatment of single and infrequent seizures In ; Engel JJ, Pedly TA, eds. Epilepsy, A Comprehensive Textbook (2nd Ed), Lippincott Williams & Wilkins, Philadelphia, 2008, p1327-34.
11) Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus? Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015 ; 56 : 1515-23.
12) 日本神経学会. てんかん治療ガイドライン 2018. 医学書院, 東京, 2018, p78.
13) Kubota M, Goishi K, Takemura S, et al. Early hemispherotomy in a patient with multilobar cortical dysplasia with intractable seizure : clinical-neurophysiological study. Eur J Paediatr Neurol 2008 ; 12 : 516-20.
14) Zimmermann LL, Martin RM, Girgis F. Treatment options for posttraumatic epilepsy. Curr Opin Neurol 2017 ; 30 (6) : 580-6.
15) Rumalla K, Smith KA, Letchuman V, et al. Nationwide incidence and risk factors for posttraumatic seizures in children with traumatic brain injury. J Neurosurg Pediatr 2018 ; 21 : 1-10. doi : 10.3171/2018.6.PEDS1813. [Epub ahead of print].
16) Huguenard AL, Miller BA, Sarda S, et al. Mild traumatic brain injury in children is associated with a low risk for posttraumatic seizures. J Neurosurg Pediatr 2016 ; 17 : 476-82.
17) Vaewpanich J, Reuter-Rice K. Continuous electroencephalography in pediatric traumatic brain injury : Seizure characteristics and outcomes. Epilepsy Behav 2016 ; 62 : 225-30.
18) Witsch J, Frey HP, Schmidt JM, et al. Electroencephalographic periodic & discharges and frequency-dependent brain tissue hypoxia in acute brain injury. JAMA Neurol 2017 ; 74 : 301-9.
19) Wilson CD, Burks JD, Rodgers RB, et al. Early and late posttraumatic epilepsy in the setting of traumatic brain injury : A meta-analysis and review of antiepileptic management. World Neurosurg 2018 ; 110 : e901-6.
20) Xu T, Yu X, Ou S, et al. Risk factors for posttraumatic epilepsy : A systematic review and meta-analysis. Epilepsy Behav 2017 ; 67 : 1-6.
21) Morgenstern L, Hemphill JC III, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke 2010 ; 41 : 2108-29.
22) Greenhalgh J, Weston J, Dundar Y, et al. Antiepileptic drugs as prophylaxis for postcraniotomy seizures. Cochrane Database of Systematic Reviews 2018, Issue 5.
23) Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter : anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 ; 54 : 1886-93.
24) Gilmore EJ, Maciel CB, Hirsch LJ, et al. Review of the utility of prophylactic anticonvulsant use in critically ill patients with intracerebral hemorrhage. Stroke 2016 ; 47 : 2666-72.
25) Naidech AM, Beaumont J, Jahromi B, et al. Evolving use of seizure medications after intracerebral hemorrhage. Neurology 2017 ; 88 : 52-6.
26) Shih JJ, Whitlock JB, Chimato N, et al. Epilepsy treatment in adults and adolescents : Expert opinion, 2016. Epilepsy Behav 2017 ; 69 : 186-222.
26) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989 ; 30 : 389-99.
27) 岡崎光俊. てんかんの症候群とは? 現在国際的に用いられている分類は? てんかん診療のクリニカルクエスチョン 194 (松浦雅人, 編). 診断と治療社, 東京, 2009, p10-3.
28) Commission on Classification and Terminology of the International League Against Epilepsy : Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981 ; 22 : 489-501.
29) 岡崎光俊. てんかん発作の種類は? てんかん症候群が特定できる発作型は? てんかん診療のクリニカルクエスチョン 194 (松浦雅人, 編). 診断と治療社, 東京, 2009, p8-10.
30) 山寺博史. 薬物惹起性けいれん発作とは? てんかん診療のクリニカルクエスチョン 194 (松浦雅人, 編). 診断と治療社, 東京, 2009, p149-50.
31) 井上有史, 川合謙介, 神山 潤, 他編. ILAEてんかん分類 : ILAE分類・用語委員会の公式声明. Epilepsia 日本語版 2017 ; 14 (2) : 3.
32) 井上有史, 川合謙介, 神山潤, 他編. 国際抗てんかん連盟によるてんかん発作型の操作的分類 : ILAE分類・用語委員会の公式声明. Epilepsia日本語版 2017 ; 14 (2) : 14.
33) Annegers JF, Hauser WA, Lee JR, et al. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia 1995 ; 36 : 327-33.
P.676 掲載の参考文献
1) 荒木信夫. 頭痛はなぜ起こるか. 神経 (厚東篤生, 他編). 医学書院, 東京, 1986, p242-53.
2) Dalessio, DJ, ed. Wolff's headache and other head pain. 4th ed, Oxford University Press, New York, 1980, p1-473.
3) Lance JW. Mechanism and management of headache, Butterworth-Heinemann Ltd, Oxford, 1993.
4) 荒木信夫, 福内靖男. 頭痛の分類. 内科 1998 ; 81 : 610-5.
5) Ad Hoc Committee on classification of headache. Classification of headache. J Amer Med Assoc 1962 ; 179 : 717-8.
6) 福内靖男, 飯国紀一郎, 坂井文彦, 他. 頭痛患者の診断と治療. 日内会誌 1993 ; 82 : 87-101.
7) 荒木信夫, 福内靖男. 片頭痛の病態. 日内会誌 1993 ; 82 : 19-23.
8) Headache Classification Committee of the International Headache Society : Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 ; 8 (Suppl 7) : 1-96.
9) 頭痛研究会. 頭痛, 頭蓋神経痛, 顔面痛の分類及び診断基準 (訳). 第18回頭痛研究会会誌 1991 ; 18 : 92-102.
11) 日本頭痛学会・国際頭痛分類委員会. 国際頭痛分類 第3版. 医学書院, 東京, 2018.
12) 日本神経学会・日本頭痛学会 編. 慢性頭痛の診療ガイドライン 2013. 医学書院, 東京, 2013.
13) Wilkinson M. Clinical features of migraine. In ; Cliford RF, ed. Handbook of Clinical Neurology 4 (48) : Headache, Elsevier Science Publishersn, Amsterdam, 1986, p117-33.
14) Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 ; 87 : 543-52.
15) De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003 ; 33 : 192-6.
16) Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005 ; 366 : 371-7.
17) Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981 ; 9 : 344-52.
18) Olesen J, Friberg L, Olsen T, et al. Timing and Topography of cerebral flow, aura and headache during migraine attacks. Ann Neurol 1990 ; 28 : 791-8.
21) Ferrari MD. Sumatriptan in the treatment of migraine. Neurology 1993 ; 43 (suppl 3) : S43-7.
22) Gotoh F, Komatsumoto S, Araki N, et al. Noradrenergic nervous activity in migraine. Arch Neurol 1984 ; 41 : 951-5.
25) Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994 ; 117 : 427-34.
26) Hardebo JE. How cluster headache is explained as an intracavernous inflammatory process lesioning sympathetic fibers. Headache 1994 ; 34 : 125-31.
27) Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other shortlasting headaches with autonomic feature, including new cases. Brain 1997 ; 120 : 193-209.
30) 荒木信夫. 緊張型頭痛の診断と治療. 日頭痛会誌 2011 ; 38 : 14-6.
31) 荒木信夫, 濱口勝彦. 筋緊張性頭痛の運動療法の実際. 臨床成人病 1999 ; 29 : 1041-6.
32) 荒木信夫, 福内靖男. 脳血管障害と頭痛. SCOPE 1995 ; 34 (10) : 20-1.
33) 亀山正邦, 山之内博. 脳血管障害と頭痛. 治療 1973 ; 55 : 1235-40.
34) 新妻博, 鈴木二郎. 脳血管障害による頭痛. Clinical Neuroscience 1983 ; 1 : 317-20.
35) Fisher CM. Headache in cerebrovascular disease. In ; Vinken PJ, et al, eds. Hnadbook of clinical neurology, Vol 5, North-Holland Publishing Co, 1968, p124.
36) 亀井博之, 西丸雄也. 脳梗塞に伴う頭痛についての検討. 脳卒中 1980 ; 2 : 345-9.
36) 亀井博之, 西丸雄也. 脳梗塞に伴う頭痛についての検討. 脳卒中 1980 ; 2 : 345-9.
37) 厚東篤生, 荒木信夫. 上矢状静脈洞血栓症. 神経内科 1987 ; 27 : 211-23.
38) 庄司紘史. 髄膜炎の頭痛. 日内会誌 1993 ; 82 : 66-9.
39) 高橋 昭. 頭痛患者の診かたと鑑別診断. 日内会誌 1993 ; 82 : 34-40.
P.686 掲載の参考文献
1) 太田富雄 編. 頭蓋内圧亢進と脳ヘルニア 意識障害. 脳神経外科学 第12版. 金芳堂, 京都, 2016.
2) 橋本信雄 編著. 頭蓋内圧亢進と脳ヘルニアの診断と治療. 脳神経外科臨床指針. 中外医学社, 東京, 2001, p10-5.
3) 日本脳神経外科学会 日本脳神経外傷学期 監修. 重症頭部外傷治療, 管理のガイドライン作成委員会 編集. 重症頭部外傷治療・管理のガイドライン 第3版. 医学書院, 東京, 2013, p35-89.
4) 厚生労働科学研究費補助金厚生労働科学特別研究事業. 「臓器提供施設における院内体制整備に関する研究」「脳死判定基準のマニュアル化に関する研究班」. 法的脳死判定マニュアル 平成22年度版.
5) 森 健太郎. 減圧開頭術. NS NOW No.8 脳神経外科基本手術 (新井一 編). メジカルビュー社, 東京, 2009, p81-92.
6) 日本脳卒中学会 脳卒中合同ガイドライン委員会 編. 脳卒中治療ガイドライン 2015. 協和企画, 東京, p66.
P.696 掲載の参考文献
1) Amano K, Kawamata T, Hori T, et al. Complications of transsphenoidal surgery. No Shinkei Geka 2012 ; 40 : 1119-29.
2) Ammirati M, Wei L, Ciric I. Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery : a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2013 ; 84 : 843-9.
3) Cinar C, Bozkaya H, Parildar M, et al. Endovascular management of vascular injury during transsphenoidal surgery. Interv Neuroradiol 2013 ; 19 : 102-9.
4) Fujitsu K, Ishiwata Y, Gondo G, et al. Wrapclipping with a Dacron mesh silastic sheet-Technical note-. J Neurosurg 1994 ; 80 : 336-7.
5) Hattori I, Iwasaki K, Horikawa F, et al. Treatment of a ruptured giant internal carotid artery pseudoaneurysm following transsphenoidal surgery : case report and literature review. No Shinkei Geka 2006 ; 34 : 1141-6.
6) 日暮雅一, 川原信隆, 小野敦史, 他. 未破裂前交通動脈瘤術中に緊急A3A3バイパスが必要となった症例-予期せぬ動脈損傷への対処法に関する考察-. 脳卒中の外科 2010 ; 38 : 48-51.
7) 石川達哉, 師井淳太, 玉川紀之, 他. 未破裂脳動脈瘤治療にかかわるさまざまなトラブルへの対処と回避方法. 脳卒中の外科 2009 ; 37 : 73-8.
8) Ishiwata Y, Inomori S, Fujitsu K, et al. A new intracranial silastic encircling clip for hemastasis. Technical note. J Neurosurg 1990 ; 73 : 638-9.
9) Ito Z. Microneurosurgery of cerebral aneuysms. Atlas by Entaro Ito, Niigata : Nishimura-Elsevier, 1985, p53-91.
10) Kubo Y, Ogasawara K, Tomitsuka N, et al. Wrapclipping with polytetrafluoroethylene for ruptured blisterlike aneurysms of the internal carotid artery. Technical note. J Neurosurg 2006 ; 105 : 785-7.
11) Laws ER. Complications of transsphenoidal surgery : the shortcomings of meta-analysis. J Neurol Neurosurg Psychiatry 2013 ; 84 : 829.
12) Matano F, Murai Y, Tateyama K, et al. Perioperative complications of superficial temporal artery to middle cerebral artery bypass for the treatment of complex middle cerebral artery aneurysms. Clin Neurol Neurosurg 2013 ; 115 : 718-24.
13) Murai Y, Adachi K, Takagi R, et al. Intraoperative Matas test using microscope-integrated intraoperative indocyanine green videoangiography with temporary unilateral occlusion of the A1 segment of the anterior cerebral artery. World Neurosurg 2011 ; 76 : 477.e7-10.
14) Okabe S, Sato A, Ito S, et al. Management of injury to the wall of a major cerebral artery. Surg Cereb Stroke (Jpn) 2006 ; 34 : 109-13.
15) 蘇慶展, 白根礼造. 手術・検査における私のちょっとした工夫 脳神経外科手術における局所止血剤サージセル (トロンビン液つけ) の使用経験および有効性. 脳外速報 2000 ; 10 : 809-10.
16) Suntd TM Jr, Nofzingger JD. Clip-grafts for aneurysm and small vessel surgery. Part 1 : Repair of segmental defects with clip-grafts ; laboratory studied and clinical correlations. Part 2 : Clinical application of clip-grafts to aneurysm ; technical considerations. J Neurosurg 1967 ; 27 : 477-89.
17) 谷川緑野, 杉村敏秀, 日野健, 他. 頭蓋内病変に対する血行再建. 脳卒中の外科 2005 ; 33 : 235-9.
18) 谷中清之, 岡崎匡雄, 鯨岡裕司, 他. 内頚動脈瘤手術時の動脈損傷の対処. 脳卒中の外科 2003 ; 31 : 24-8.
19) Yanaka K, Meguro K, Nose T. Repair of a tear at the base of a blister-like aneurysm with suturing and encircling clip. Technical note. Neurosurgery 2002 ; 50 : 218-21.
20) 渡辺伸一, 加藤庸子, 佐野公俊, 他. IC blister-like aneurysmに対する治療法. 脳卒中の外科 1997 ; 25 : 53-8.
P.707 掲載の参考文献
1) Crawford SC, Digre KB, Palmer CA, et al. Thrombosis of the deep venous drainage of brain in adults. Arch Neurol 1995 ; 52 : 1101-8.
2) Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991 ; 338 : 597-600.
3) Ferroli P, Acerbi F, Tringali G, et al. Venous sacrifice in neurosurgery : new insights from venous indocyanine green videoangiography. J Neurosurg 2011 ; 115 (1) : 18-23. doi : 10.3171/2011.3.JNS10620. Epub 2011 Apr 8.
4) Fries G, Perneczky A. Intraoperative obliteration of cerebral veins with special reference to the vein ob Labbe. In ; Hakuba A, ed. Surgery of the Intracranial Venous System, p299-303, Tokyo, Springer-Verlag, 1996.
5) Fries G, Wallenfang T, Hennen J, et al. Occlusion of the pig superior sagittal sinus, bridging and cortical veins : multistep evolution of sinus-vein thrombosis. J Neurosurg 1992 ; 77 : 127-33.
6) Fujimaki T, Kirino T. Coagulation of the petrosal vein for MVD. J Neurosurg 1999 ; 90 (6) : 1148.
7) Guppy KH, Origitano TC, Reichman OH, et al. Venous drainage of the inferolateral temporal lobe in relationship to transtemporal/transtentorial approaches to the cranial base. Neurosurgery 1997 ; 41 : 615-20.
8) Hakuba A, Huh CW, Tsujisawa S, et al. Total removal of a parasagittal meningioma of the posterior third of sagittal sinus and its repair by autologous vein graft. Case report. J Neurosurg 1979 ; 51 : 379-82.
9) Hanley DF, Feldman E, Borel CO, et al. Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension. Stroke 1998 ; 19 : 903-9.
10) Hongo K, Kobayashi S, Yokoh A, et al. Monitoring retraction pressure on the brain. An experimental and clinical study. J Neurosurg 1987 ; 66 : 270-5.
11) Kazumata K, Kamiyama H, Ishikawa T, et al. Operative anatomy and classification of the sylvian veins for the distal transsylvian approach. Neurol Med Chir (Tokyo) 2003 ; 43 (9) : 427-33 ; discussion 434.
12) Metz C, Holzchuh M, Bein T, et al. Moderate hupothermia in patients with severe head injury : cerebral and extracerebral effects. J Neurosurg 1996 ; 85 : 533-41.
13) Morita A, Sekhar LN. Reconstruction of Vein ob Labbe using Saphenous Vein Graft. J Neurosurg 1998 ; 89 : 671-5.
14) Ohnishi H, Nakase H, Watanabe Y, et al. Preservation of the vein of Labbe in the approach of skull-base lesion. In ; Hakuba A, ed. Surgery of the Intra-cranial Venous System, p386-392, Tokyo, Springer-Verlag, 1996.
15) Ohata K, Haque M, Morino M, et al. Occlusion of the sigmoid sinus after surgery via the presigmoidal-transpetrosal approach. J Neurosurg 1998 ; 89 (4) : 575-84.
16) Oka K, Rhoton AL Jr, Barry M, Rodriquez R. Microsurgical anatomy of superficial veins of the cerebrum. Neurosurgery 1985 ; 17 : 711-48.
17) Phillips MF, Bagley LJ, Sinson GP, et al. Endovas-cular thrombolysis for symptomatic cerebral venous thrombosis. J Neurosurg 1999 ; 90 : 65-71.
18) Rastogi P, wagle W, Popp AJ. Galenic Venous System thrombosis after colloid cyst surgery. In ; Hakuba A, ed. Surgery of the Intracranial Venous System, p330-7, Tokyo, Springer-Verlag, 1996.
19) Sakaki T, Morimoto T, Nakase H, et al. Dural arteriovenous fistula of the posterior fossa developing after surgical occlusion of the sigmoid sinus. Report of five cases. J Neurosurg 1996 ; 84 (1) : 113-8.
20) Schmid-Elsaesser R, Steiger HJ, Yousry T, et al. Radical resection of meningiomas and arteriovenous fistulas involving critical dural sinus segments : Experience with intraoperative sinus pressure monitoring and elective reconstruction in 10patients. Neurosurgery 1997 ; 41 : 1005-18.
21) Sekhar LN, Tzortzidis FN, Bejjani GK, et al. Saphenous vein graft bypass of the sigmoid sinus and jugular bulb during the removal of glomus jugulare tumors. Report of two case. J Neurosurg 1997 ; 86 : 1036-41.
22) Sekhar LN, Chanada A, Morita A. The preservation and reconstruction of cerebral veins and sinuses. J Clin Neurosci 2002 ; 9 (4) : 391-9.
23) Sindou M, Mercier P, Bokor J, et al. Bilateral thrombosis of the transverse sinuses : Microsurgical revascularization with venous bypass. Surg Neurol 1980 ; 13 : 215-20.
24) Spetzler RF, Daspit CP, Pappas CTE. The combined supra-and infratentorial approach for lesions of the petrous and clival regions : experience with 46 cases. J Neurosurg 1992 ; 76 : 588-99.
25) Sugita K, Kobayashi S, Yokoo A. Preservation of large bridging veins during brain retraction. Technical note. J Neurosurg 1982 ; 57 : 856-8.
26) Tsutsumi K, Shiokawa Y, Sasaki T, et al. Venous infarction following the interhemispheric approach in patients with acute subarachnoid hemorrhage. J Neurosurg 1991 ; 74 : 715-9.
27) Ueba T, Okawa M, Abe H, et al. Identification of venous sinus, tumor location, and pial supply during meningioma surgery by transdural indocyanine green videography. J Neurosurg 2013 ; 118 (3) : 632-6. doi : 10.3171/2012.11.JNS121113. Epub 2013 Jan 11.
28) Yokoo A, Sugita K, Kobayashi S. Intermittent versus continuous brain retraction. An experimental study. J Neurosurg 1983 ; 58 : 918-23.
P.717 掲載の参考文献
1) Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med 1982 ; 72 (2) : 339-53.
2) Robertson GL. The regulation of vasopressin function in health and disease. Recent Prog Horm Res 1976 ; 33 : 333-85.
3) 石倉透, 上田陽一. バゾプレシン分泌機構. ホルモンと臨床 2011 ; 59 (5) : 425-9.
4) 林松彦. 腎臓におけるバゾプレシン受容体. ホルモンと臨床 2011 ; 59 (5) : 439-43.
5) Saito T, Ishikawa S, Sasaki S, et al. Urinary excretion of aquaporin-2 in the diagnosis of central diabetes insipidus. J Clin Endocrinol Metab 1997 ; 82 (6) : 1823-7.
6) 佐々木成. 尿中アクアポリン2 の病態検査上の意義. 臨床検査 2013 ; 57 (6) : 637-41.
7) 鴨井久司. 高ナトリウム血症の鑑別診断. ホルモンと臨床 2011 ; 59 (5) : 451-5.
8) McKenna K, Thompson C. Osmoregulation in clinical disorders of thirst appreciation. Clin Endocrinol 1998 ; 49 (2) : 139-52.
9) 岩崎泰正. 中枢性尿崩症に関する最近の動向. ホルモンと臨床 2011 ; 59 (5) : 457-61.
10) Iwama S, Sugimura Y, Kiyota A, et al. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis. J Clin Endocrinol Metab 2015 ; 100 (7) : E946-54.
11) Capatina C, Paluzzi A, Mitchell R, et al. Diabetes Insipidus after Traumatic Brain Injury. J Clin Med 2015 ; 4 (7) : 1448-62.
12) Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am 1995 ; 24 (3) : 549-72.
13) Vande Walle J, Stockner M, Raes A, et al. Desmopressin 30 years in clinical use : a safety review. Curr Drug Saf 2007 ; 2 (3) : 232-8.
14) Cuesta M, Hannon MJ, Thompson CJ. Adipsic diabetes insipidus in adult patients. Pituitary 2017 ; 20 (3) : 372-380.
15) Hiyama TY, Matsuda S, Fujikawa A, et al. Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia. Neuron 2010 ; 66 (4) : 508-22.
16) Kataoka Y, Nishida S, Hirakawa A, et al. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus. Endocr J 2015 ; 62 (2) : 195-200.
17) 宮内隆政. 電解質・酸塩基平衡異常補正の輸液, ナトリウム代謝異常に対する補正の実際. 内科 2017 ; 120 (1) : 23-30.
18) Gross P, Reimann D, Neidel J, et al. The treatment of severe hyponatremia. Kidney Int Suppl 1998 ; 64 : S6-11.
19) Harrigan MR. Cerebral salt wasting syndrome : A review. Neurosurgery 1996 ; 38 (1) : 152-60.
20) 木村時久, 森建文, 佐畑貴之. SIADHの薬物療法. ホルモンと臨床 1997 ; 45 (4) : 341-7.
21) Maesaka JK, Imbriano LJ, Miyawaki N. High Prevalence of Renal Salt Wasting Without Cerebral Disease as Cause of Hyponatremia in General Medical Wards. Am J Med Sci 2018 ; 356 (1) : 15-22.
22) Cerda-Esteve M, Cuadrado-Godia E, Chillaron JJ, et al. Cerebral salt wasting syndrome : review. Eur J Intern Med 2008 ; 19 (4) : 249-54.
23) Maimaitili A, Maimaitili M, Rexidan A, et al. Pituitary hormone level changes and hypxonatremia in aneurysmal subarachnoid hemorrhage. Exp Ther Med 2013 ; 5 (6) : 1657-62.
24) Uozumi Y, Mizobe T, Miyamoto H, et al. Decreased serum sodium levels predict symptomatic vasospasm in patients with subarachnoid hemorrhage. J Clin Neurosci 2017 ; 46 : 118-123.
25) Kinoshita Y, Tominaga A, Arita K, et al. Postoperative hyponatremia in patients with pituitary adenoma : post-operative management with a uniform treatment protocol. Endocr J 2011 ; 58 (5) : 373-9.
26) Jahangiri A, Wagner J, Tran MT, et al. Factors predicting postoperative hyponatremia and efficacy of hyponatremia management strategies after more than 1000 pituitary operations. J Neurosurg 2013 ; 119 (6) : 1478-83.
27) Burke WT, Cote DJ, Iuliano SI, et al. A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery. Pituitary 2018 ; 21 (1) : 25-31.
28) Suzuki H, Sugimura Y, Iwama S, et al. Minocycline prevents osmotic demyelination syndrome by inhibiting the activation of microglia. J Am Soc Nephrol 2010 ; 21 (12) : 2090-8.
29) Katayama K, Tokuda Y. Mineralocorticoid responsive hyponatremia of the elderly : A systematic review. Medicine (Baltimore) 2017 ; 96 (27) : e7154.
30) Upala S, Sanguankeo A. Association Between Hyponatremia, Osteoporosis, and Fracture : A Systematic Review and Meta-analysis. J Clin Endocrinol Metab 2016 ; 101 (4) : 1880-6.
P.741 掲載の参考文献
1) 日本麻酔科学会 安全委員会. 悪性高熱症WG 作成「悪性高熱症患者の管理に関するガイドライン 2016」
1) Haemovigilance by JRCS. 日本赤十字社血液事業本部 技術部 安全管理課.
1) 日本血栓止血学会DIC診断基準 2017年版.
1) Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989 ; 50 : 18.
2) TRALI, TACO 鑑別診断のためのガイドライン. Japanese Journal of Transfusion and Cell Therapy Vol 61. No. 46 (14) : 474-9, 2015.
2) Levi M, Toh CH, Thachil J, et al. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009 ; 145 : 24.
2) Modi S, Dharaiya D, Schultz L, et al. Neuroleptic Malignant Syndrome : Complications, Outcomes, and Mortality. Neurocrit Care 2016 ; 24 : 97.
3) Siegal T, Seligsohn U, Aghai E, et al. Clinical and laboratory aspects of disseminated intravascular coagulation (DIC) : a study of 118 cases. Thromb Haemost 1978 ; 39 : 122.
3) TRALI/TACO. http://www.jrc.or.jp/mr/reaction/non_hemolytic/trali_taco/
3) Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985 ; 142 : 1137.
4) Steven Kleinman, Tim Caulfield et al. Toward an understanding of transfusion-related acute lung injury : statement of a consensus panel. TRANSFUSION 2004 ; 44 : 1774-89.
4) Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001 ; 86 : 1327.
4) Velamoor VR. Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Saf 1998 ; 19 : 73.
5) Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993 ; 77 : 185.
5) Gando S, Nanzaki S, Kemmotsu O. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma : application of clinical decision analysis. Ann Surg 1999 ; 229 : 121.
6) Selladurai BM, Vickneswaran M, Duraisamy S, Atan M. Coagulopathy in acute head injury -a study of its role as a prognostic indicator. Br J Neurosurg 1997 ; 11 : 398.
6) Silva RR, Munoz DM, Alpert M, et al. Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999 ; 38 : 187.
7) Fourrier F, Chopin C, Goudemand J, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992 ; 101 : 816.
7) Margetic B, Aukst-Margetic B. Neuroleptic malignant syndrome and its controversies. Pharmacoepidemiol Drug Saf 2010 ; 19 : 429.
8) Keck PE Jr, Pope HG Jr, Cohen BM, et al. Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry 1989 ; 46 : 914.
8) Toh CH, Alhamdi Y, Abrams ST. Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation. Ann Lab Med 2016 ; 36 : 505.
9) Chandran GJ, Mikler JR, Keegan DL. Neuroleptic malignant syndrome : case report and discussion. CMAJ 2003 ; 169 : 439.
9) Squizzato A, Hunt BJ, Kinasewitz GT, et al. Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost 2016 ; 115 : 896.
10) Stephan F, Hollande J, Richard O, et al. Thrombocytopenia in a surgical ICU. Chest 1999 ; 115 : 1363.
10) Strawn JR, Keck PE Jr, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007 ; 164 : 870.
11) Olson JD, Kaufman HH, Moake J, et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 1989 ; 24 : 825.
11) Seitz DP, Gill SS. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients : case reports and a review of the literature. Psychosomatics 2009 ; 50 : 8.
12) Kogoj A, Velikonja I. Olanzapine induced neuroleptic malignant syndrome-a case review. Hum Psychopharmacol 2003 ; 18 : 301.
12) Garcia-Avello A, Lorente JA, Cesar-Perez J, et al. Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma. Thromb Res 1998 ; 89 : 59.
13) Pope HG Jr, Aizley HG, Keck PE Jr, et al. Neuroleptic malignant syndrome : long- term follow-up of 20 cases. J Clin Psychiatry 1991 ; 52 : 208.
13) Yu M, Nardella A, Pechet L. Screening tests of disseminated intravascular coagulation : guidelines for rapid and specific laboratory diagnosis. Crit Care Med 2000 ; 28 : 1777.
14) Hermesh H, Aizenberg D, Weizman A, et al. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Br J Psychiatry 1992 ; 161 : 254.
14) Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol 2004 ; 124 : 567.
15) Bakhtiari K, Meijers JC, de Jonge E, et al. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004 ; 32 : 2416.
15) Berardi D, Amore M, Keck PE Jr, et al. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome : a case-control study. Biol Psychiatry 1998 ; 44 : 748.
16) Koch M, Chandragiri S, Rizvi S, et al. Catatonic signs in neuroleptic malignant syndrome. Compr Psychiatry 2000 ; 41 : 73.
16) Gando S, Iba T, Eguchi Y, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients : comparing current criteria. Crit Care Med 2006 ; 34 : 625.
17) Gando S, Saitoh D, Ogura H, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients : results of a multicenter, prospective survey. Crit Care Med 2008 ; 36 : 145.
17) Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth 2000 ; 85 : 129.
18) http://www.hematology.org/Clinicians/Guidelines-Quality/Quick-Ref/6976.aspx (Accessed on February 02, 2017).
18) Haddow AM, Harris D, Wilson M, et al. Clomipramine induced neuroleptic malignant syndrome and pyrexia of unknown origin. BMJ 2004 ; 329 : 1333.
19) Nimmagadda SR, Ryan DH, Atkin SL. Neuroleptic malignant syndrome after venlafaxine. Lancet 2000 ; 355 : 289.
21) Wu YF, Kan YS, Yang CH. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease- a case report. Gen Hosp Psychiatry 2011 ; 33 : 301.e7.
22) http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020667s030lbledt.pdf (Access ed on April 21, 2015).
23) Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005 ; 64 : 1162.
24) Boulant JA. Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000 ; 31 Suppl 5 : S157.
25) Henderson VW, Wooten GF. Neuroleptic malignant syndrome : a pathogenetic role for dopamine receptor blockade? Neurology 1981 ; 31 : 132.
26) Gurrera RJ. Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia? Clin Neuropharmacol 2002 ; 25 : 183.
27) Mihara K, Kondo T, Suzuki A, et al. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome. Am J Med Genet B Neuropsychiatr Genet 2003 ; 117B : 57.
28) Waldorf S. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome. AANA J 2003 ; 71 : 389.
29) Velamoor VR, Norman RM, Caroff SN, et al. Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994 ; 182 : 168.
30) Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry 1998 ; 44 : 499.
31) Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med 2003 ; 4 : 63.
32) Lejoyeux M, Fineyre F, Ades J. The serotonin syndrome. Am J Psychiatry 1992 ; 149 : 1410.
33) Gurrera RJ, Caroff SN, Cohen A, et al. An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method. J Clin Psychiatry 2011 ; 72 : 1222.
34) Tural U, Onder E. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death. Psychiatry Clin Neurosci 2010 ; 64 : 79.
36) Davis JM, Janicak PG, Sakkas P, et al. Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome. Convuls Ther 1991 ; 7 : 111.
37) Nakamura M, Yasunaga H, Miyata H, et al. Mortality of neuroleptic malignant syndrome induced by typical and atypical antipsychotic drugs : a propensity-matched analysis from the Japanese Diagnosis Procedure Combination database. J Clin Psychiatry 2012 ; 73 : 427.
P.753 掲載の参考文献
1) 矢津卓宏, 藤岡博文, 太田雅弘, 他. 術後肺血栓塞栓症の治療の検討. Ther Res 2000 ; 21 : 1113-4.
2) 安藤太三, 伊藤正明, 應儀成二, 他. 肺血栓塞栓症および深部静脈血栓症の診断・治療・予防に関するガイドライン (2009年改訂版). 日本循環器学会ホームページ http://www.j-circ.or.jp/guideline/index.htm オリジナル http://www.j-circ.or.jp/guideline/pdf/JCS2009_andoh_h.pdf ダイジェスト http://www.j-circ.or.jp/guideline/pdf/JCS2009_andoh_d.pdf
3) Goldhaber SZ. Pulmonary embolism. N Engl J Med 1998 ; 339 : 93-104.
4) Kumasaka N, Sakuma M, Shirato K. Incidence of pulmonary thromboembolism in Japan. Jpn Circ J 1999 ; 63 : S439-41.
5) Nakamura M, Fujioka H, Yamada N, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan : results of a multicenter registry in the Japanese society of pulmonary embolism research. Clin Cardiol 2001 ; 24 : 132-8.
6) 栗林幸夫. 肺血栓塞栓症の放射線診断の進歩. Ther Res 2000 ; 21 : 1148-55.
7) Timsit JF, Reynaud P, Meyer G, et al. Pulmonary embolectomy by catheter device in massive pulmonary embolism. Chest 1991 ; 100 : 655-8.
8) Skaf E, Beemath A, Siddiqui T, et al. Cathetertip embolectomy in the management of acute massive pulmonary embolism. Am J Cardiol 2007 ; 99 : 415-20.
9) Gray HH, Morgan JM, Paneth M, et al. Pulmonary embolectomy for acute massive pulmonary embolism. An analysis of 71 cases. Br Heart J 1988 ; 60 : 196-200.
10) Meyer G, Tamisier D, Sors H, et al. Pulmonary embolectomy. A 20-year experience at one center. Ann Thorac Surg 1991 ; 51 : 232-6.
11) 安藤太三, 田鎖治, 花房雄治, 他. 急性肺血栓塞栓症に対する人工心肺使用下血栓摘除術症例の検討. Ther Res 2000 ; 21 : 1131-3.
12) Ando M, Yamashita M, Sato M, et al. Surgical treatment for acute massive pulmonary thromboembolism in Japan. Venous Thromboembolism : Prevention and Treatment, K Shirato, Springer, 2004, p47-54.
13) 樗木等, 堺正仁, 赤塚裕, 他. 急性肺塞栓症に対する診断の工夫と治療方針. 静脈学 1995 ; 6 : 307-13.
14) 福田幾夫. 最近の急性肺血栓塞栓症の外科治療. メディカル・サイエンス・ダイジェスト 2007 ; 33 : 983-6.
P.766 掲載の参考文献
1) Johanson CE. Production and flow of cerebrospinal fluid. In ; Winn HR, ed. Youmans and Winn Neurological Surgery, 7th ed. Chap 29. Elsevier, Philadelphia, 2017, pp157-163.
2) 三浦真弘, 内野哲哉, 高橋明弘. 脳脊髄液に関する最近の知見. 脊椎脊髄 2015 ; 28 : 694-703.
3) 西山健一. 脳脊髄液動態に関する新しい概念. 臨床画像 2017 ; 33 : 1256-63.
4) Osborn AC, Hedlund CL. Hydrocephalus and CSF Disorders. In ; Osborn AG, ed. Osborn's Brain 2nd. ed, Chap 34, Elsevier Salt, Lake City, 2017, p1119-55.
5) Schalenbrand G. Ncuere Anschauungen zur pathophysiologie der Liquorzirkulation. Zentralbl Neurochir 1938 ; 3 : 290-300.
7) Chiapparini L, Farina L, D'Incerti L, et al. Spinal radiological findings in nine patients with spontaneous intracranial hypotension. Neuroradiology 2002 ; 44 : 143-50.
10) Headache Classification Committee of the International Headache Society (IHS) : The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018 ; 38 : 1-211.
11) 篠永正道, 鈴木伸一. 外傷性低髄液圧症候群 (髄液減少症) の診断と治療. 神経外傷 2003 ; 26 : 98-102.
13) Moriyama E, Terada H, Ishikawa S. Spinal cerebrospinal fluid leakage after motor vehicle accident-Two case reports. Neurol Med Chir (Tokyo). 2009 ; 49 : 306-9.
14) 佐藤慎哉, 嘉山孝正. 低髄液圧症候群, 脳脊髄液減少症, 脳脊髄液漏出症. 脳外誌 2013 ; 22 : 443-51.
15) 佐藤慎哉. 厚生労働省研究事業の総括. 脊椎脊髄 2016 ; 29 : 926-31.
17) 鹿戸将史, 守山英二, 細谷貴亮他. 脳脊髄液漏出症. 画像診断 2018 ; 38 : 325-31.
18) Moriyama E, Ogawa T, Nishida A, et al. Quantitative analysis of radioisotope cisternography in the diagnosis of intracranial hypotension. J Neurosurg 2004 ; 101 : 421-6.
19) 守山英二. 脳脊髄液減少症の診断と治療 (守山英二, 編著). 金芳堂, 京都, 2010.
20) 守山英二. 脳脊髄液漏出症診断の最前線. 神経外傷 2014 ; 37 : 7-17.
21) 守山英二. 脳脊髄液漏出症画像診断 : 治療成績からの検証. 神経外傷 2014 ; 37 : 96-104.
22) 守山英二. 脳脊髄液漏出症画像診断-理論と臨床. 脊椎脊髄 2016 ; 29 : 939-48.
23) 守山英二. 脳脊髄液漏出症の診断と管理. 神経外傷診療ガイドブック (三宅康史, 編集). メジカルビュー社, 東京, 2017.
24) Schievink WI, Louy C. Precipitating factors of spontaneous spinal CSF leak and intracranial hypotension. Neurology 2007 ; 69 : 700-2.
25) 友塚直人, 石川慎一, 他. 頚椎ねんざの慢性化因子および脳脊髄液減少症の割合の検討. ペインクリニック 2008 ; 29 : 1363-70.
26) Mea E, Chiapparini L, Savoiardo M. Application of IHS criteria to headache attributed to spontaneous intracranial hypotension in a large population. Cephalgia 2008 ; 29 : 418-22.
27) Mokri B. Spontaneous Cerebrospinal Fluid Leaks : From Intracranial Hypotension to Cerebrospinal Fluid Hypovolemia-Evolution of a Concept. Mayo Clin Proc 1999 ; 74 : 1113-23.
28) Hunderfund ANL, Mokri B. Orthostatic Headache with and without Cerebrospinal Fluid Leak : A Review. ENJ 2009 ; 1 : (1) www.slmoncology.com
29) 中川紀充, 小林修一. 小児・若年者の起立性頭痛と脳脊髄液減少症, 金芳堂, 京都, 2014.
30) 佐藤昌. 脳脊髄液減少症 : 臨床と診断. 臨床画像 2017 ; 33 : 1306-19.
31) 傳田定平. 脳脊髄液減少症 : 治療. 臨床画像 2017 ; 33 : 1320-30.
32) 柳下章. Duropathies-多様な類縁疾患-. 画像診断 2018 ; 38 : 313-24.
33) Sakurai K, MD, Kanoto M, Nakagawa M. Dinosaur tail sign : A useful spinal MRI finding indicative of cerebrospinal fluid leakage. Headache 2017 ; 57 : 917-25.
35) Turnbull1 DK, Shepherdl DB. Post-dural puncture headache : pathogenesis, prevention and treatment. British Journal of Anaesthesia 2003 ; 91 : 718-29.
36) Bezov D, Ashina S, Lipton R. Post-dural puncture headache : Part II-Prevention, management, and prognosis. Headache 2010 ; 50 : 1482-98.
37) Gormly JB. Treatment of post-spinal headache. Anesthesiology 1960 ; 21 : 565-6.
38) Ishikawa S, Yokoyama M, Mizobuchi S, et al. Epidural blood patch therapy for chronic whiplash associated disorder. Anesth Analg 2007 ; 105 : 809-14.
39) 石川慎一, 溝渕知司, 松山孝, 他. 硬膜外自家血注入治療の実際. 脊椎脊髄 2006 ; 19 : 278-85.
40) 石川慎一. VIII 硬膜下自家血注入. 脳脊髄液減少症の診断と治療 (守山英二, 編著). 金芳堂, 京都, 2010, p75-89.
42) 横須賀公彦, 松原俊二, 山口真司, 他. 救命しえなかった重症特発性低髄桜丘症候群の1例. 脳外誌 2012 ; 21 : 796-800.
43) 高橋浩一, 美馬達夫, 他. 慢性硬膜下血腫を合併した特発性低髄液圧症候群. 脊椎脊髄 2016 ; 29 : 949-56.
P.776 掲載の参考文献
1) Iseki C, Kawanami T, Nagasawa H, et al. Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly ; A prospective study in a Japanese population. J Neurol Sci 2009 ; 277 : 54-7.
2) Hashimoto M, Ishikawa M, Mori E, et al. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme : a prospective cohort study. Cerebrospinal Fluid Res 2010 ; 7 : 18.
3) Ishikawa M, Hashimoto M, Mori E, et al. The value of the cerebrospinal fluid tap test for predicting shunt effectiveness in idiopathic normal pressure hydrocephalus. Fluids Barriers CNS 2012 ; 9 : 1 doi : 10. 1186/2045-8118-9-1.
4) Kameda M, Yamada S, Atsuchi M, et al. Cost-effectivenessanalysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials. Acta Neurochir (Wien) 2017 ; 159 (6) : 995-1003.
5) Kawaguchi T, Hirata Y, Bundo M, et al. Role of computerized tomographic cisternography in idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 2011 ; 153 : 2041-8 ; discussion 2048. doi : 10.1007/s00701-011-1047-9. Epub 2011 May 25.
6) Kazui H, Mori E, Ohkawa S, et al. Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery. J Neurol Sci 2013 ; 328 : 64-9.
7) Kazui H, Miyajima M, Mori E, et al. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2) : an open-label randomised trial. Lancet Neurol 2015 ; 14 (6) : 585-94.
8) Klarica M, Oreskovic D, Bozic B, et al. New Experimental model of acute aqueductal blockage in cats : Effects on cerebrospinal fluid pressure and the size of brain ventricles. Neuroscience 2009 ; 158 : 1397-405.
9) Kubo Y, Kazui, Yoshida T, et al. Validation of grading scale for evaluating symptoms of idiopathic normal pressure hydrocephalus. Dementia Geriatr Cogn Disord 2008 ; 25 : 37-45.
10) Kuriyama N, Miyajima M, Nakajima M, et al. Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan : Epidemiological and clinical characteristics. Brain Behav 2017 ; 7 (3) : e00635.
11) Marmarou A, Bergsneideer M, Klinge P, et al. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal pressure hydrocephalus. Neurosurgery 2005 ; 57 : S17-28.
12) Miyake H, Kajimoto Y, Tsuji M, et al. Development of a quick reference table for setting programmable valves in patients with idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 2005 ; 48 : 427-37.
13) 石川正恒, 佐々木博信. iNPH診療における医療経済効果の検討. 脳21 2011 ; 14 : 154-8.
14) 「正常圧水頭症の疫学・病態と治療に関する研究」班. 特発性正常圧水頭症 (i-NPH) の地域連携パスと連携ノート. 平成22年度厚生労働科学研究費補助金難治性疾患克服事業 Ver.3, 2010, p1-32.
15) 日本正常圧水頭症研究会特発性正常圧水頭症診療ガイドライン作成委員会. 特発性正常圧水頭症診療ガイドライン. メディカルレビュー社, 大阪, 2004.
16) 日本正常圧水頭症研究会特発性正常圧水頭症診療ガイドライン作成委員会. 特発性正常圧水頭症診療ガイドライン 第2版. メディカルレビュー社, 大阪, 2011.

[XI] 検査・治療

P.787 掲載の参考文献
1) 杉生憲志. 脳脊髄血管撮影超実践マニュアル. メディカ出版, 大阪, 2015.
2) 日本アイソトープ協会. 国際放射線防護委員会の2007年勧告. ICRP Publ. 103, 2007.
3) Hankey GJ, Warlow CP, Sellar RJ. Cerebral angiographic risk in mild cerebrovascular disease. Stroke 1990 ; 21 : 209-22.
4) Heiserman JE, Dean BL, Hodak JA. Neurologic complications of cerebral angiography. AJNR Am J Neuroradiol 1994 ; 15 : 1401-7.
5) Kaufmann TJ, Huston J 3rd, Mandrekar JN, et al. Complications of diagnostic cerebral angiography : evaluation of 19,826 consecutive patients. Radiology 2007 ; 243 : 812-9.
6) 藤本俊一郎, 吉野公博. 経上腕動脈法脳血管撮影の基本. メディカ出版, 大阪, 2004.
7) Gonzalez LF, Albuquerque FC, McDougall C. Neurointerventional Techniques. Thieme, New York, 2014.
8) Morris PP. Practical Neuroangiography. 3rd ed. Lippincott Williams & Willkins, Philadelphia, 2013.
9) 勝間田篤, 杉生憲志, 佐々原渉, 他. 内頚動脈閉塞症の合併症-119例の経験から-. 脳外誌 2004 ; 13 : 572-7.
10) Date I. Symptomatic unruptured cerebral aneurysms : features and surgical outcome. Neurol Med Chir (Tokyo) 2010 ; 50 : 788-99.
P.796 掲載の参考文献
1) Adler JR Jr, Chang SD, Murphy MJ, et al. The Cyberknife : a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg 1997 ; 69 : 124-8.
2) Wowra B, Muacevic A, Tonn JC. Quality of radiosurgery for single brain metastases with respect to treatment technology : a matchedpair analysis. J Neurooncol 2009 ; 94 : 69-77.
3) Kuo CY, Tsai YC, Shiau AC, et al. Evaluation of Clinical Application and Dosimetric Comparison of Treatment Plans of Gamma Knife and CyberKnife in Treating Arteriovenous Malformations. Stereotact Funct Neurosurg 2017 ; 95 : 142-8.
4) Flickinger JC, Kondziolka D, Maitz AH, et al. Analysis of neurological sequelae from radiosurgery of arteriovenous malformations : how location affects outcome. Int J Radiat Oncol Biol Phys 1998 ; 40 : 273-8.
5) Timmerman RD. An overview of hypofractionation and introduction to this issue of Seminars in Radiation Oncology. Semin Radiat Oncol 2008 ; 18 : 215-22.
6) Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases : phase III results of the RTOG 9508 randomised trial. Lancet 2004 ; 363 : 1665-72.
7) Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases : a randomized controlled trial. JAMA 2006 ; 95 : 2483-91.
8) Davey P, O'Brien PF, Schwartz ML, et al. A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases. Br J Neurosurg 1994 ; 8 : 717-23.
9) Hasegawa T1, Kida Y, Kato T, Iizuka H, et al. Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg 2011 ; 115 : 1078-86.
10) Ishihara H, Saito K, Nishizaki T, et al. CyberKnife radiosurgery for vestibular schwannoma. Minim Invasive Neurosurg 2004 ; 47 : 290-3.
11) Shin M, Kurita H, Sasaki T et al. Stereotactic radiosurgery for pituitary adenoma invading the cavernous sinus. J Neurosurg 2000 ; 93 : 2-5.
12) Roberts BK, Ouyang DL, Lad SP, et al. Efficacy and safety of CyberKnife radiosurgery for acromegaly. Pituitary 2007 ; 10 : 19-25.
13) Pollock BE, Stafford SL, Link MJ, et al. Singlefraction radiosurgery for presumed intracranial meningiomas : efficacy and complications from a 22-year experience. Int J Radiat Oncol Biol Phys 2012 ; 83 : 1414-8.
14) Adler JR Jr, Gibbs IC, Puataweepong P, et al. Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 2008 ; 62 : 733-43.
15) Ogilvy CS, Stieg PE, Awad I, et al ; Special Writing Group of the Stroke Council, American Stroke Association. AHA Scientific Statement : Recommendations for the management of intracranial arteriovenous malformations : a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 2001 ; 32 : 1458-71.
17) Maruyama K, Kondziolka D, Niranjan A, et al. Stereotactic radiosurgery for brainstem arteriovenous malformations : factors affecting outcome. J Neurosurg 2004 ; 100 : 407-13.
19) Hasegawa T, McInerney J, Kondziolka D, et al. Long-term results after stereotactic radiosurgery for patients with cavernous malformations. Neurosurgery 2002 ; 50 : 1190-8.
20) Lee CC, Sheehan JP, Kano H, et al. Gamma Knife radiosurgery for hemangioma of the cavernous sinus. J Neurosurg 2017 ; 126 : 1498-505.
P.806 掲載の参考文献
1) Oka K, Yamamoto M, Ikeda K, et al. Flexible endoneurosurgical therapy for aqueductal stenosis. Neurosurgery 1993 ; 33 (2) : 236-42.
2) Kulkarni AV, Drake JM, Mallucci CL, et al. Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus. J Pediatr 2009 ; 155 (2) : 254-9.
3) Schroeder HW, Warzok RW, Assaf JA, et al. Fatal subarachnoid hemorrhage after endoscopic third ventriculostomy. Case report. J Neurosurg 1999 ; 90 (1) : 153-5.
4) Hayashi N, Murai H, Ishihara S, et al. Nationwide investigation of the current status of therapeutic neuroendoscopy for ventricular and paraventricular tumors in Japan. J Neurosurg 2011 ; 115 (6) : 1147-57.
5) Kinoshita Y, Yamasaki F, Tominaga A, et al. Pitfalls of Neuroendoscopic Biopsy of Intraventricular Germ Cell Tumors. World Neurosurg 2017 ; 106 : 430-4.
6) Hamada H, Hayashi N, Kurimoto M, et al. Neuroendoscopic septostomy for isolated lateral ventricle. Neurol Med Chir (Tokyo) 2003 ; 43 (12) : 582-7.
7) Oertel J, Linsler S, Csokonay A, et al. Management of severe intraoperative hemorrhage during intraventricular neuroendoscopic procedures : the dry field technique. J Neurosurg 2018 ; 1 : 1-9.
8) Horowitz M, Albright AL, Jungreis C, et al. Endovascular management of a basilar artery false aneurysm secondary to endoscopic third ventriculostomy : case report. Neurosurgery 2001 ; 49 (6) : 1461-4 ; discussion 1464-5.
9) Ibanez-Botella G, Segura M, De Miguel L, et al. Purely neuroendoscopic resection of intraventricular tumors with an endoscopic ultrasonic aspirator. Neurosurg Rev 2018 Jul 17.
10) Drake J, Chumas P, Kestle J, et al. Late rapid deterioration after endoscopic third ventriculostomy : additional cases and review of the literature. J Neurosurg 2006 ; 105 (2 Suppl) : 118-26.
P.815 掲載の参考文献
2) 渡辺英寿. 定位脳手術, CT/MRIガイド下手術. 脳神経外科 周術期管理のすべて 第3版 (松谷雅生, 田村晃, 編集). メジカルビュー社, 東京, 2009, p664-71.
3) 駒井則彦. 定位脳手術の歴史. 定位脳手術 (駒井則彦, 監修). 金芳堂, 京都, 1998, p127-40.
4) Ishibashi H, Simos PG, CastilloEM, et al. Detection and significance of focal, interictal, slow wave activity visualized by magnetoencephalography for localization of a primary epileptogenic region. J Neurosurg 2002 ; 96 : 724-30.
5) Valaki C, Maestu F, Simos PG, et al. Do different writing systems involve distinct profiles of brain activation? A magnetoencephalography study. J Neurolinguist 2003 ; 16 : 429-38.
6) Ishibashi H, Morioka T, Shigeto H, et al. Three-dimensional localization of subclinical ictal activity by magnetoencephalography : correlation with invasive monitoring. Surg Neurol 1998 ; 50 : 157-63.
7) 妹尾淳史. 脳機能画像解析の概要. SPM8 脳画像解析マニュアル (菊池吉晃, 妹尾淳史, 安保雅博, 他, 編). 医歯薬出版, 東京, 2012, p2-4.
8) Kunii N, Kamada K, Ota T, et al. A detailed analysis of functional magnetic resonance imaging in the frontal language area : a comparative study with extraoperative electrocortical stimulation. Neurosurgery 2011 ; 9 : 590-7.
9) 鎌田恭輔. DTI-based tractographyによる白質マッピングの脳神経外科手術への応用. 脳外誌 2009 ; 18 : 792-9.
10) Kamada K, Sawamura Y, Takeuchi F, et al. Expressive and receptive language areas determined by a non-invasive reliable method using functional magnetic resonance imaging and magnetoencephalography. Neurosurgery 2007 ; 60 : 296-306.
11) Mori S, van Zijl PC. Fiber tracking : principles and strategies- a technical review. NMR Biomed 2002 ; 15 : 468-80.
12) Masutani Y, Aoki S, Abe O, et al. MR diffusion tensor imaging : recent advance and new techniques for diffusion tensor visualization. Eur J Radiol 2003 ; 46 : 53-66.
13) Maruyama K, Koga T, Kamada K, et al. Arcuate fasciculus tractography integrated into Gamma Knife surgery. J Neurosurg 2009 ; 111 : 520-6.
14) Kamada K, Todo T, Ota T, et al. The motorevoked potential threshold evaluated by tractography and electrical stimulation. J Neurosurg 2009 ; 111 : 785-95.
15) Kamada K, Todo T, Masutani Y, et al. Visualization of the frontotemporal language fibers by tractography combined with functional magnetic resonance imaging and magnetoencephalography. J Neurosurg 2007 ; 106 : 90-8.
P.821 掲載の参考文献
1) Goto T, et al. Staple electrodes : an innovative alternative for intraoperative electrophysiological monitoring. J Neurosurg 2008 ; 108 : 816-9.
2) Horiuchi K, et al. Intraoperative monitoring of blood flow insufficiency during middle cerebral artery aneurysm surgery. J Neurosurg 2005 ; 103 : 275-83.
3) Sasaki T, et al. Intraoperative monitoring of visual evoked potential : introduction of a clinically useful method. J Neurosurg 2010 ; 112 : 273-84.
4) 佐々木達也, 他. 脳動脈瘤clipping術における術中視覚誘発電位モニタリング. 脳卒中の外科 2010 ; 38 : 403-8.
5) 佐々木達也, 西嶌美知春. 術中VEPモニタリングによる視機能の温存-VEPに変化をきたした手術手技の検討から-. No Shinkei Geka 2013 ; 41 : 961-76.
7) 鈴木恭一, 他. 運動誘発電位モニタリングを用いた脳動脈瘤手術. 脳卒中の外科 2006 ; 34 : 101-8.
P.832 掲載の参考文献
1) Baron JC, Bousser MG, Rey A, et al. Reversal of focal "misery-perfusion syndrome" by extraintracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke 1981 ; 12 : 454-9.
2) Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991 ; 29 : 231-40.
3) Vorstrup S, Engell HC, Lindewald H, et al. Hemodynamically significant stenosis of the internal carotid artery treated with endarterectomy. Case report. J Neurosurg 1984 ; 60 : 1070-5.
4) Kuroda S, Kamiyama H, Abe H, et al. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting longterm prognosis in patients with internal carotid artery occlusion. Neurosurgery 1993 ; 32 : 912-8 ; discussion 918-9.
5) Kuroda S, Houkin K, Kamiyama H, et al. Longterm prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion : can acetazolamide test predict it? Stroke 2001 ; 32 : 2110-6.
6) Kuroda S, Shiga T, Houkin K, et al. Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease. Stroke 2006 ; 37 : 393-8.
7) Kuroda S, Shiga T, Ishikawa T, et al. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases. J Nucl Med 2004 ; 45 : 943-9.
8) Ogasawara K, Tomitsuka N, Kobayashi M, et al. Stevens-Johnson syndrome associated with intravenous acetazolamide administration for evaluation of cerebrovascular reactivity. Case report. Neurol Med Chir (Tokyo) 2006 ; 46 : 161-3.
9) Yamauchi H, Fukuyama H, Nagahama Y, et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med 1999 ; 40 : 1992-8.
10) Grubb RL Jr, Derdeyn CP, Fritsch SM, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998 ; 280 : 1055-60.
11) Ogasawara K, Ogawa A, Terasaki K, et al. Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome : comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography. J Cereb Blood Flow Metab 2002 ; 22 : 1142-8.
12) Hokari M, Kuroda S, Shiga T, et al. Impact of oxygen extraction fraction on long-term prognosis in patients with reduced blood flow and vasoreactivity because of occlusive carotid artery disease. Surg Neurol 2009 ; 71 : 532-9.
13) Hokari M, Kuroda S, Shiga T, et al. Combination of a mean transit time measurement with an acetazolamide test increases predictive power to identify elevated oxygen extraction fraction in occlusive carotid artery diseases. J Nucl Med 2008 ; 49 : 1922-7.
14) Chida K, Ogasawara K, Kuroda H, et al. Centralbenzodiazepine receptor binding potential and CBF images on SPECT correlate with oxygen extraction fraction images on PET in the cerebral cortex with unilateral major cerebral artery occlusive disease. J Nucl Med 2011 ; 52 : 511-8.
15) EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. New Engl J Med 1985 ; 313 : 1191-200.
16) 脳血行再建術の効果に関する共同研究グループ. 閉塞性脳血管障害に対する脳血行再建術の効果-多施設共同研究の成績-. 脳卒中 1997 ; 19 : 217-24.
17) 小笠原邦昭. 脳主幹動脈閉塞性病変慢性期に対するバイパス術後過灌流症候群. 脳外誌 2008 ; 17 : 596-600.
18) Powers WJ, Clarke WR, Grubb RL Jr, et al. Extracranial-intracranial bypass surgery forstroke prevention in hemodynamic cerebral ischemia : the Carotid Occlusion Surgery Study randomized trial. JAMA 2011 ; 306 : 1983-92.
19) Uchino H, Kuroda S, Hirata K, et al. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease : a serial single photon emission CT/positron emission tomography study. Stroke 2012 ; 43 : 2610-6.
20) Kaku Y, Iihara K, Nakajima N, et al. Cerebral blood flow and metabolism of hyperperfusion after cerebral revascularization in patients with moyamoya disease. J Cereb Blood Flow Metab 2012 ; 32 : 2066-75.
21) Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting : risk factors, prevention, and treatment. J Am Coll Cardiol 2004 ; 43 : 1596-601.
23) Kuroda S, Kamiyama H, Abe H, et al. Temporary neurological deterioration caused by hyperperfusion after extracranial-intracranial bypass-case report and study of cerebral hemodynamics. Neurol Med Chir (Tokyo) 1994 ; 34 : 15-9.
24) Kuroda S, Houkin K, Abe H, et al. Near-infrared monitoring of cerebral oxygenation state during carotid endarterectomy. Surg Neurol 1996 ; 45 : 450-8.
25) Kuroda S, Houkin K, Abe H, et al. Cerebral hemodynamic changes during carotid artery balloon occlusion monitored by near-infrared spectroscopy. Neurol Med Chir (Tokyo) 1996 ; 36 : 78-86.
26) Uchino H, Nakamura T, Kuroda S, et al. Intraoperative dual monitoring during carotid endarterectomy using motor evoked potentials and near-infrared spectroscopy. World Neurosurg 2012 ; 78 : 651-57.
27) Kashiwazaki D, Kuroda S, Terasaka S, et al. Detection of hemodynamic transient ischemic attack during hemodialysis with near-infrared monitoring in a patient with internal carotid artery occlusion. Surg Neurol 2007 ; 68 : 292-4 ; discussion 294-5.
P.850 掲載の参考文献
1) 今井 裕, 山下智祐. 画像診断の過去・現在・未来-MRI領域. 日獨医報 2005 ; 50 : 40-51.
2) http://www.jira-net.or.jp/vm/chronology_mri_01.html
3) Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke : correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990 ; 11 : 423-9.
4) Warntjes JB, Leinhard OD, West J, et al. Rapid magnetic resonance quantification on the brain : Optimization for clinical usage. Magn Reson Med 2008 ; 60 : 320-9.
5) Kangarlu, A, Robitaille, PML. Biological effects and health implications in magnetic resonance imaging. Concepts in Magnetic Resonance, 2000 ; 5 : 321-59.
6) Young GS. Advanced MRI of adult brain tumors. Neurol Clin 2007 ; 25 : 947-73, viii.
7) Rydberg JN, Hammond CA, Huston J 3rd, et al. T1-weighted MR imaging of the brain using a fast inversion recovery pulse sequence. J Magn Reson Imaging 1996 ; 6 : 356-62.
8) Yoshino M, Kin T, Ito A, et al. Feasibility of diffusion tensor tractography for preoperative prediction of the location of the facial and vestibulocochlear nerves in relation to vestibular schwannoma. Acta Neurochir (Wien) 2015 ; 157 : 939-46.
9) Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network : anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008 ; 1124 : 1-38.
10) https://www.radiologyinfo.org/en/info.cfm?pg=safety-mri-pregnancy
11) https://www.nhs.uk/conditions/mri-scan/whocan-have-it/
12) http://www.esur-cm.org/index.php/en/
13) 対馬義人. ガドリニウム造影剤安全性情報UP TO DATE. 日本小児放射線学会雑誌 2017 ; 33 : 91-6.
14) Kanda T, Ishii K, Kawaguchi H, et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images : relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014 ; 270 : 834-41.
15) McDonald RJ, McDonald JS, Kallmes DF, et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology 2015 ; 275 : 772-82.
16) Kanda T, Fukusato T, Matsuda M, et al. Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction : Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. Radiology 2015 ; 276 : 228-32.
17) Khant ZA, Hirai T, Kadota Y, et al. T1 Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents. Magn Reson Med Sci 2017 ; 16 : 84-6.
18) Kanda T, Osawa M, Oba H, et al. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images : Association with Linear versus Macrocyclic Gadolinium Chelate Administration. Radiology 2015 ; 275 : 803-9.
P.858 掲載の参考文献
1) Shellock FG, et al. Aneurysm clips : Evaluation of magnetic field interaction and translational attraction by use of "long-bore" and "shortbore" 3.0-T MR imaging systems. AJNR Am J Nueroragdiol 2003 ; 24 : 463-71.
2) Watanabe A, et al. Investigation of Radiofrequencyinduced temperature elevation of aneurysm clip in a 3.0-tesla magnetic resonance environment. Neurosurgery 2007 ; 61 : 1062-6.
3) Kangarlu A, et al. Aneurysm clips : evaluation of magnetic field interaction with an 8.0 T MR system. J Magn Reson Imaging 2000 ; 12 : 107-11.
4) 宮地利明. MRIの安全性. 日放技学誌 2003 ; 59 : 1508-16.
5) Pinto A, et al. Role of computed tomography in the assessment of intraorbital foreign bodies. Semin Ultrasound CT MR 2012 ; 33 : 392-5.
6) 卸DI実例集 第353回Question No.1563. MRI検査時にはがさなければならない貼付剤にはどのような薬剤があるのか? 月刊卸薬業 2012 ; 57 : 47-8.
7) Zebramski JM, et al. 3T magnetic resonance imaging testing of externally programmable shunt valves. Surg Neurol Int 2012 ; 3 : 81.
8) Inoue T, et al. Effect of 3-tesla magnetic resonance imaging on various programmable shunt valves. J Neurosurg 2005 ; 103 : 163-5.
9) 磁性アタッチメントとMRI (日本磁気歯科学会安全基準検討委員会, 監修). 日磁歯誌 2012 ; 21 : 1-15.
10) 日本医学放射線学会, 日本磁気共鳴医学会, 日本不整脈学会. MRI対応植込み型不整脈治療デバイス患者のMRI検査の施設基準. 2014.
11) 川光秀昭, 他. 3T-MR装置の安全性. 日本医放会誌 2008 ; 64 : 1575-99.
12) 畑雄一. MRIの安全性-体内埋め込み装置あるいは金属について. 日磁医誌 1999 ; 19 : 303-10.
13) 引地健生. MRI検査における安全管理-事故事例の検討-. 日職災医誌 52 ; 257-264, 2004

最近チェックした商品履歴

Loading...